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Professor Tobias Ritter Theresa Liang 
 
SILVER-MEDIATED TRIFLUOROMETHOXYLATION OF ARYL 
NUCLEOPHILES AND SYNTHESIS OF 3-DEOXY-3-FLUOROMORPHINE 
 
Abstract 
 
Fluorine incorporation has become increasingly important in pharmaceutical applications.  Upon fluorination and 
incorporation of fluorinated moieties such as trifluoromethoxy groups, many small molecules become more 
bioavailable and metabolically stable and additionally can better cross the blood-brain-barrier.  This thesis describes 
the development of a method mediated by silver salts for the synthesis of pharmaceutical-like trifluoromethoxylated 
compounds via C±OCF3 bond formation.  Additionally, the synthesis of 3-deoxy-3-fluoromorphine via late-stage 
fluorination of morphine is described as well as in vitro and in vivo evaluation of 3-deoxy-3-fluoromorphine as a 
potential analgesic. 
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Isaiah 43:1-7 (NI V) 
1 But now, this is what the Lord says² 
he who created you, Jacob, 
he who formed you, Israel: 
³'RQRWIHDUIRU,KDYHUHGHHPHG\RX 
I have summoned you by name; you are mine. 
2 When you pass through the waters, 
I will be with you;  
and when you pass through the rivers, 
they will not sweep over you. 
When you walk through the fire, 
you will not be burned; 
the flames will not set you ablaze.  
3 For I am the Lord your God, 
the Holy One of Israel, your Savior; 
I give Egypt for your ransom, 
Cush and Seba in your stead.  
4 Since you are precious and honored in my sight, 
and because I love you, 
I will give people in exchange for you, 
nations in exchange for your life. 
5 Do not be afraid, for I am with you;  
I will bring your children from the east 
and gather you from the west.  
6 ,ZLOOVD\WRWKHQRUWKµ*LYHWKHPXS¶ 
DQGWRWKHVRXWKµ'RQRWKROGWKHPEDFN¶ 
Bring my sons from afar 
and my daughters from the ends of the earth² 
7 everyone who is called by my name, 
whom I created for my glory, 
ZKRP,IRUPHGDQGPDGH´ 
  
xvii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F or my Redeeme r , foreve r my f i rst Love  
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1. Introduction 
1.1. Importance of fluorine incorporation 
Pharmaceuticals,1 agrochemicals,2 new materials3 such as electronic/optoelectronic materials (electroluminescent 
diodes or liquid crystals),3a±d polymers (Teflon or elastomers), 3e±h and metal-organic frameworks, 3d as well as 
positron emission tomography4 have benefited from fluorine incorporation. Over the past thirty years; the number of 
fluorinated pharmaceuticals has grown to 20% of all developed drugs1f while fluorinated agrochemicals1e consist of 
up to 30% of all agrochemicals developed, compared to 4% in the late 1970s.2b 
 
F igure 1. Selected fluorinated brand-name drugs and their ranking by retail sales in the United States for 20105 
                                                          
1  (a) Bohm, H. J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Muller, K.; Obst-Sander, U.; Stahl, M. 
ChemBioChem 2004, 5, 637. (b) Kirk, K. L. Curr. Top. Med. Chem. 2006, 6, 1445. (c) Kirk, K. L. Curr. Top. Med. 
Chem. 2006, 6, 1447. (d) Begue, J.-P.; Bonnet-Delpon, D. J. F luorine Chem. 2006, 127, 992. (e) Isanbor, C.; 
2¶+DJDQ'J. F luorine Chem. 2006, 127, 303. (f) Muller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881. (g) 
Hagmann, W. K. J. Med. Chem. 2008, 51, 4359. (h) O'Hagan, D. Chem. Soc. Rev. 2008, 37, 308. (i) Purser, S.; 
Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37, 320. (k) Ismail, F. M. D. J. F luorine Chem. 
2002, 118, 27. 
2 (a) Jeschke, P. ChemBioChem 2004, 5, 570.(b) Maienfisch, P.; Hall, R. G. Chimia 2004, 58, 93. (c) Jeschke, P. 
ChemBioChem 2004, 5, 570. 
3 (a) Guittard, F.; de Givenchy, E. T.; Geribaldi, S.; Cambon, A. J. F luorine Chem. 1999, 100, 85. (b) Babudri, F.; 
Farinola, G. M.; Naso, F.; Ragni, R. Chem. Commun. 2007,  1003. (c) Cametti, M.; Crousse, B.; Metrangolo, P.; 
Milani, R.; Resnati, G. Chem. Soc. Rev. 2012, 41, 31. (d) Berger, R.; Resnati, G.; Metrangolo, P.; Weber, E.; 
Hulliger, J. Chem. Soc. Rev. 2011, 40, 3496. (e) Kassis, C. M.; Steehler, J. K.; Betts, D. E.; Guan, Z. B.; Romack, T. 
J.; DeSimone, J. M.; Linton, R. W. Macromolecules 1996, 29, 3247. (f) Dhara, M. G.; Banerjee, S. Prog. Polym. 
Sci. 2010, 35, 1022. (g) Schloegl, S.; Kramer, R.; Lenko, D.; Schroettner, H.; Schaller, R.; Holzner, A.; Kern, W. 
Eur. Polym. J. 2011, 47, 2321. (h) Anton, D. Adv. Mater. 1998, 10, 1197. 
4 (a) Phelps, M. E. Proc. Natl. Acad. Sci. USA 2000, 97, 9226. (b) Bolton, R. J. Labelled Compd. Radiopharm. 2002, 
45, 485. (c) Ametamey, S. M.; Honer, M.; Schubiger, P. A. Chem. Rev. 2008, 108, 1501. (d) Cai, L.; Lu, S.; Pike, V. 
W. Eur. J. Org. Chem. 2008,  2853. (e) Miller, P. W.; Long, N. J.; Vilar, R.; Gee, A. D. Angew. Chem. Int. Ed. 2008, 
47, 8998. (f) Littich, R.; Scott, P. J. H. Angew. Chem. Int. Ed. 2012, 51, 1106. 
5 Ranking taken from: http://cbc.arizona.edu/njardarson/group/top-pharmaceuticals-poster (downloaded 07/18/2012) 
2 
 
1.1.1. F luorine incorporation for medicinal chemistry applications 
Fluorine can provide many beneficial properties when incorporated into a molecule.  As the most electronegative 
element of the periodic table, fluorine can increase the Brønsted acidity of nearby functional groups thereby 
allowing for the modulation of the pKaH of the functional group.1f,6 This is especially useful in medicinal chemistry 
to attenuate the basicity of amines or other basic residues that can hinder membrane penetration due to protonation 
at physiological pH.7 Upon fluorine incorporation, arenes are reported to show increased lipophilicity,6,8 which has 
been advantageously used in drug development.1a,c,d,f,g,i Fluorination and incorporation of fluorinated moieties such 
as ±CF3, ±OCF3, and ±SCF3 groups typically lead to increased bioavailability and blood-brain-barrier penetrability.9 
Additionally, the high electronegativity of fluorine contributes to the polar nature of carbon±fluorine bonds and the 
interaction of the bond with hydrogen bond donors10 (the existence of a genuine hydrogen bond with the fluorinated 
moiety in molecules is under debate), 11  other fluorinated compounds, 12 ,3c,d,h polar functional groups such as 
carbonyls,13 and hydrophobic moieties.1 The polar nature of the carbon±fluorine bond additionally contributes to its 
                                                          
6 Smart, B. E. J. F luorine Chem. 2001, 109, 3. 
7 (a) van Niel, M. B.; Collins, I.; Beer, M. S.; Broughton, H. B.; Cheng, S. K. F.; Goodacre, S. C.; Heald, A.; 
Locker, K. L.; MacLeod, A. M.; Morrison, D.; Moyes, C. R.; O'Connor, D.; Pike, A.; Rowley, M.; Russell, M. G. 
N.; Sohal, B.; Stanton, J. A.; Thomas, S.; Verrier, H.; Watt, A. P.; Castro, J. L. J. Med. Chem. 1999, 42, 2087. (b) 
Morgenthaler, M.; Schweizer, E.; Hoffmann-Roeder, A.; Benini, F.; Martin, R. E.; Jaeschke, G.; Wagner, B.; 
Fischer, H.; Bendels, S.; Zimmerli, D.; Schneider, J.; Diederich, F.; Kansy, M.; Mueller, K. ChemMedChem 2007, 2, 
1100. 
8 (a) Leo, A.; Hansch, C.; Elkins, D. Chem. Rev. 1971, 71, 525. (b) Hansch, C.; Leo, A.; Unger, S. H.; Kim, K. H.; 
Nikaitan.D; Lien, E. J. J. Med. Chem. 1973, 16, 1207. (c) Hansch, C.; Rockwell, S. D.; Jow, P. Y. C.; Leo, A.; 
Steller, E. E. J. Med. Chem. 1977, 20, 304. (d) Hansch, C.; Leo, A.; Taft, R. W. Chem. Rev. 1991, 91, 165. 
9 Sun, S.; Adejare, A. Curr. Top. Med. Chem. 2006, 6, 1457. 
10 (a) Abraham, R. J.; Smith, T. A. D.; Thomas, W. A. J. Chem. Soc., Perkin Trans. 2 1996,  1949. (b) Lahmani, F.; 
Zehnacker, A.; Denisov, G.; Furin, G. G. J. Phys. Chem. 1996, 100, 8633. (c) Evans, T. A.; Seddon, K. R. Chem. 
Commun. 1997,  2023. (d) Pham, M.; Gdaniec, M.; Polonski, T. J. Org. Chem. 1998, 63, 3731. 
11 (a) Schneider, H. J. Chem. Sci. 2012, 3, 1381. (b) Dunitz, J. D. ChemBioChem 2004, 5, 614. 
12 Berkessel, A.; Adrio, J. A.; Huettenhain, D.; Neudorfl, J. M. J. Am. Chem. Soc. 2006, 128, 8421. 
13 (a) Olsen, J. A.; Banner, D. W.; Seiler, P.; Sander, U. O.; D'Arcy, A.; Stihle, M.; Muller, K.; Diederich, F. Angew. 
Chem. Int. Ed. 2003, 42, 2507. (b) Hof, F.; Scofield, D. M.; Schweizer, W. B.; Diederich, F. Angew. Chem. Int. Ed. 
2004, 43, 5056. (c) Olsen, J.; Seiler, P.; Wagner, B.; Fischer, H.; Tschopp, T.; Obst-Sander, U.; Banner, D. W.; 
Kansy, M.; Muller, K.; Diederich, F. Org. Biomol. Chem. 2004, 2, 1339. (d) Olsen, J. A.; Banner, D. W.; Seiler, P.; 
Wagner, B.; Tschopp, T.; Obst-Sander, U.; Kansy, M.; Muller, K.; Diederich, F. ChemBioChem 2004, 5, 666. (e) 
Paulini, R.; Muller, K.; Diederich, F. Angew. Chem. Int. Ed. 2005, 44, 1788. 
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bond strength1h,14 making carbon±fluorine bonds difficult to fragment.  Most fluorinated compounds, but not all,15 
exhibit increased metabolic stability by impedance of undesired oxidative metabolism pathways.16  
Although fluorine is often used as an isostere for hydrogen in medical chemistry, the van der Waals radius of 
fluorine is more similar to oxygen (1.47 Å versus 1.52 Å for oxygen and 1.20 Å for hydrogen).17 Exploiting the 
steric likeness of oxygen and fluorine, alkenyl fluorides have been investigated as isosteres for amide bonds in 
peptides.18 Fluorine incorporation has been shown to increase binding affinity to target systems19 probably due to 
advantageous polar interactions;20 however, in many cases this phenomenon is empirically observed and rationalized 
ex post facto and cannot be predicted or designed a priori.  Additionally, fluorinated compounds can be strategically 
used as transition state inhibitors (i.e inhibitors that react with the target system and are trapped as the covalently 
linked inhibitor±target complex), which advantageously use the fluorinated moiety to halt further reactivity in the 
                                                          
14 Peters, D. J. Chem. Phys. 1963, 38, 561. 
15 For examples in which fluorination does not increase metabolic stability, please see: (a) Kaufman, S. Biochim. 
Biophys. Acta 1961, 51, 619. (b) Guroff, G.; Daly, J. W.; Jerina, D. M.; Renson, J.; Witkop, B.; Udenfrie.S Science 
1967, 157, 1524. 
16 (a) Barnette, W. E. Crit. Rev. Biochem. 1984, 15, 201. (b) Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, 
J. S.; Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.; Miyashiro, J. M.; Rogers, R. S.; Rogier, 
D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.; Cogburn, J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.; 
Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P. C. J. Med. Chem. 1997, 40, 1347. (c) VanHeek, M.; 
France, C. F.; Compton, D. S.; McLeod, R. L.; Yumibe, N. P.; Alton, K. B.; Sybertz, E. J.; Davis, H. R. J. 
Pharmacol. Exp. Ther. 1997, 283, 157. (d) Clader, J. W. J. Med. Chem. 2004, 47, 1. 
17 Bondi, A. J. Phys. Chem. 1964, 68, 441. 
18 Bartlett, P. A.; Otake, A. J. Org. Chem. 1995, 60, 3107. 
19 (a) Piepenbrink, K. H.; Borbulevych, O. Y.; Sommese, R. F.; Clemens, J.; Armstrong, K. M.; Desmond, C.; Do, 
P.; Baker, B. M. Biochem. J 2009, 423, 353. (b) Burke, T. R.; Ye, B.; Yan, X. J.; Wang, S. M.; Jia, Z. C.; Chen, L.; 
Zhang, Z. Y.; Barford, D. Biochemistry 1996, 35, 15989. (c) DerHovanessian, A.; Doyon, J. B.; Jain, A.; Rablen, P. 
R.; Sapse, A. M. Org. Lett. 1999, 1, 1359. (d) Doyon, J. B.; Jain, A. Org. Lett. 1999, 1, 183. (e) Kim, C. Y.; Chang, 
J. S.; Doyon, J. B.; Baird, T. T.; Fierke, C. A.; Jain, A.; Christianson, D. W. J. Am. Chem. Soc. 2000, 122, 12125. (f) 
Kim, C. Y.; Chandra, P. P.; Jain, A.; Christianson, D. W. J. Am. Chem. Soc. 2001, 123, 9620. (g) Abbate, F.; Casini, 
A.; Scozzafava, A.; Supuran, C. T. J. Enzyme Inhib. Med. Chem. 2003, 18, 303. (h) Chou, Y. L.; Davey, D. D.; 
Eagen, K. A.; Griedel, B. D.; Karanjawala, R.; Phillips, G. B.; Sacchi, K. L.; Shaw, K. J.; Wu, S. C.; Lentz, D.; 
Liang, A. M.; Trinh, L.; Morrissey, M. M.; Kochanny, M. J. Bioorg. Med. Chem. Lett. 2003, 13, 507. (i) Koga, H.; 
Itoh, A.; Murayama, S.; Suzue, S.; Irikura, T. J. Med. Chem. 1980, 23, 1358. (j) Kotoris, C. C.; Chen, M. J.; Taylor, 
S. D. Bioorg. Med. Chem. Lett. 1998, 8, 3275. (k) Domagala, J. M.; Hanna, L. D.; Heifetz, C. L.; Hutt, M. P.; Mich, 
T. F.; Sanchez, J. P.; Solomon, M. J. Med. Chem. 1986, 29, 394. (l) Domagala, J. M.; Heifetz, C. L.; Mich, T. F.; 
Nichols, J. B. J. Med. Chem. 1986, 29, 445. (m) Grunewald, G. L.; Seim, M. R.; Lu, J.; Makboul, M.; Criscione, K. 
R. J. Med. Chem. 2006, 49, 2939. (n) Roth, B. D.; Ortwine, D. F.; Hoefle, M. L.; Stratton, C. D.; Sliskovic, D. R.; 
Wilson, M. W.; Newton, R. S. J. Med. Chem. 1990, 33, 21. 
20 DiMagno, S. G.; Sun, H. Curr. Top. Med. Chem. 2006, 6, 1473. 
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target system.1c Likewise, fluorinated functional groups such as monofluoromethyl and difluoromethyl groups have 
been used as pseudo-oxygen replacements in molecules such as nucleotides, phosphate esters, and sulphate esters.21 
Difluoromethyl moieties can act as electrophilic alkylating agents and inhibit target systems via irreversible 
alkylation.22  
1.1.2. F luorination with fluorine-18 for positron emission tomography (PE T) 
Positron emission tomography (PET) is the molecular imaging of in vivo processes via detection of positron decay 
of radioactively tagged molecules called radiotracers.4a±d There is continual growing interest in using fluorine-18, 
the radioactive isotope of sole naturally occurring fluorine isotope fluorine-19, in radiochemistry due to the 
convenient half-life time of 110 minutes.  Methods to introduce fluorine-18 into molecules should occur, if not at the 
last step, at the latest stage of the radiotracer synthesis as possible.  Ideally, the time used to synthesize, purify, and 
formulate radiotracers for injection should take less than two half-life cycles.  The method for fluorine-18 
introduction should be highly efficient at nanomolar concentrations such that picomolar amounts of radiotracers can 
be obtained, which is often difficult; thus, a 103- or 104-fold excess of the unlabeled precursor is often times used to 
facilitate the reaction.  Multiple fluorinated and non-fluorinated products can arise from non-selective and inefficient 
radiofluorination reagent reactivity, especially for electrophilic radiofluorination methods.  This phenomenon is 
undesirable because of difficulties in separating the fluorinated products from each other and non-fluorinated 
products from the fluorinated products.  A minimally water-sensitive method that allows for the efficient 
incorporation of high specific activity 18F as one single 18F-fluorinated product would provide the ideal 
radiofluorination reaction. 
Nucleophilic methods for the incorporation of 18F 
Fluorine-18 is synthesized by the bombardment of oxygen-18±enriched water with protons to afford wet 18F-fluoride 
in high specific activity (18F/19F is >100:1).  Desolvation of wet 18F-fluoride to anhydrous 18F-fluoride is difficult 
                                                          
21 (a) Blackburn, G. M.; Perree, T. D.; Rashid, A.; Bisbal, C.; Lebleu, B. Chem. Scri. 1986, 26, 21. (b) Phillion, D. 
P.; Cleary, D. G. J. Org. Chem. 1992, 57, 2763. (c) Berkowitz, D. B.; Shen, Q. R.; Maeng, J. H. Tetrahedron Lett. 
1994, 35, 6445. (d) Berkowitz, D. B.; Bose, M. J. F luorine Chem. 2001, 112, 13. (e) Lapierre, J.; Ahmed, V.; Chen, 
M. J.; Ispahany, M.; Guillemette, J. G.; Taylor, S. D. Bioorg. Med. Chem. Lett. 2004, 14, 151. (f) Burke, T. R., Jr. 
Curr. Top. Med. Chem. 2006, 6, 1465. 
22 Hanson, S. R.; Whalen, L. J.; Wong, C.-H. Biorg. Med. Chem. 2006, 14, 8386. 
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due to strong hydrogen bonding interaction of the fluoride with water,23 deterring use of anhydrous 18F-fluoride for 
PET chemistry.  In theory, the maximum achievable yield with high specific activity fluorine-18 is 100%.  18F-
Fluoride can be diluted with 19F-fluorine gas to generate an 18F-enriched electrophilic fluorinating reagent but would 
result in low specific activity reagent due 18F dilution with 19F.  Reactions with high specific activity 18F are thus 
more desirable.  
Radiofluorinations with 18F-fluoride is the most common for substitution reactions that occur on alkyl or aryl 
substrates and is dependent on leaving group ability as well as activation by EWGs of the alkane or arene.  Because 
generation of 18F-fluoride occurs in aqueous conditions, cryptands along with alkali salts are typically used to 
increase fluoride nucleophilicity4d (nucleophilicity is diminished via hydrogen bonding23).  Reactions solvents are 
chosen such that SN2-type and SNAr-type reactions are facilitated with the most commonly used solvents being polar 
aprotic solvents DMF, DMSO, and acetonitrile.  Alkyl halides or sulfonates (such as triflates) are substituted via SN2 
reaction with activated 18F-fluoride with no additional EWGs required unlike with nucleophilic aromatic 
substitution.  18F-Fluoride is basic when rendered more nucleophilic with cryptands and alkali salts,4d making protic 
and some electrophilic functional groups incompatible and leading to elimination side reactions.  Tert-butanol may 
be used to temper the basicity of 18F-fluoride for aliphatic substitution reactions without excessively losing the 
nucleophilicity of the fluoride.24 The most commonly produced radiotracer for imaging, 2-deoxy-2-[18F]fluoro-D-
glucose ([18F]FDG), can be made via 18F-fluoride substitution of the triflate leaving group (Scheme 1).25  
 
Scheme 1. Nucleophilic radiochemical fluorination with 18F-fluoride to afford [18F]FDG 
                                                          
23 Emsley, J. Chem. Soc. Rev. 1980, 9, 91. 
24 (a) Kim, D. W.; Ahn, D.-S.; Oh, Y.-H.; Lee, S.; Kil, H. S.; Oh, S. J.; Lee, S. J.; Kim, J. S.; Ryu, J. S.; Moon, D. 
H.; Chi, D. Y. J. Am. Chem. Soc. 2006, 128, 16394. (b) Kim, D. W.; Jeong, H.-J.; Litn, S. T.; Sohn, M.-H.; 
Katzenellenbogen, J. A.; Chi, D. Y. J. Org. Chem. 2008, 73, 957. 
25 Hamacher, K.; Coenen, H. H.; Stocklin, G. J. Nucl. Med. 1986, 27, 235. 
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Nucleophilic aromatic substitution with 18F-fluoride can be used to synthesize 18F-labelled arenes.26 Substrates that 
undergo SNAr-type substitutions generally require at least one EWG on the arene ortho or para to the leaving group, 
which can be nitro, trialkylammonium, halide, or sulfonate leaving groups, and substantial heating, even microwave 
heating in some instances.  Use of polar aprotic solvents is especially important for SNAr reactions, which is 
drastically impacted by the nucleophilicity of the fluoride.  Nicotinic acetylcholine receptor radioligands have been 
synthesized via nucleophilic aromatic substitution (Scheme 2).27   
 
Scheme 2. Nucleophilic aromatic substition with 18F-fluoride 
Diaryliodonium salts have also been fluorinated with 18F-fluoride28 with arene selectivity based on electronics (the 
more electron-poor arene is fluorinated) and sterics (ortho-substituted arenes are more susceptible to fluorination) 
(Scheme 3).  Currently, 2-thiophene can be advantageously used as a dummy ligand on iodine.28b The counterion of 
the iodonium salts also have an effect on the yield of fluorination²the more dissociative and non-nucleophilic 
counteranions promote higher radiochemical yields (decay-corrected yields, radiochemical yields of 10±50% are 
useful for imaging).  With ortho-substituted substrates, the radiochemical yield can be as high as ~60%.  The major 
drawback to this approach with diaryliodonium salts is that complex, natural product-like substrates are difficult to 
synthesize as diaryliodonium salts with the current methodologies available.  The synthesis of aryl iodonium salts 
often employs oxidants such as mCPBA or peroxydisulfate salts and strong acids such as sulfuric acid and triflic 
acid.29 
                                                          
26 (a) Attina, M.; Cacace, F.; Wolf, A. P. J. Chem. Soc., Chem. Commun. 1983,  108. (b) Angelini, G.; Speranza, M.; 
Wolf, A. P.; Shiue, C. Y. J. F luorine Chem. 1985, 27, 177. 
27 Ding, Y. S.; Gatley, S. J.; Fowler, J. S.; Volkow, N. D.; Aggarwal, D.; Logan, J.; Dewey, S. L.; Liang, F.; Carroll, 
F. I.; Kuhar, M. J. Synapse 1996, 24, 403. 
28 (a) Pike, V. W.; Aigbirhio, F. I. J. Chem. Soc., Chem. Commun. 1995,  2215. (b) Ross, T. L.; Ermert, J.; Hocke, 
C.; Coenen, H. H. J. Am. Chem. Soc. 2007, 129, 8018. 
29 Merritt, E. A.; Olofsson, B. Angew. Chem. Int. Ed. 2009, 48, 9052. 
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Scheme 3. Nucleophilic radiochemical fluorination of aryl(2-thienyl)iodonium bromides 
Electrophilic methods for the incorporation of 18F 
Electrophilic radiofluorination reactions with low specific activity 18F-fluorine gas have a highest achievable yield 
of 50% due to dilution of 18F with 19F.  Many other 18F-electrophilic fluorinating reagents have been synthesized 
from 18F-fluorine gas such as 18F-acetyl hypofluorite,30 18F-xenon difluoride,31 18F-N-fluorosulfonamide or imide 
reagents,32 18F-N-fluoropyridinium salts,33 and 18F-TEDA salts.34 Electrophilic radiofluorination approaches with the 
aforementioned reagents are hindered by the use of low specific activity fluorinating reagents.  Electrophilic 
radiofluorination via direct, non-specific fluorination of substrates such as alkenes35 for the synthesis of [18F]FDG 
and related sugars as well as arenes36 for the synthesis of [18F]fluoro-3,4-dihydroxy phenylalanine ([18F]F-DOPA) 
commonly leads to multiple fluorinated products and does not demonstrate functional group tolerance.  
Radiochemical fluorodemetalation has also been used for aryl organometallic reagents,32a aryl silanes,37 and aryl 
                                                          
30 (a) Chirakal, R.; Firnau, G.; Couse, J.; Garnett, E. S. Int. J. Appl. Radiat. Isot. 1984, 35, 651. (b) Namavari, M.; 
Bishop, A.; Satyamurthy, N.; Bida, G.; Barrio, J. R. Appl. Radiat. Isot. 1992, 43, 989. 
31 (a) Frame, H. D.; Huston, J. L.; Sheft, I. Inorg. Chem. 1969, 8, 1549. (b) Firnau, G.; Chirakal, R.; Sood, S.; 
Garnett, E. S. J. Labelled Compd. Radiopharm. 1981, 18, 7. (c) Shiue, C. Y.; To, K. C.; Wolf, A. P. J. Labelled 
Compd. Radiopharm. 1983, 20, 157. (d) Chirakal, R.; Firnau, G.; Couse, J.; Garnett, E. S. Int. J. Appl. Radiat. Isot. 
1984, 35, 651. (e) Aigbirhio, F. I.; Pike, V. W.; Smith, R. G.; Ramsden, C. A. J. Nucl. Med. 1998, 39, 231P. (f) 
Vasdev, N.; Pointner, B. E.; Chirakal, R.; Schrobilgen, G. J. J. Am. Chem. Soc. 2002, 124, 12863. 
32 (a) Satyamurthy, N.; Bida, G. T.; Phelps, M. E.; Barrio, J. R. Appl. Radiat. Isot. 1990, 41, 733. (b) Teare, H.; 
Robins, E. G.; Arstad, E.; Luthra, S. K.; Gouverneur, V. Chem. Commun. 2007,  2330. 
33 Oberdorfer, F.; Hofmann, E.; Maier-Borst, W. J. Labelled Compd. Radiopharm. 1988, 35, 999. 
34 Teare, H.; Robins, E. G.; Kirjavainen, A.; Forsback, S.; Sandford, G.; Solin, O.; Luthra, S. K.; Gouverneur, V. 
Angew. Chem. Int. Ed. 2010, 49, 6821. 
35 Ido, T.; Wan, C. N.; Casella, V.; Fowler, J. S.; Wolf, A. P.; Reivich, M.; Kuhl, D. E. J. Labelled Compd. 
Radiopharm. 1978, 14, 175. 
36 Firnau, G.; Garnett, E. S.; Chirakal, R.; Sood, S.; Nahmias, C.; Schrobilgen, G. Appl. Radiat. Isot. 1986, 37, 669. 
37 (a) Diraddo, P.; Diksic, M.; Jolly, D. J. Chem. Soc., Chem. Commun. 1984,  159. (b) Speranza, M.; Shiue, C. Y.; 
Wolf, A. P.; Wilbur, D. S.; Angelini, G. J. F luorine Chem. 1985, 30, 97. 
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stannanes38 and can afford better fluorination selectivity but requires the use of toxic precursor molecules such as 
stannanes.  Oxidative fluorination of p-tert-butylphenols with replacement of the p-tert-butyl group with 18F-fluoride 
is possible in the presence of iodobenzene diacetate and trifluoroacetic acid in dichloromethane (Scheme 4).39 The 
isolated fluorination radiochemical yields for various p-tert-butylphenol can range from 7±21% and tolerates a wide 
range of electronically-diverse ortho-substituents including halides, other tert-butyl groups, carbonyls, and olefins. 
 
Scheme 4. Oxidative radiochemical fluorination of p-tert-butyl phenols with 18F-fluoride 
A novel approach to electrophilic radiofluorination involves the umpolung of 18F-fluoride with a Pd(IV) complex 
(Scheme 5).40 The Pd(IV) complex is an efficient scavenger of fluoride and can be used for the radiochemical 
fluorination of benzoquinolylsulfonamide Pd(II) complexes to afford 18F-labeled arenes.  Direct SN2 transfer and an 
electron-coupled fluoride transfer have both been proposed as possible reaction pathways. An advantage of using 
this method is that 18F-fluoride can be incorporated into high complexity arenes and also high specific activity 
electrophilic radiochemical fluorination can be achieved in up to 33% radiochemical yield.  Additionally, the 
                                                          
38 (a) Adam, M. J.; Pate, B. D.; Ruth, T. J.; Berry, J. M.; Hall, L. D. J. Chem. Soc., Chem. Commun. 1981,  733. (b) 
Adam, M. J.; Ruth, T. J.; Jivan, S.; Pate, B. D. J. F luorine Chem. 1984, 25, 329. (c) Namavari, M.; Bishop, A.; 
Satyamurthy, N.; Bida, G.; Barrio, J. R. Appl. Radiat. Isot. 1992, 43, 989. 
39 Gao, Z.; Lim, Y. H.; Tredwell, M.; Li, L.; Verhoog, S.; Hopkinson, M.; Kaluza, W.; Collier, T. L.; Passchier, J.; 
Huiban, M.; Gouverneur, V. Angew. Chem. Int. Ed. 2012,  6733. 
40 Lee, E.; Kamlet, A. S.; Powers, D. C.; Neumann, C. N.; Boursalian, G. B.; Furuya, T.; Choi, D. C.; Hooker, J. M.; 
Ritter, T. Science 2011, 334, 639. 
9 
 
Pd(IV)±[18F] complex is not water-sensitive and is also thermally stable at room temperature.  Ortho-substituted 
arenes are currently not viable substrates for this radiochemical fluorination. 
 
Scheme 5. Synthesis of 18F-labelled aryl fluorides with an electrophilic 18F±Pd(IV) fluorinating reagent 
1.2. F luorination 
)OXRULQH LV WKHPRVWHOHFWURQHJDWLYHHOHPHQWDQG WKXV LVGLIILFXOW WRR[LGL]HE\RQHHOHFWURQ WRIOXRURQLXP³)+´
WKXVR[LGDWLRQRIIOXRULGHWR³)+´LVGLIILFXOWWUDQVIRUPDWLRQ$VWKHWKLUWHHQWKPRVWDEXQGDQWHOHPHQWLQWKHHDUWK¶V
crust, fluorine exists as fluoride. 41  This has direct implications in the chemistry that nature uses for fluorine 
incorporation²the few naturally occurring fluorinated molecules41 such as fluoroacetate are enzymatically 
synthesized in nature with fluoride.42 This is not the case with other halogens such as iodide43 or bromide,44 which 
can accomplish iodination and bromination with an electrophilic haloperoxidase.  Fluoride also forms strong 
                                                          
41 Harper, D. B.; O'Hagan, D. Natural Product Reports 1994, 11, 123. 
42 (a) Sanada, M.; Miyano, T.; Iwadare, S.; Williamson, J. M.; Arison, B. H.; Smith, J. L.; Douglas, A. W.; Liesch, J. 
M.; Inamine, E. J. Antibiot. 1986, 39, 259. (b) Reid, K. A.; Hamilton, J. T. G.; Bowden, R. D.; O'Hagan, D.; 
Dasaradhi, L.; Amin, M. R.; Harper, D. B. Microbiology-UK 1995, 141, 1385. 
43 Kupper, F. C.; Schweigert, N.; Gall, E. A.; Legendre, J. M.; Vilter, H.; Kloareg, B. Planta 1998, 207, 163. 
44 Slebodnick, C.; Hamstra, B. J.; Pecoraro, V. L. Modeling the biological chemistry of vanadium: structural and 
reactivity studies elucidating biological function. In Metal Sites in Proteins and Models: Phosphatases, Lewis Acids 
and Vanadium; Hill, H. A. O.; Sadler, P. J.; Thomson, A. J., Eds.; Springer-Verlag: Berlin, 1997; Vol. 89, pp 51-
108. 
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hydrogen bonds45 that diminish its nucleophilicity; in the laboratory setting, nucleophilic and anhydrous sources of 
fluoride have been established for use in reactions. 
Fluorination reactions investigated in the laboratory have utilized both nucleophilic and electrophilic fluorination 
approaches to afford fluorinated materials.  Many different fluoride sources exist, ranging from metal fluoride salts 
to organic nucleophilic fluorinating reagents.  Highly nucleophilic fluoride sources tend to deliver small unsolvated, 
densely charged fluoride anions that correspondingly are basic. For certain substrates, this basicity is problematic 
because undesired side products result from deprotonation with fluoride. 
The direct chemical oxidation of fluoride to electrophilic fluorine, as mentioned previously, cannot occur due to the 
highly negative oxidation potential value of fluoride.  Conceptually, the closest example of this type of 
transformation would be oxidative electron-transfer coupled with fluoride incorporation.  Electrophilic fluorination 
approaches involve the use of fluorine gas and various electrophilic fluorinating reagents. Most electrophilic 
fluorinating reagents are ultimately derived from fluorine gas, the strongest elemental oxidizing agent known, 
synthesized by electrolysis of potassium bifluoride in hydrogen fluoride.46 Direct use of fluorine gas as the oxidant 
even with specialized equipment, training, and protocols is hazardous due to the dangers of improper handling²
fluorine gas is fatal if inhaled.  Use of less-oxidizing electrophilic fluorinating reagents has facilitated the 
development of more functional group tolerant fluorination methods encompassing a broader substrate scope. 
1.2.1. E lectrophilic fluorination 
Electrophilic fluorination was first reported with highly oxidizing fluorinating reagents such as fluorine gas, 
hypofluorites, fluoroxysulfates, and perchloryl fluoride that are explosive if handled incorrectly.  Xenon difluoride 
was examined as a more stable electrophilic fluorination source; however, it still displayed uncontrollable reactivity 
to many functional groups.  The development of crystalline, benchtop-stable fluorinating reagents such as N-
fluorobis(phenyl)sulfonimide (NFSI) 47  and related analogs, 48  N-fluoropyridinium salts, 49  and 1-chloromethyl-4-
                                                          
45 Emsley, J. Chem. Soc. Rev. 1980, 9, 91. 
46 Villalba, G.; Ayres, R. U.; Schroder, H. J. Ind. Ecol. 2007, 11, 85. 
47 Differding, E.; Ofner, H. Synlett 1991,  187. 
48 (a) Barnette, W. E. J. Am. Chem. Soc. 1984, 106, 452. (b) Differding, E.; Lang, R. W. Tetrahedron Lett. 1988, 29, 
6087. (c) Differding, E.; Lang, R. W. Helv. Chim. Acta 1989, 72, 1248. (d) Davis, F. A.; Han, W. Tetrahedron Lett. 
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fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (F-TEDA-BF4)50 was crucial for the development of 
selective, functional group tolerant fluorination methods (Figure 2).  Even though N±fluoro reagents can formally 
behave as source of fluoroQLXP³)+´WKH1±F bonds are polarized toward fluorine, with partial negative charge on 
fluorine.  Because the V*N±F orbital on the nitrogen are sterically not accessible, the nucleophiles attack at the V*N±F 
orbital on fluorine.  Possibly due to the small orbital coefficient of the V*N±F on fluorine and the low energy level of 
the V*N±F orbital, other reactions such as single-electron transfer can compete with electrophilic fluorination.  The 
process in which these oxidants mediate the two-electron oxidation is under discussion; two single-electron transfers 
or concerted two-electron transfer for fluorination both have been proposed.51 
 
F igure 2. Comparison of the redox potential of crystalline, bench-top stable fluorinating reagents 
1.2.1.1. E lectrophilic fluorination for the synthesis of fluorinated arenes 
Originally, aromatic fluorination was accomplished with fluorine gas, acetyl hypofluorite, and xenon difluoride by 
functionalization of toxic or moisture-sensitive aryl nucleophiles and later shifted to less-basic, less-toxic main 
group aryl nucleophiles.  The development of transition-metal±based fluorination methods provides functional group 
                                                                                                                                                                                           
1991, 32, 1631. (e) Differding, E.; Ofner, H. Synlett 1991,  187. (f) Resnati, G.; Desmarteau, D. D. J. Org. Chem. 
1991, 56, 4925. (g) Davis, F. A.; Zhou, P.; Murphy, C. K. Tetrahedron Lett. 1993, 34, 3971. 
49 (a) Umemoto, T.; Kawada, K.; Tomita, K. Tetrahedron Lett. 1986, 27, 4465. (b) Umemoto, T.; Tomita, K. 
Tetrahedron Lett. 1986, 27, 3271. (c) Tomita, K.; Kawada, K.; Umemoto, T. J. F luorine Chem. 1987, 35, 52. (d) 
Umemoto, T.; Tomita, K. J. F luorine Chem. 1987, 35, 14. (e) Umemoto, T.; Tomizawa, G. Tetrahedron Lett. 1987, 
28, 2705. (f) Umemoto, T.; Fukami, S.; Tomizawa, G.; Harasawa, K.; Kawada, K.; Tomita, K. J. Am. Chem. Soc. 
1990, 112, 8563. (g) Umemoto, T.; Harasawa, K.; Tomizawa, G.; Kawada, K.; Tomita, K. Bull. Chem. Soc. Jpn. 
1991, 64, 1081. (h) Umemoto, T.; Tomizawa, G. J. Org. Chem. 1995, 60, 6563. (i) Umemoto, T.; Nagayoshi, M.; 
Adachi, K.; Tomizawa, G. J. Org. Chem. 1998, 63, 3379. 
50 Banks, R. E.; Mohialdinkhaffaf, S. N.; Lal, G. S.; Sharif, I.; Syvret, R. G. J. Chem. Soc., Chem. Commun. 1992,  
595. 
51 (a) Lal, G. S.; Pez, G. P.; Syvret, R. G. Chem. Rev. 1996, 96, 1737. (b) Nyffeler, P. T.; Duron, S. G.; Burkart, M. 
D.; Vincent, S. P.; Wong, C. H. Angew. Chem. Int. Ed. 2005, 44, 192. 
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tolerant fluorination of pre-functionalized aryl nucleophiles.  Current investigations are focused on the development 
of functional group tolerant, direct conversion of the C±H bonds of arenes to the corresponding C±F bonds with 
predictable regioselectivity. 
Traditional electrophilic fluorination methods with main-group elements 
Aryl carbon±fluorine bonds can be constructed via reaction of an aryl nucleophile with an electrophilic fluorinating 
reagent.  Fluorination via electrophilic aromatic substitution to directly functionalize C±H bonds of arene is 
challenging when compared to other halogenations, possibly due to electronegative fluorine atom disfavoring the 
rate-limiting formation of the Wheland52 intermediate.  Arylmetal reagents including aryltin,53 -mercury,54 lead,55 -
germanium, 56  -silicon, 57  and -boron 58  can react with fluorine gas, xenon difluoride, hypofluorites, and 
fluoroxysulfates to afford fluorinated arenes; however, the substrate scope is limited due to the high reactivity of the 
reagents, often resulting in unselective fluorination.  On the other hand, aryl nucleophiles with more electropositive 
                                                          
52 Wheland, G. W. J. Am. Chem. Soc. 1942, 64, 900. 
53 (a) Adam, M. J.; Pate, B. D.; Ruth, T. J.; Berry, J. M.; Hall, L. D. J. Chem. Soc., Chem. Commun. 1981,  733. (b) 
Adam, M. J.; Berry, J. M.; Hall, L. D.; Pate, B. D.; Ruth, T. J. Can. J. Chem. 1983, 61, 658. (c) Adam, M. J.; Ruth, 
T. J.; Jivan, S.; Pate, B. D. J. F luorine Chem. 1984, 25, 329. (d) Bryce, M. R.; Chambers, R. D.; Mullins, S. T.; 
Parkin, A. J. F luorine Chem. 1984, 26, 533. (d) Bryce, M. R.; Chambers, R. D.; Mullins, S. T.; Parkin, A. J. Chem. 
Soc., Chem. Commun. 1986,  1623. (e) Coenen, H. H.; Moerlein, S. M. J. F luorine Chem. 1987, 36, 63. (f) Hodson, 
H. F.; Madge, D. J.; Widdowson, D. A. Synlett 1992,  831. (g) Matthews, D. P.; Miller, S. C.; Jarvi, E. T.; Sabol, J. 
S.; McCarthy, J. R. Tetrahedron Lett. 1993, 34, 3057. (i) Tius, M. A.; Kawakami, J. K. Tetrahedron 1995, 51, 3997. 
(j) Tius, M. A.; Kawakami, J. K. Synth. Commun. 1992, 22, 1461. (k) Tius, M. A. Tetrahedron 1995, 51, 6605. 
54 (a) Bryce, M. R.; Chambers, R. D.; Mullins, S. T.; Parkin, A. J. F luorine Chem. 1984, 26, 533. (b) Visser, G. W. 
M.; Vonhalteren, B. W.; Herscheid, J. D. M.; Brinkman, G. A.; Hoekstra, A. J. Chem. Soc., Chem. Commun. 1984,  
655. (c) Visser, G. W. M.; Bakker, C. N. M.; Vonhalteren, B. W.; Herscheid, J. D. M.; Brinkman, G. A.; Hoekstra, 
A. J. Org. Chem. 1986, 51, 1886. (d) Butin, K. P.; Kiselev, Y. M.; Magdesieva, T. V.; Reutov, O. A. J. Organomet. 
Chem. 1982, 235, 127. 
55 (a) De Meio, G. V.; Pinhey, J. T. J. Chem. Soc., Chem. Commun. 1990, 1065. (b) De Meio, G. V.; Morgan, J.; 
Pinhey, J. T. Tetrahedron 1993, 49, 8129. (c) Adam, M. J.; Berry, J. M.; Hall, L. D.; Pate, B. D.; Ruth, T. J. Can. J. 
Chem. 1983, 61, 658. 
56 Coenen, H. H.; Moerlein, S. M. J. F luorine Chem. 1987, 36, 63. 
57 (a) Diraddo, P.; Diksic, M.; Jolly, D. J. Chem. Soc., Chem. Commun. 1984, 159. (b) Speranza, M.; Shiue, C. Y.; 
Wolf, A. P.; Wilbur, D. S.; Angelini, G. J. F luorine Chem. 1985, 30, 97. (c) Lothian, A. P.; Ramsden, C. A. Synlett 
1993,  753. (d) Coe, P. L.; Stuart, A. M.; Moody, D. J. J. F luorine Chem. 1998, 92, 27. (e) Stuart, A. M.; Coe, P. L.; 
Moody, D. J. J. F luorine Chem. 1998, 88, 179. (f) Tredwell, M.; Gouverneur, V. Org. Biomol. Chem. 2006, 4, 26. 
58 (a) Grushin, V. V.; Kantor, M. M.; Tolstaya, T. P.; Shcherbina, T. M. Bull. Acad. Sci. USSR, Div. Chem. Sci. 
1984, 33, 2130. (b) Diorazio, L. J.; Widdowson, D. A.; Clough, J. M. Tetrahedron 1992, 48, 8073. (c) Cazorla, C.; 
Metay, E.; Andrioletti, B.; Lemaire, M. Tetrahedron Lett. 2009, 50, 3936. 
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metals, such as aryllithium reagents,59 can react with less reactive electrophilic fluorinating reagents, such as N-
fluorinated reagents.  Such basic nucleophiles can undergo single electron transfer and result in protodemetallation 
byproducts.  Fluorination of Grignard reagents with electrophilic N-fluorinated reagents is the most reliable method 
with basic aryl nucleophiles but demonstrates a narrow substrate scope due to the basicity and nucleophilicity of the 
arylmagnesium reagents (Scheme 6).59a, 60  Through appropriate choice of solvent and reagents, undesired 
protodemetallation products can be minimized.60 
 
Scheme 6. Synthesis of aryl fluorides from aryl Grignard reagents 
Transition-metal±mediated or ±catalyzed electrophilic fluorination 
In the past decade, functional-group tolerant and regioselective fluorination with redox active transition metals has 
been investigated.  In contrast to main group organometallic fluorination, transition-metal±mediated electrophilic 
fluorination often forms metal±carbon bond via transmetallation or direct C±H metalation, followed with oxidation 
at the metal center with an electrophilic fluorinating reagent.  Depending on the reaction conditions, oxidation can 
result in formation of a monometallic high valent intermediate61 or a high valent multi-metallic complex.62 In both 
instances, aryl fluoride products are produced upon reductive elimination. 
                                                          
59 (a) DeYoung, J.; Kawa, H.; Lagow, R. J. J. Chem. Soc., Chem. Commun. 1992, 811. (b) Snieckus, V.; Beaulieu, 
F.; Mohri, K.; Han, W.; Murphy, C. K.; Davis, F. A. Tetrahedron Lett. 1994, 35, 3465. (c) Slocum, D. W.; Shelton, 
P.; Moran, K. M. Synthesis 2005,  3477. 
60 (a) Anbarasan, P.; Neumann, H.; Beller, M. Angew. Chem. Int. Ed. 2010, 49, 2219. (b) Yamada, S.; Gavryushin, 
A.; Knochel, P. Angew. Chem. Int. Ed. 2010, 49, 2215. (c) Anbarasan, P.; Neumann, H.; Beller, M. Chem. Asian J. 
2010, 5, 1775. 
61 (a) Desai, L. V.; Stowers, K. J.; Sanford, M. S. J. Am. Chem. Soc. 2008, 130, 13285. (b) Stowers, K. J.; Sanford, 
M. S. Org. Lett. 2009, 11, 4584. 
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The first transition-metal±catalyzed aromatic fluorination reactions were developed by means of utilizing an ortho-
directing group (Scheme 7).63 Direct C±H fluorination is desirable, but the necessity of directing groups limits the 
structural diversity of the substrates that can be fluorinated.  An additional challenge was to prevention of double 
fluorination at both ortho positions on an arene without ortho or meta substituents.  Double fluorination was 
addressed with a benzoic acid-derived, weakly coordinating anionic ortho-directing group N-perfluorotolylamide 
that allows for rapid displacement of the monofluorinated product by the substrate, thus affording high selectivity 
for monofluorination (Scheme 8).64 
 
Scheme 7. N-directed Pd-catalyzed fluorination of arenes 
 
Scheme 8. N-Perfluorotolylamide±directed Pd-catalyzed fluorination of arenes 
Arylboronic acids have been used to synthesize Pd(II) aryl benzoquinoline-sulfonamide complexes that undergo 
fluorination with F-TEDA-BF4 in the presence of functional groups ranging from aldehydes to phenols (Scheme 
                                                                                                                                                                                           
62 (a) Powers, D. C.; Xiao, D. Y.; Geibel, M. A. L.; Ritter, T. J. Am. Chem. Soc. 2010, 132, 14530. (b) Powers, D. 
C.; Ritter, T. Nat. Chem. 2009, 1, 302. 
63 (a) Hull, K. L.; Anani, W. Q.; Sanford, M. S. J. Am. Chem. Soc. 2006, 128, 7134. (b) Wang, X.; Mei, T.-S.; Yu, 
J.-Q. J. Am. Chem. Soc. 2009, 131, 7520. 
64 Chan, K. S. L.; Wasa, M.; Wang, X.; Yu, J.-Q. Angew. Chem. Int. Ed. 2011, 50, 9081. 
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9);65 however, stoichiometric amounts of Pd complex are needed for the transformation of arylboronic acids to aryl 
fluorides.  Mechanistic studies on the oxidation of the benzoquinoline phenylpyridinesulfonamide palladium(II) 
complex with F-TEDA-BF4 support the presence of a distinct intermediary N3-sulfonamide Pd(IV) species that 
undergoes reductive elimination to make aryl carbon±fluorine bonds (Scheme 10).66 
 
Scheme 9. Fluorination of Pd(II) benzoquinolyl sulfoamide complexes with F-TEDA-BF4 
 
Scheme 10. Reductive elimation from Pd(IV) phenylpyridyl sulfonamide complexes 
Silver-mediated fluorination of aryl stannanes,67 boronic acids,68 and silanes69 has been proposed to proceed through 
multi-metallic, high valent silver species obtained by oxidation of silver(I) complexes with F-TEDA-PF6 and 
followed by reductive elimination.  Multi-metallic redox synergy of silver may enable fluorination of aryl stannanes 
and boronic acids at 23 °C.  This method displays a broad substrate scope²nitrogenous heteroaryl and mesityl 
nucleophiles as well as nucleophiles containing electron-rich, electron-poor, electrophilic, and protic functional 
groups can be successfully fluorinated²to afford fluorinated complex natural product-derived products (Scheme 
                                                          
65 Furuya, T.; Kaiser, H. M.; Ritter, T. Angew. Chem. Int. Ed. 2008, 47, 5993. 
66 (a) Furuya, T.; Ritter, T. J. Am. Chem. Soc. 2008, 130, 10060. (b) Furuya, T.; Benitez, D.; Tkatchouk, E.; Strom, 
A. E.; Tang, P.; Goddard, W. A., III; Ritter, T. J. Am. Chem. Soc. 2010, 132, 3793. 
67 Furuya, T.; Strom, A. E.; Ritter, T. J. Am. Chem. Soc. 2009, 131, 1662. 
68 Furuya, T.; Ritter, T. Org. Lett. 2009, 11, 2860. 
69 Tang, P.; Ritter, T. Tetrahedron 2011, 67, 4449. 
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11).70 Although the silver catalyzed fluorination of aryl stannanes requires the synthesis of toxic aryl stannanes, it 
displays the broadest substrate scope and functional group tolerance in the field. 
  
Scheme 11. Ag-catalyzed fluorination of complex aryl stannanes (names of products refer to non-fluorinated parent 
structure) 
1.2.1.2. E lectrophilic fluorination for the synthesis of aliphatic fluorides 
Nucleophiles employed in aliphatic electrophilic fluorination reactions are often stabilized carbanions, such as those 
GHULYHG IURP ȕ-ketocarbonyl compounds.  Other methods for the synthesis of aliphatic fluorides can involve 
fluorination and nucleophile addition cascades across double bonds.71 Enantioselective variants for both fluorination 
of C±H acidic substrates and fluorination-addition cascades have been reported and can be promoted with Lewis 
acids, organocatalysts, or phase-transfer catalysts.  Aliphatic C±F bond forming reactions via radicals have been 
                                                          
70 Tang, P.; Furuya, T.; Ritter, T. J. Am. Chem. Soc. 2010, 132, 12150. 
71 (a) Wu, T.; Yin, G.; Liu, G. J. Am. Chem. Soc. 2009, 131, 16354. (b) Dilman, A. D.; Belyakov, P. A.; Struchkova, 
M. I.; Arkhipov, D. E.; Korlyukov, A. A.; Tartakovsky, V. A. J. Org. Chem. 2010, 75, 5367. (c) Qiu, S.; Xu, T.; 
Zhou, J.; Guo, Y.; Liu, G. J. Am. Chem. Soc. 2010, 132, 2856. (d) Peng, H.; Liu, G. Org. Lett. 2011, 13, 772. (e) Xu, 
T.; Liu, G. Synlett 2012,  955. 
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disclosed and can provide a substrate scope complementary to more commonly used nucleophilic or electrophilic 
fluorination reactions, making further development in this field desirable. 
Electrophilic fluorination of acidic C±H bonds in methylene and methyne units 
Į-)OXRULQDWLRQRIFDUERQ\OVĮ¶-ketocarbonyls, and related carbonyl derivatives with strongly oxidizing fluorinating 
reagents including gaseous fluorine,72 hypofluorite,73 perchloryl fluoride,74 fluoroxysulfate,75 and XeF276 generally 
JLYH XQGHVLUHG ĮĮ-GLIOXRULQDWHG SURGXFWV LQ DGGLWLRQ WR WKH Į-monofluorinated products.74a,76 Less reactive, more 
functional group tolerant electrophilic fluorinating reagents like N-fluoropyridinium salts, NFSI, and F-TEDA-BF4 
KDYH EHHQ XVHG WR VHOHFWLYHO\ Į-monofluorinate carbonyl derivatives without providing difluorinated 
products.49a,b,e,h,51,77 7KHDV\PPHWULFĮ-fluorination of carbonyl substrates was explored first with chiral electrophilic 
fluorinating reagents48b,c,78 and later with chiral catalysts for the generation of chiral enolate intermediates. 
Many methods have exploited the two-point binding of dicarbonyl compounds to chiral Lewis acid complexes to 
control enantioselective fluorination.  Asymmetric fluorination RI ȕ-ketoesters was achieved with titanium-
TADDOLate-based catalysts (Scheme 12),79 Cu(II)- (Scheme 13)80 and Ni(II)-BOX complexes (Scheme 14),81 
                                                          
72 (a) Purrington, S. T.; Lazaridis, N. V.; Bumgardner, C. L. Tetrahedron Lett. 1986, 27, 2715. (b) Chambers, R. D.; 
Hutchinson, J. J. F luorine Chem. 1998, 89, 229. 
73 (a) Middleton, W. J.; Bingham, E. M. J. Am. Chem. Soc. 1980, 102, 4845. (b) Middleton, W. J.; Bingham, E. M. 
J. Am. Chem. Soc. 1980, 102, 4845. 
74 (a) Inman, C. E.; Oesterling, R. E.; Tyczkowski, E. A. J. Am. Chem. Soc. 1958, 80, 6533. (b) Gershon, H.; 
Schulman, S. G.; Spevack, A. D. J. Med. Chem. 1967, 10, 536. (c) Sheppard, W. A. Tetrahedron Lett. 1969, 10, 83. 
(d) Shapiro, B. L.; Chrysam, M. M. J. Org. Chem. 1973, 38, 880. 
75 (a) Stavber, S.; Zupan, M. J. Chem. Soc., Chem. Commun. 1981,  795. 
76 Zajc, B.; Zupan, M. J. Org. Chem. 1982, 47, 573. 
77 (a) Lal, G. S. J. Org. Chem. 1993, 58, 2791. (b) Davis, F. A.; Han, W.; Murphy, C. K. J. Org. Chem. 1995, 60, 
4730. (c) Singh, R. P.; Shreeve, J. M. Acc. Chem. Res. 2004, 37, 31. 
78 Cahard, D.; Audouard, C.; Plaquevent, J. C.; Roques, N. Org. Lett. 2000, 2, 3699. 
79 (a) Hintermann, L.; Togni, A. Angew. Chem. Int. Ed. 2000, 39, 4359. (b) Hintermann, L.; Perseghini, M.; Togni, 
A. Beil. J. Org. Chem. 2011, 7, 1421. (c) Piana, S.; Devillers, I.; Togni, A.; Rothlisberger, U. Angew. Chem. Int. Ed. 
2002, 41, 979. (d) Frantz, R.; Hintermann, L.; Perseghini, M.; Broggini, D.; Togni, A. Org. Lett. 2003, 5, 1709. (e) 
Bertogg, A.; Hintermann, L.; Huber, D. P.; Perseghini, M.; Sanna, M.; Togni, A. Helv. Chim. Acta 2012, 95, 353. 
80 Ma, J. A.; Cahard, D. Tetrahedron: Asymmetry 2004, 15, 1007. 
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chiral bis(imino)bis(phosphine)ruthenium(II) complexes (Scheme 15), 82  and scandium binapthylphosphate 
complexes.83 The Ni-catalyzed reaction (10 mol% catalyst) has demonstrated the broadest substrate scope so far, and 
DOORZVIRUĮ-IOXRULQDWLRQRIDYDULHW\RIȕ-ketoesters and N-Boc-protected amides81 in 71±93% yield and 83±99% ee.  
7KH FDWDO\WLF HQDQWLRVHOHFWLYH Į-IOXRULQDWLRQ RI Į-substituted methyl, tert-butyl malonate was accomplished via 
chiral Lewis acid catalysis with Zn(II) acetate, (R,R)-4,6-dibenzofurandiyl-¶-bis(4-phenyloxazoline) ligand, and 
NFSI. 84  This approach, however, was specifically optimized for the malonate substrate en route to the 
HQDQWLRVHOHFWLYHV\QWKHVLVRIIOXRULQDWHGȕ-lactams. 
 
Scheme 12. Ti-FDWDO\]HGDV\PPHWULFĮ-IOXRULQDWLRQRIȕ-ketoesters 
 
Scheme 13. Cu-FDWDO\]HGDV\PPHWULFĮ-IOXRULQDWLRQRIȕ-ketoesters 
                                                                                                                                                                                           
81 Shibata, N.; Kohno, J.; Takai, K.; Ishimaru, T.; Nakamura, S.; Toru, T.; Kanemasa, S. Angew. Chem. Int. Ed. 
2005, 44, 4204. 
82 (a) Althaus, M.; Becker, C.; Togni, A.; Mezzetti, A. Organometallics 2007, 26, 5902. (b) Althaus, M.; Togni, A.; 
Mezzetti, A. J. F luorine Chem. 2009, 130, 702. 
83 Suzuki, S.; Furuno, H.; Yokoyama, Y.; Inanaga, J. Tetrahedron: Asymmetry 2006, 17, 504. 
84 Reddy, D. S.; Shibata, N.; Nagai, J.; Nakamura, S.; Toru, T.; Kanemasa, S. Angew. Chem. Int. Ed. 2008, 47, 164. 
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Scheme 14. Ni-FDWDO\]HGDV\PPHWULFĮ-IOXRULQDWLRQRIȕ-ketoesters and N-Boc oxindoles 
 
Scheme 15. Ru-FDWDO\]HGDV\PPHWULFĮ-IOXRULQDWLRQRIȕ-ketoesters 
Chiral Pd-%,1$3FRPSOH[HVFDWDO\]HWKHHQDQWLRVHOHFWLYHIOXRULQDWLRQRIĮ-ketoesters,85 ȕ-ketoesters (Scheme 16),86 
ȕ-ketophosphonates, 87  oxindoles (Scheme 17), 88  DQG Į-ester lactones/lactams. 89  The use of chiral palladium 
FRPSOH[HVZDVSDUWLFXODUO\VXFFHVVIXOIRUWKHĮ-IOXRULQDWLRQRIDF\FOLFĮ-ketoesters, cyclic and acyclic tert-EXW\Oȕ-
ketoester as welO DV R[LQGROHV Į-substituted with an electronically diverse range of aryl and alkyl groups.85,86,88 
Chiral palladium-bound enolates are proposed to induce facial selectivity; stronger bonds between the palladium 
FRPSOH[ DQG WKH R[LQGROH Į-NHWRHVWHU RU ȕ-ketoester enolate, respectively, may explain the higher enantiomeric 
H[FHVVDVFRPSDUHGWRWKRVHREWDLQHGIRUȕ-NHWRSKRVSKRQDWHVRUĮ-ester lactones/lactams.  
                                                          
85 Suzuki, S.; Kitamura, Y.; Lectard, S.; Hamashima, Y.; Sodeoka, M. Angew. Chem. Int. Ed. 2012, 51, 4581. 
86 (a) Hamashima, Y.; Yagi, K.; Takano, H.; Tamas, L.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124, 14530. (b) 
Hamashima, Y.; Takano, H.; Hotta, D.; Sodeoka, M. Org. Lett. 2003, 5, 3225. 
87 (a) Hamashima, Y.; Suzuki, T.; Shimura, Y.; Shimizu, T.; Umebayashi, N.; Tamura, T.; Sasamoto, N.; Sodeoka, 
M. Tetrahedron Lett. 2005, 46, 1447. (b) Hamashima, Y.; Suzuki, T.; Takano, H.; Shimura, Y.; Tsuchiya, Y.; 
Moriya, K.-i.; Goto, T.; Sodeoka, M. Tetrahedron 2006, 62, 7168. 
88 Hamashima, Y.; Suzuki, T.; Takano, H.; Shimura, Y.; Sodeoka, M. J. Am. Chem. Soc. 2005, 127, 10164. 
89 Suzuki, T.; Goto, T.; Hamashima, Y.; Sodeoka, M. J. Org. Chem. 2007, 72, 246. 
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Scheme 16. Pd-catalyzed DV\PPHWULFĮ-IOXRULQDWLRQRIȕ-ketoesters 
 
Scheme 17. Pd-FDWDO\]HGDV\PPHWULFĮ-fluorination of oxindoles.  
Organocatalysts provide enantioinduction by participating as a chiral fluorinating reagent or by activating of the 
substrate to generate a chiral nucleophile during the course of the reaction.  The chiral fluorinating reagent approach 
is challenging in that potential background reaction with achiral fluorinating reagents leads to a racemic mixture.  
Catalytic asymmetric fluorination via chiral fluorinated organocatalysts intermediates has been challenging to 
accomplish but can be achieved with fluorinating reageQWVVXFKDV1)6,DWWHPSHUDWXUHV& 
Cinchona alkaloids have been used to enantioselectively fluorinate nucleophiles in the presence of achiral 
fluorinating reagent.  Enantioselective fluorination of the activated methyne groups was accomplished using 
stoichiometric amounts of cinchona alkaloid derivatives (Scheme 18).90 Cinchona alkaloids have also been used to 
                                                          
90 Shibata, N.; Suzuki, E.; Takeuchi, Y. J. Am. Chem. Soc. 2000, 122, 10728. 
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PHGLDWHHQDQWLRVHOHFWLYHĮ±IOXRULQDWLRQRIVLO\OHQROHWKHUVĮĮ-cyanoester C±+DFLGVȕ-ketoesters, and oxindoles.91 
The methodology was applied to the synthesis of BMS-204352 (Scheme 19).92 Cinchona-alkaloid±derived thiourea 
FDWDO\VW KDYH DOVR EHHQ XVHG WR HQDQWLRVHOHFWLYHO\ Į-IOXRULQDWH ȕ±ketoesters.93 The substrate scope with cinchona 
alkaloids when compared to the Lewis acid±FDWDO\]HG DSSURDFK IRU ȕ-ketoesters and oxindoles is rather limited; 
KRZHYHUZLWKFLQFKRQDDONDORLGVVLO\OHQROHWKHUVFDQEHHQDQWLRVHOHFWLYHO\Į-fluorinated, which is not possible with 
the Lewis acid±catalyzed two-point binding approach. 
 
Scheme 18. Enantioselective cinchona-alkaloid±mediated fluorination of C±H acidic substrates 
 
Scheme 19. (QDQWLRVHOHFWLYHĮ-fluorination of oxindoles mediated by N-fluoroammonium salts of cinchona 
alkaloids  
(QDQWLRVHOHFWLYH RUJDQRFDWDO\WLF Į-fluorination of aldehydes was accomplished by Enders,94 MacMillan (Scheme 
20),95 Jørgensen (Scheme 20),96 and Barbas (Scheme 21);97 VLPLODUO\HQDQWLRVHOHFWLYHĮ-fluorination of ketones has 
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been accomplished with enamine catalysis.98 The method described by MacMillan demonstrates a broader substrate 
scope; the method described by Jørgensen uses lower catalyst loading and does not require five equivalents of NFSI.  
Branched aldehyde substrates IRUHQDQWLRVHOHFWLYHĮ-fluorination are currently challenging; Barbas reported 98±99% 
yield but only 45±66% ee for such substrates. The fluorinated aldehyde products are especially useful for the 
V\QWKHVLVRIHQDQWLRSXUHȕ-fluoroamines, which can be accomplish by a chiral sulfinylimine condensation, directed 
reduction sequence of the enantioenriched fluorinated aldehyde.99  
 
Scheme 20. 2UJDQRFDWDO\WLFDV\PPHWULFĮ-fluorination of aldehydes 
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Scheme 21. 2UJDQRFDWDO\WLFDV\PPHWULFĮ-fluorination of aldehydes 
7KHHQDQWLRVHOHFWLYHĮ-fluorination of acid chlorides was accomplished by combining a palladium catalyst, a chiral 
nucleophile, and an alkali metal (Scheme 22).100 The cinchona alkaloid-based nucleophile reacts with the acid 
chloride in the presence of the palladium catalyst to generate a chiral zwitterion amide±enolate intermediate.  Both 
catalysts work cooperatively such that a chiral enolate can be generated for fluorination.  The alkali metal catalyst is 
hypothesized to play a role in the activation of NFSI through chelation of the sulfonyl oxygens with the cation, thus 
activating the reagent for nucleophilic attack by the chiral enolate.  After fluorination, addition of an amine 
QXFOHRSKLOHDIIRUGVWKHĮ-fluorinated amide product in >99% ee and de.  Thiourea catalysts derived from cinchona 
DONDORLGV FDQ DOVR EH XVHG DV V\QHUJLVWLF ELIXQFWLRQDO FDWDO\VWV IRU WKH DV\PPHWULF Į-fluorination of cyclic and 
DF\FOLFȕ-ketoesters with NFSI.101 The catalyst is able to act as a base (via the quinuclidine moiety) and also as a 
hydrogen-bond donor (via the thiourea moiety), and is proposed to have proper hydrogen-bonding interactions with 
the substrate and NFSI to afford good enantioselectivity. 
 
Scheme 22. 2UJDQRFDWDO\WLFDV\PPHWULFĮ-fluorination of acid chlorides 
Phase-transfer catalysis (PTC) for enantioselective fluorination can often benefit from simple operation procedures 
and high yield and enantioselectivity.  The formation of a tight chiral ion pair is important for enantioinduction; 
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thus, solvents in which the ion pairs remain associated such as dichloromethane and toluene are preferred for PTC.  
Chiral quaternary ammonium salts have been used as cationic phase-transfer catalysts for enantioselective 
IOXRULQDWLRQRIȕ-ketoesters with ion pairing between the enolate and chiral ammonium counterion (Scheme 23).102 
7KHĮ-IOXRULQDWLRQRIȕ-ketoesters is reported in 69% ee or less, most likely resulting from poor ion pairing between 
WKHFKLUDODPPRQLXPVDOWDQGWKHHQRODWHRUIDVWĮ-fluorination background reaction. 
 
Scheme 23. (QDQWLRVHOHFWLYHĮ-IOXRULQDWLRQRIȕ-ketoesters with quaternary ammonium salts 
A non-traditional approach to chiral allylic fluorides and chiral propargylic fluorides utilizes organocatalysis to 
facilitate the asymmetric fluorination step with subsequent olefination or introduction of the propargyl group 
(Scheme 24).103 The organocatalytic approach can give >90% ee by avoiding the SN1 racemization pathway that 
encumbers chiral allylic alcohol fluorination; however, it can only afford ethynyl-substituted propargylic fluorides 
DQG Įȕ-unsaturated ester allylic fluorides (Scheme 24). Fluorination of Į-methylstyrene can occur via oxidative 
fluorination of the allylic C±H bond with a N-fluoropyridinium salt promoted by catalytic amounts of ytterbium(III) 
triflate.104 Electrophilic fluorodesilyation of allenyl and allylsilanes was reported to yield propargylic and allylic 
fluoride products. 105  Acyclic secondary allylic fluorides can be prepared via a cross-metathesis±electrophilic 
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fluorodesilyation sequence.106 Chiral tertiary allylic fluorides have been prepared via cinchona alkaloid-mediated 
electrophilic fluorodesilyation.107 
 
Scheme 24. Enantioselective synthesis of propargyl and allylic fluoride with organocatalysis  
F luorination±nucleophile addition cascades across double bonds 
For activated alkenes like enamines, fluorination can occur without catalysts; for example, fluorocyanation of 
enamines is hypothesized to occur via electrophilic fluorination of the enamine with NFSI followed by trapping of 
the iminium intermediate with cyanide.71b With unactivated alkenes, fluorination-nucleophile addition reactions 
need to be assisted by a catalyst.  Both the intramolecular aminofluorination of unactivated alkenes (Scheme 25)71a 
and the intermolecular aminofluorination of styrenes (Scheme 25)71c were facilitated by the use of palladium 
catalysts.  Although both reactions accomplish aminofluorination of alkenes, different approaches and reaction 
mechanisms are hypothesized for each case.  The intramolecular variant utilizes an iodine(III) oxidant coupled with 
fluoride to accomplish the oxidative fluorination of the resultant complex after the intramolecular amino-palladation 
step with the alkene.  For the intermolecular case with styrenyl substrates, fluoro-palladation with NFSI and the 
active Pd catalyst is proposed to occur first, followed by oxidation to a putative Pd(IV) species, and subsequent 
reductive elimination to form the carbon±nitrogen bond.  The reactivity of high valent transition-metal complexes to 
induce C±F reductive elimination at sp3 carbon centers.108 has also been investigated with Pt(IV) complexes.108c 
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Oxidation of stoichiometric alkyl Au(I) complexes with XeF2 to Au(III) intermediates followed by reductive 
elimination also affords the corresponding aliphatic fluorides.108a TKH SURSHQVLW\ IRU ȕ-hydride elimination with 
Au(III) complexes and the use of XeF2 KDVOLPLWHGWKHVXEVWUDWHVFRSHWRPRVWO\ȕȕ-disubstituted alkanes. 
 
Scheme 25.   (top) Intramolecular Pd-catalyzed aminofluorocyclization of alkene sulfonamides 
 (bottom) Intermolecular aminofluorination of styrenes with NFSI 
For enantioselective fluorocyclization of indole substrates mediated or catalyzed by cinchona alkaloids, the 
enantioselectivity is proposed to arise from the chiral fluorinating reagent generated by reaction of the fluorinating 
reagent with the cinchona alkaloid catalyst (Scheme 26).109 
 
Scheme 26. Enantioselective fluorocyclizations mediated and catalyzed by cinchona alkaloids 
Enantioselective fluoro-spiro cyclization reactions via chiral anionic PTC have been reported (Scheme 27) by using 
chiral anion pairing with cationic F-TEDA to provide a source of chiral electrophilic fluorinating reagent.110 Because 
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the F-TEDA-BF4 is sparingly soluble in the solvent, resulting in a negligible rate of background reaction, the chiral 
anion acts as a shuttle to solubilize the cationic F-TEDA as a chiral fluorinating reagent in the fluorination-spiro 
cyclization reaction.  Enantiomeric excess of 79±96% can be achieved using this approach.  Similarly, with chiral 
anionic PTC, enamines can be enantioselectively fluorinated to afIRUGĮ-fluoroimines.111  
 
Scheme 27. Enantioselective spiro-cyclizations via chiral anionic PTC 
1.2.1.3. F luorination via radical mechanisms 
The N±F bonds in electrophilic fluorinating reagents have relatively low bond dissociation energies (2.84 V for N-
fluorosultam). 112  Under either photolysis or thermolysis, a variety of tert-butyl alkylperoxoates afforded the 
corresponding alkyl fluorides upon treatment with NFSI (Scheme 28).113 The generality of this reaction was not 
reported and primary alkyl fluoride formation was not efficient which supports a mechanism via radicals. 
 
Scheme 28. Fluorination of tert-butyl alkylperoxoates with NSFI 
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More recently silver-catalyzed decarboxylative fluorination of secondary and tertiary aliphatic carboxylic acids with 
F-TEDA-BF4 was reported (Scheme 29).114 This approach is complementary to traditional nucleophilic fluorination 
reactions with DAST-type reagents.  Involvement of Ag-mediated decarboxylation to form an alkyl radical during 
the reaction was demonstrated, but the detailed mechanism for the key C±F bond formation is still indeterminate. 
 
Scheme 29. Ag-catalyzed decarboxylative fluorination of aliphatic carboxylic acids with F-TEDA 
1.2.2. Nucleophilic fluorination 
The challenges associated with nucleophilic fluorination ultimately derive from the high electronegativity of 
fluorine, which contributes to the high kinetic barriers in forming carbon±fluorine bond despite the thermodynamic 
driving force of forming the strongest carbon±heteroatom bond.  Propensity of fluoride to form strong hydrogen 
bonds23 attenuates its nucleophilicity under standard reaction conditions.  Rigorous exclusion of potential hydrogen 
bond donors can make fluoride nucleophilic but also basic which often leads to side reactions. 
Use of alkali metal fluoride salts is desirable due to low cost especially compared to electrophilic fluorinating 
reagents.115 The strong lattice energy of such salts makes them weak nucleophiles and poorly soluble in organic 
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solvents. Crown ethers in combination with alkali metal fluorides such as 18-crown-6 can be used to increase 
solubility of fluoride salts such as KF and therefore often increases reactivity.116 Aprotic solvents especially polar 
aprotic solvents116b,117 are preferred for nucleophilic fluorination such that nucleophilicity of fluoride anions is not 
attenuated by hydrogen bonding interactions; however, consequently fluoride is highly basic and leads to 
elimination byproducts.  The addition of tertiary alcohols such as tert-butanol24 has been shown to retain the fluoride 
nucleophilicity while diminishing fluoride basicity, thereby reducing undesired byproduct formation.  
Tetrabutylammonium difluorotriphenylsilicate (TBAT), tetramethylammonium fluoride (TMAF), and 
tetrabutylammonium fluoride (TBAF) are commonly used soluble inorganic fluoride sources but generally exhibit 
lower nucleophilicity. 
Fluorodeoxygenation of carbon centers commonly requires specialized fluorinating reagents that are dually used for 
oxygen activation/deoxygenation and as the fluoride source. Various aryl and aminosulfur trifluorides 118  and 
derivatives thereof as well as 2,2-difluoroimidazoline±type reagents119 participate in fluorodeoxygenation reactions. 
Several hydrogen fluoride±based reagents120 have been developed to assist sulfur displacement with fluoride in 
fluorodesulfurization reactions.  Electrochemical fluorination with alkali metal±fluorides has been explored as an 
approach for the synthesis of organofluorides.121 Catalysis has enabled many nucleophilic fluorination reactions that 
are otherwise kinetically difficult to accomplish; uncatalyzed nucleophilic aromatic fluorination is problematic for 
electron-rich substrates because the rate-determining step is typically the addition of fluoride to form a 
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Meisenheimer±type complex.122 Additionally, chiral transition-metal complexes and organocatalysts can be used for 
nucleophilic fluorination reactions to afford enantioenriched fluorinated compounds. 
1.2.2.1. Nucleophilic fluorination for the synthesis of fluorinated arenes 
SNAr reactions are currently used on an industrial scale in the Halex process,123 although one or more electron-
withdrawing groups on the arene are typically required.  Aromatic substitution, catalyzed and non-catalyzed, is one 
of the most direct methods for nucleophilic fluorination at this time with control of regioselectivity.  Improvement in 
the substrate scope is desirable because nucleophilic fluorination is preferred both on industrial scale for cost 
efficiency and for radiochemical fluorination methods in positron emission tomography imaging because of the 
availability of 18F-fluoride. 
Traditional nucleophilic fluorination methods with main group elements 
Balz and Schiemann first developed the nucleophilic fluorination of arenes via thermal decomposition of aryl 
diazonium tetrafluoroborate salts in 1927,124 a process which was improved.125 Displacement of chloride in 1-
chloro-2,4-dinitrobenzene under forcing conditions with anhydrous potassium fluoride (the Halex process) was 
developed in 1936126 followed by fluorodenitration of arenes, by ipso-attack at the carbon bearing the nitro group 
(Scheme 30).127 More recent work in this area has allowed for the fluorination of electron-poor, chloro-, nitro-, or 
trimethylammoniumarenes with anhydrous tetrabutylammonium fluoride at room temperature in up to >95% 
yield.128 Aryl fluorides can be accessed from reaction of aryl bromides with anhydrous tetramethylammonium 
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fluoride; however, the process actually occurs through fluoride trapping of aryne intermediates generated from the 
elimination of the bromide with the strongly basic anhydrous fluoride and therefore provides a mixture of 
regioisomers (Scheme 31). 129  Other approaches that have been explored involve two-step nucleophilic fluoro-
demetallation of toxic organothallium(III) substrates130 as well as diaryliodonium substrates.131 Although simple 
fluorinated arenes can be synthesized with some of the aforementioned reactions, even on industrial processes,123 
none of these methods are tolerant of many functional groups or exhibit broad substrate scope such that densely 
functionalized substrates may be nucleophilically fluorinated. 
 
Scheme 30. Nucleophilic aromatic substitution with KF 
 
Scheme 31. Fluorination of naphthyl bromide via aryne intermediates 
Transition-metal±catalyzed nucleophilic fluorination 
Transition-metal±catalyzed cross-coupling with fluoride as nucleophile has been investigated with late transition 
metals such as nickel, copper, ruthenium, rhodium, palladium, iridium, and platinum.132 Reductive elimination from 
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Pd(II) is challenging because a stable fluoride-bridge dimer complex formation is favored due to the high basicity of 
the fluoride ligand.  Cross-coupling fluorination of aryl triflates with fluoride via palladium catalysis (Scheme 
32)132f, 133  was developed with the key use of bulky monodentate phosphine ligand tBuBrettPhos that afford 
mononuclear, tri-coordinate palladium(II) complexes positioned for successful C±F reductive elimination. This 
method displays a broad substrate scope and tolerates nucleophilic functional groups that are often not tolerated in 
electrophilic fluorination methods due to competing fluorination of the nucleophile.  Protic functional groups are not 
yet tolerated under the reaction conditions and constitutional isomers were formed in some cases, which may result 
from the use of basic fluoride salts.133 
 
Scheme 32. Pd-catalyzed cross-coupling of aryl triflates with CsF 
An oxidative addition²C±F reductive elimination sequence was established via a Cu(I)-Cu(III) cycle using a 
contrived substrate that allowed for isolation of the intermediates (Scheme 33).132h Oxidative addition of copper(I) 
into the aryl halide supported by the tris(amine) ligand generates a copper(III) complex which upon ligand 
metathesis with silver fluoride gives a copper(III) fluoride complex that undergoes reductive elimination to extrude 
                                                                                                                                                                                           
Nguyen, H.; Becker, J. J.; Gagne, M. R. Chem. Commun. 2012, 48, 443. (k) Fier, P. S.; Hartwig, J. F. J. Am. Chem. 
Soc. 2012, 10795. 
133 Maimone, T. J.; Milner, P. J.; Kinzel, T.; Zhang, Y.; Takase, M. K.; Buchwald, S. L. J. Am. Chem. Soc. 2011, 
133, 18106. 
33 
 
the aryl fluoride product.  Copper-mediated fluorination of aryl iodides was subsequently reported with 3 
equivalents of copper(I) complex and AgF (Scheme 34).132k  
 
Scheme 33. Cu-catalyzed halide exchange on arenes with AgF 
 
Scheme 34. Cu-mediated fluorination of aryl iodides with AgF 
Nucleophilic aromatic deoxyfluorination 
The ability to directly substitute the hydroxy group in phenols with fluoride avoids pre-functionalization of the 
phenol. Catechol can be monodeoxyfluorinated by oxidation of the catechol to the ortho-quinone followed by 
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nucleophilic fluorination with Deoxo-Fluor®.134 This oxidation-fluorination method affords a mixture of ortho-
fluorinated phenol isomers.  One of the first examples of deoxyfluorination of nitro-substituted phenol was 
accomplished with N,1¶-dimethyl-2,2-difluoroimidazolidine.119a A general method for the ipso-deoxyfluorination of 
phenols was subsequently accomplished with the sterically hindered difluoroimidazole reagent shown in Scheme 35 
(PhenoFluor®) and cesium fluoride.119b Electron-poor, -neutral, and -rich aryl fluorides in addition to heteroaromatic 
fluorides can be synthesized from the corresponding phenol precursors using this method but requires a 
stoichoimetric amount of the reagent. 
 
Scheme 35. Deoxyfluorination of phenols with PhenoFluor® 
1.2.2.2. Nucleophilic fluorination for the synthesis of aliphatic fluorides 
Through appropriate selection of fluoride source, leaving group, and solvent, nucleophilic fluorination at a primary 
carbon center is well established.135 Nucleophilic fluorination at a secondary or tertiary carbon center is inherently 
more difficult. Deoxyfluorination with sulphur tetrafluoride or derivatives thereof can afford fluoride from 
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secondary or tertiary carbinols, but competing elimination 136  and rearrangement136, 137  reactions are often 
problematic.  Halofluorination of alkenes were accomplished via treatment of the alkene with N-iodosuccinimide 
and tetraalkylammonium hydrogen fluoride.138 Epoxide139 and aziridine140 openings with fluoride afford vicinal 
fluoroalcohols and fluoroamines respectively which have been elaborated to multivicinal multi-fluoroalkanes.141 
Deoxy/dethiofluorination via nucleophilic fluorination 
Carbonyl compounds were first converted to geminal difluoromethylene functional groups with sulphur 
tetrafluoride.142 The toxicity and volatility of sulfur tetrafluoride discouraged its use and lead to the use of less 
volatile reagents such as aryl and aminosulfur trifluorides.118 Diethylaminosulfur trifluoride (DAST)136,143 has most 
commonly been used to fluorinate oxygenated (carbonyl, hydroxyl) or sulfur-containing (thiocarbonyl, sulfide) 
substrates.118c,144 The mechanism of DAST-mediated fluorination is proposed to be initiated by a nucleophilic attack 
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of a hydroxyl group to the sulphur atom of DAST to form an alkoxyaminodifluorosulfane intermediate145 that is 
activated for a SN2 attack by fluoride.  In some cases, however, fluoride attack afford products consistent with an 
SN1 intermediate.144l Additional drawbacks of DAST include moisture sensitivity as well as potential explosion upon 
heating.118f  
 
F igure 3. A selection of nucleophilic fluorinating reagents 
Besides with DAST, deoxyfluorination and dethiofluorination can be accomplished with many different fluoride 
sources (Figure 3) S\ULGLQLXP SRO\K\GURJHQ IOXRULGH 2ODK¶V UHDJHQW 146  nitrosonium 
tetrafluoroborate/pyridinium poly(hydrogen fluoride), 147  WULHWK\ODPLQH WULVK\GURJHQ IOXRULQH 75($7+) 148 
perfluoro-1-butanesulfonyl fluoride (PBSF),149 VXOIRQ\O IOXRULGH75($7+)PL[WXUe (Scheme 36),150 <DURYHQNR¶V
reagent, 151  ,VKLNDZD¶V UHDJHQW 152  TFEDMA, 153  N,1¶-dimethyl-2,2,-difluroimidazolidine,119a 4-morpholinosulfur 
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trifluoride,118e,154 Deoxo-Fluor®,118g,155 bromine trifluoride,156 and 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride 
(Fluolead®).118j Deoxo-Fluor® has been the most commonly used reagent for fluorination reactions and is considered 
a safer, more thermally stable alternative to DAST but is similarly moisture-sensitive and prone to decomposition to 
JHQHUDWH WR[LF +)  /LNHZLVH 2ODK¶V UHDJHQW H[KLELWV FRUURVLYH SURSHUWLHV DQG WR[LFLW\ GXH WR SUHVence of HF; 
75($7+)KDVEHHQXVHGDVDOHVVKD]DUGRXVUHSODFHPHQWDQGLVPLOGHQRXJKWREHXVHGLQERURVLOLFDWHJODVVZDUH 
 
Scheme 36. Deoxyfluorination of various alcohols with perfluorobutanesulfonyl fluoride-trialkylamine adduct and 
TREATHF 
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Development of non-explosice crystalline, less moisture-sensitive deoxyfluorinating reagent XtalFluor-E® 
(diethylaminodifluorosulfinium tetrafluoroborate)157 and related reagents158 has resulted in fluorodeoxygenation with 
less byproducts (Scheme 37). Unlike DAST or Deoxo-Fluor®, addition of amine hydrogen fluoride such as 
triethylamine tris(hydrogen fluorine) is required as a fluoride source for fluorination with XtalFluor-type reagents 
because after addition of the alcohol to XtalFluor, the diethylamino group is fully protonated and release the fluoride 
does not occur.  Instead of adding an external fluoride source, addition of DBU can also promote release of fluoride 
by deprotonation of ammonium. 
 
Scheme 37. Deoxyfluorination of alcohols, carbonyls, and carboxylic acids with XtalFluor-E® 
Preparation of propargylic and allylic fluorides 
The synthesis of propargylic fluorides can be accomplished via deoxyfluorination of propargylic alcohols with 
DAST 159  or fluorination of variety of activated propargylic substrates 160  such as propargylic mesylates and 
silylethers.  Commonly used fluoride sources besides DAST for the synthesis of propargylic fluorides include 
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SF4,160b,g,161 dialkylaminosulfur trifluorides,160d±f,i <DURYHQNR¶VUHDJHQW162 DQG*KRVH]¶VUHDJHQWN,N-diisopropyl-1-
fluoro-2-methylpropenamine).163 For the synthesis of chiral propargylic fluorides, Grée used chiral propargylic 
alcohols and introduced fluoride via SN2 displacement.164 This approach is substrate dependent as many chiral 
propargylic alcohols can give enantiomeric excess±eroded or racemized products through alternate SN1 pathways.  
Most reported methods utilize nucleophilic fluorination to give propargylic fluorides; Hammond 165  and 
Gouverneur166have investigated electrophilic fluorination routes to propargylic fluorides. 
Middleton first reported the dehydroxyfluorination of allylic alcohols with DAST,159 which later was used to study 
the fluorination of allylic alcohol substrates containing different substituents and substitution patterns. 167 
Complexation of the double bonds using stoichiometric amount of rhenium168 and iron169complexes were developed 
for allylic alcohols and dienols, respectively. This strategy successfully prevented transposition of the double bonds 
with complete retention of the stereochemistry of deoxyfluorination but the use of stoichiometric amounts of 
transition-metal complex as well as additional protection-deprotection steps has limited utility of the complexation 
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approach. Besides DAST, other fluoride sources can be used, for example, bis(dialkylamino)sulfur difluorides,159,170 
<DURYHQNR¶V UHDJHQW 171 *KRVH]¶V UHDJHQW172 and IF5 in NEt3+). 173 Other activated allylic substrates besides 
allylic alcohols were also employed.174 An attractive route to allylic fluorides is the Tsuji-Trost±type fluoride 
displacement of a leaving group catalyzed by a transition-metal complex. As fluoride serves as a better leaving 
group than the typically used acetate in the Tsuji-Trost reaction,175 selection of an appropriate leaving group is 
important.  Cinnamyl allylic carbonates can be transformed to terminal allylic fluorides via palladium catalysis176 as 
well as secondary and tertiary allylic fluorides from allylic trichloroacetamidates under iridium catalysis (Scheme 
38).177 The enantioselective fluorination of cyclic178 and acyclic (Scheme 39)179 allylic chlorides in the presence of a 
chiral Pd catalyst was reported; from acyclic (linear) allylic chlorides, branched or linear allylic fluorides can be 
synthesized.  The selectivity reported for the linear allylic chloride substrates is for branched products and is >20:1 
for most substrates.  Additionally, a variety of functional groups can be tolerated; however, this method requires the 
use of three equivalents of silver fluoride. 
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Scheme 38. Ir-catalyzed fluorination of allylic trichloroacetamidates 
 
Scheme 39. Pd-catalyzed enantioselective synthesis of branched allylic fluorides 
F luoride addition olefins and epoxides 
In addition to SN2 reactions, fluoride addition to olefins can occur through bromofluorination of olefins, which can 
be done efficiently on large scale to afford simple fluorinated aliphatic products.120e Epoxide opening with fluoride 
can provide access to secondary or tertiary fluorinated aliphatic molecules as well.  Asymmetric opening of meso-
epoxides with fluoride was first reported with stoichiometric amounts of chiral Lewis acid complexes180 and later 
with a Co(III)-salen catalyst (Scheme 40)181 for non-linear meso-epoxides and terminal epoxides.  In situ fluoride 
release from benzoyl fluoride was employed to suppress background reactions and catalyst inhibition.  Mechanistic 
studies suggest that the rate-determining epoxide opening proceeds via a bimetallic complex, which led to the design 
of a more efficient dimeric catalyst with two cobalt-salen complexes tethered together (Scheme 40).  
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Scheme 40. Co(III)-catalyzed asymmetric opening of meso-epoxides with fluoride 
1.3. T rifluoromethoxylation 
Trifluoromethoxylated molecules have been used as agrochemicals, pharmaceuticals, and electro-optical 
materials.182 The increase in lipophilicity183 from trifluoromethoxy group incorporation has made this functional 
group an attractive substituent to use in medicinal chemistry.  Additionally, the ability to induce molecular 
conformation changes with the trifluoromethoxy substituent, which in arenes sits orthogonal to the plane of the 
arene184 compared to a methoxy group which normally rests in plane of the arene, attests to the added value of 
trifluoromethoxy group incorporation into molecules. 
The formation of the oxygen±CF3 bond as well as the carbon±OCF3 bond has been difficult to accomplish for two 
main reasons: reactivity of the trifluoromethylating reagents with carbon sites of the oxygenated nucleophile leading 
to formation of byproducts and the thermal instability of many trifluoromethoxide salts.  Consequently, many 
nucleophilic fluorodesulfurization and fluorodeoxygenation of functionalized alcohols and phenols have been 
established for the synthesis of trifluoromethyl ethers whereas fewer methods for the formation of oxygen±CF3 and 
carbon±OCF3 bonds have been successfully accomplished.  Most approaches for the synthesis of trifluoromethyl 
ethers have low functional group tolerance because of the use of hydrogen fluoride, Lewis acids, or thermally 
unstable, reactive trifluoromethylating reagents.  Synthesis of aryl trifluoromethyl ethers via O-trifluoromethylation 
of phenols has not been a successful approach due to carbon trifluoromethylation side reactions or use of impractical 
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reaction conditions with thermally unstable O-(trifluoromethyl)dibenzofuranium reagents.  In contrast, O-
trifluoromethylation of primary and secondary alcohols with thermally stable Togni reagent affords the desired 
trifluoromethyl ethers. 
1.3.1. A ryl trifluoromethyl ethers  
Nucleophilic fluorination of phenols functionalized as aryl trichloromethyl ethers, 185  aryl 
chlorothionoformates,185b, 186  phenyl fluoroformates, 187  and aryl xanthates 188  constitutes most of the methods 
developed for the synthesis of trifluoromethoxyarenes.  The development of a broad substrate scope, functional 
group tolerant method with the phenol functionalization-fluorination approach has yet to come due to the use of HF 
and antimony-based Lewis acids.  Aryl trichloromethyl ethers185b,189 synthesized in situ190 or prior to the reaction by 
chlorination of the aryl methyl ether185b,c,f as well as aryl chlorothionoformates185b,186 can be nucleophilically 
fluorinated with hydrogen fluoride,185e SbF5, 185g SbF3 in the presence of SbF5, 185a,b,f and molybdenum hexafluoride. 
186 Likewise, phenol fluoroformates can be treated with SbF3 or SF4/HF to afford desired trifluoromethoxyarenes 
(Scheme 41).187 Furthermore, aryl xanthates were used as substrates for fluorodesulfurization with HF/pyridine and 
dibrominated hydantoin (Scheme 42).188a These aforementioned reactions conditions cannot be used to synthesize 
complex, functionalized trifluoromethyoxyarenes. 
 
Scheme 41. Synthesis of aryl trifluoromethyl ethers via fluoroformate intermediates 
                                                          
185 (a) Yagupolskii, L. M. Dokl. Akad. Nauk S.S.S.R. 1955, 105, 100. (b) Yarovenko, N. N.; Vasileva, A. S. Zh. 
Obshch. Khim. 1958, 28, 2502. (c) Yagupolskii, L. M.; Troitskaya, V. I. Zh. Obshch. Khim. 1961, 31, 915. (d) 
Louw, R.; Franken, P. W. Chem. Ind. (London) 1977,  127. (e) Feiring, A. E. J. Org. Chem. 1979, 44, 2907. (f) 
Yagupolskii, L. M.; Orda, V. V. Zh. Obshch. Khim. 1964, 34, 1979. (g) Salome, J.; Mauger, C.; Brunet, S.; Schanen, 
V. J. F luorine Chem. 2004, 125, 1947. 
186 Mathey, F.; Bensoam, J. Tetrahedron Lett. 1973,  2253. 
187 Sheppard, W. A. J. Org. Chem. 1964, 29, 1. 
188 (a) Kuroboshi, M.; Suzuki, K.; Hiyama, T. Tetrahedron Lett. 1992, 33, 4173. (b) Ben-David, I.; Rechavi, D.; 
Mishani, E.; Rozen, S. J. F luorine Chem. 1999, 97, 75. (c) Kanie, K.; Tanaka, Y.; Suzuki, K.; Kuroboshi, M.; 
Hiyama, T. Bull. Chem. Soc. Jpn. 2000, 73, 471. 
189 Louw, R.; Franken, P. W. Chem. Ind. (London) 1977,  127. 
190 Feiring, A. E. J. Org. Chem. 1979, 44, 2907. 
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Scheme 42. Synthesis of aryl trifluoromethyl ethers by fluorodesulfurization of aryl xanthates 
Simple phenol derivatives can undergo trifluoromethylation with O-(trifluoromethyl)dibenzofuranium reagents in 
the presence of alkyl amine bases to afford simple trifluoromethoxyarenes (Scheme 43).191 The reagent requires 
photochemical decomposition of the trifluoromethyoxybiaryl diazonium salt at  ±100 to  ±90 °C to generate the 
active O-(trifluoromethyl)dibenzofuranium reagent.  Trifluoromethylation of phenols with Togni reagent II was 
investigated but O-trifluoromethylation only occurred with 2,4,6-trimethylphenol in 15% yield along with carbon 
trifluoromethylation products (Scheme 44).192  
 
Scheme 43. O-Trifluoromethylation of phenols to afford aryl trifluoromethyl ethers 
 
Scheme 44. O-Trifluoromethylation of phenols with Togni reagent II 
The use of trifluoromethoxide anion to form the aryl carbon±oxygen bond has not been as widely explored as other 
approaches.  SNAr reaction with trifluoromethoxide was attempted but does not occur; SNAr with fluoride 
abstraction from trifluoromethoxide to generate volatile carbonyl difluoride occurs instead to afford aryl fluorides.193 
Phenyl and naphthyl carbon±OCF3 formation occurred when trifluoromethoxide anion was added into the 
corresponding benzynes to afford aryl trifluoromethyl ethers (Scheme 45).193  
                                                          
191 Umemoto, T.; Adachi, K.; Ishihara, S. J. Org. Chem. 2007, 72, 6905. 
192 Stanek, K.; Koller, R.; Togni, A. J. Org. Chem. 2008, 73, 7678. 
193 Kolomeitsev, A. A.; Vorobyev, M.; Gillandt, H. Tetrahedron Lett. 2008, 49, 449. 
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Scheme 45. Trifluoromethoxide anion addition to ortho-trimethylsilylnaphthyl triflate via aryne intermediate 
With silver salts, aryl stannanes and boronic acids can undergo cross-coupling with tris(dimethylamino)sulfonium 
trifluoromethoxide to afford functionalized aryl trifluoromethyl ethers (Scheme 46).194 This method affords the 
cross-coupling products of complex, functionalized aryl stannanes with trifluoromethoxide but is limited to non-
heteroaryl nucleophiles and additionally cannot tolerate nucleophilic amine and protic substituents. 
 
Scheme 46. Ag-mediated cross-coupling of aryl stannanes with trifluoromethoxide salt 
1.3.2. A liphatic trifluoromethyl ethers 
Alkyl trifluoromethyl ethers can be synthesized via the trifluoromethylation of alcohols or displacement of a leaving 
group on alkyl electrophiles by trifluoromethoxide anion.  Primary and secondary alcohols can be 
                                                          
194 Huang, C.; Liang, T.; Harada, S.; Lee, E.; Ritter, T. J. Am. Chem. Soc. 2011, 133, 13308. 
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trifluoromethylated with Togni reagent in the presence of Zn(NTf2)2 (Scheme 47).195 The soluble zinc catalyst with 
non-nucleophilic triflimide anions is proposed to activate Togni reagent for attack by coordinating to the carboxy 
group of the reagent.   
 
Scheme 47. O-Trifluoromethylation of alcohols with Togni reagent II 
Ring-opening polymerization of tetrahydrofuran in the presence of Lewis or Brønsted acids and Togni reagent II 
affords trifluoromethyl ethers 196  while additionally Togni reagent II reacts with sulfonic acids to afford O-
trifluoromethylated sulfonic acids (Scheme 48). 197  2-Phenylethanol, n-decanol, and (2-naphthyl)methanol were 
reported to react with O-(trifluoromethyl)dibenzofuranium reagents (shown in Scheme 43 with phenols) to afford 
the corresponding trifluoromethylated alcohols.191 Analogous to the method for the fluorination of aryl xanthates,188a 
alkyl xanthates were treated with BrF3 to afford alkyl trifluoromethyl ethers198 while simple alkyl triflates can be 
substituted with trifluoromethoxide anion to afford alkyl trifluoromethyl ethers as well (Scheme 49).193  
 
Scheme 48. O-Trifluoromethylation of sulfonic acids with Togni reagent II 
                                                          
195 Koller, R.; Stanek, K.; Stolz, D.; Aardoom, R.; Niedermann, K.; Togni, A. Angew. Chem. Int. Ed. 2009, 48, 
4332. 
196 Fantasia, S.; Welch, J. M.; Togni, A. J. Org. Chem. 2010, 75, 1779. 
197 Koller, R.; Huchet, Q.; Battaglia, P.; Welch, J. M.; Togni, A. Chem. Commun. 2009,  5993. 
198 Ben-David, I.; Rechavi, D.; Mishani, E.; Rozen, S. J. F luorine Chem. 1999, 97, 75. 
47 
 
 
Scheme 49. Synthesis of trifluoromethyl ethers via displacement of alkyl triflates with trifluoromethoxide salts 
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2. Results and Discussion 
2.1. Silver-mediated tr ifluoromethoxylation of aryl nucleophiles1 
Silver salts are used to catalyze chemical transformations spanning asymmetric catalysis2 to C±H functionalization.3 
Much of the homogenous silver reaction chemistry for organic transformations involve the use of silver(I) as Lewis 
acids or as a one-electron chemistry participant.2±4 Examples of redox participation of homogenous high valent 
silver intermediates are rare compared to abundance of silver(I) chemistry that has been developed.  Silver-catalyzed 
aziridination5 as well as C±H amidation6 and amination, 7 have been reported with disilver complexes and are 
postulated to proceed via high valent silver intermediates.  Putative Ag(II)±Ag(II) intermediates have also been 
suggested in the aminofluorination of allenes catalyzed by AgNO3. 8  A silver-mediated trifluoromethoxylation 
reaction of aryl nucleophiles with trifluoromethoxide salt 1 (Figure 4) has been developed and is postulated to occur 
through high valent silver intermediates as proposed for the analogous fluorination reaction of aryl stannanes.9 The 
general approach for the trifluoromethoxylation of aryl nucleophiles is summarized in Figure 4. 
 
F igure 4. Ag-mediated trifluoromethoxylation of aryl nucleophiles 
                                                          
1 Huang, C.; Liang, T.; Harada, S.; Lee, E.; Ritter, T. J. Am. Chem. Soc. 2011, 133, 13308. 
2 For a review on asymmetric silver-catalyzed reactions, please see Naodovic, M.; Yamamoto, H. Chem. Rev. 2008, 
108, 3132. 
3 For reviews on silver-catalyzed C±H functionalization reactions, please see: (a) Diaz-Requejo, M. M.; Perez, P. J. 
Chem. Rev. 2008, 108, 3379. (b) Yamamoto, Y. Chem. Rev. 2008, 108, 3199. 
4 (a) Harmata, M. Silver in Organic Chemistry, John Wiley & Sons: Hoboken, NJ, 2010. (b) Weibel, J. M.; Blanc, 
A.; Pale, P. Chem. Rev. 2008, 108, 3149. 
5 Cui, Y.; He, C. J. Am. Chem. Soc. 2003, 125, 16202. 
6 Cui, Y.; He, C. Angew. Chem. Int. Ed. 2004, 43, 4210. 
7 Li, Z.; Capretto, D. A.; Rahaman, R.; He, C. Angew. Chem. Int. Ed. 2007, 46, 5184. 
8 Xu, T.; Mu, X.; Peng, H.; Liu, G. Angew. Chem. Int. Ed. 2011, 50, 8176. 
9  For discussions on bimetallic high valent silver intermediates proposed in silver-mediated aryl stannane 
fluorination, please see: Furuya, T.; Strom, A. E.; Ritter, T. J. Am. Chem. Soc. 2009, 131, 1662. 
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2.1.1. Design of the silver-mediated trifluoromethoxylation reaction 
Methods to synthesize aryl trifluoromethyl ethers have mainly relied on pre-functionalization of phenols as aryl 
trichloromethyl ethers,10 aryl chlorothionoformates,11 phenyl fluoroformates, 12 and aryl xanthates13 followed with 
exhaustive nucleophilic fluorination at the carbonyl carbon with various harsh fluorinating reagents such as SF4 and 
HF to afford the trifluoromethoxy group (for other methods, please see Chapter 1.3).  Cross-coupling reactions have 
been strategically used to form aryl carbon±heteroatom bonds14 and have resulted in successful formation of aryl C±
N, C±O, C±S, and C±F bonds.  Transition-metal±mediated cross-coupling was proposed as an alternative to 
traditional methods for the synthesis of aryl trifluoromethyl ethers from an aryl equivalent and a trifluoromethoxy 
group source.  One possible combination involves the oxidative cross-coupling of aryl nucleophiles with 
trifluoromethoxide; however, this cross-coupling reaction would most likely need to occur below room temperature 
because trifluoromethoxide reversibly decomposes to fluoride and carbonyl difluoride (b.p. ±84 °C) above room 
temperature.15 Additionally, ȕ-fluoride elimination16 from transition-metal±trifluoromethoxide complexes could also 
potentially obstruct successful aryl carbon±OCF3 bond formation.  Reductive elimination of C±OCF3 is considered 
more difficult than reductive elimination of C±OCH3 due to the inductively electron-withdrawing nature of the 
                                                          
10 (a) Yagupolskii, L. M. Dokl. Akad. Nauk S.S.S.R. 1955, 105, 100. (b) Yarovenko, N. N.; Vasileva, A. S. Zh. 
Obshch. Khim. 1958, 28, 2502. (c) Yagupolskii, L. M.; Troitskaya, V. I. Zh. Obshch. Khim. 1961, 31, 915. (d) 
Louw, R.; Franken, P. W. Chem. Ind. (London) 1977,  127. (e) Feiring, A. E. J. Org. Chem. 1979, 44, 2907. (f) 
Yagupolskii, L. M.; Orda, V. V. Zh. Obshch. Khim. 1964, 34, 1979. (g) Salome, J.; Mauger, C.; Brunet, S.; Schanen, 
V. J. F luorine Chem. 2004, 125, 1947.  
11  (a) Yarovenko, N. N.; Vasileva, A. S. Zh. Obshch. Khim. 1958, 28, 2502. (b) Mathey, F.; Bensoam, J. 
Tetrahedron Lett. 1973,  2253. 
12  Sheppard, W. A. J. Org. Chem. 1964, 29, 1. 
13 (a) Kuroboshi, M.; Suzuki, K.; Hiyama, T. Tetrahedron Lett. 1992, 33, 4173. (b) Ben-David, I.; Rechavi, D.; 
Mishani, E.; Rozen, S. J. F luorine Chem. 1999, 97, 75. (c) Kanie, K.; Tanaka, Y.; Suzuki, K.; Kuroboshi, M.; 
Hiyama, T. Bull. Chem. Soc. Jpn. 2000, 73, 471. 
14 For reviews on aryl carbon±heteroatom bond formation, please see: (a) Muci, A. R.; Buchwald, S. L. Practical 
Palladium Catalysts for C-N and C-O Bond Formation. In Cross-Coupling Reactions; Miyaura, N., Ed.; Top. Curr. 
Chem.; Springer Publishing: New York, 2002; 219, 131. (b) Ley, S. V.; Thomas, A. W. Angew. Chem. Int. Ed. 
2003, 42, 5400. (c) Beletskaya, I. P.; Cheprakov, A. V. Coord. Chem. Rev. 2004, 248, 2337. (d) Schlummer, B.; 
Scholz, U. Adv. Synth. Catal. 2004, 346, 1599. (e) Hartwig, J. F. Nature 2008, 455, 314. (f) Monnier, F.; Taillefer, 
M. Angew. Chem. Int. Ed. 2009, 48, 6954. (g) Furuya, T.; Kamlet, A. S.; Ritter, T. Nature 2011, 473, 470. 
15 (a)  Taylor, S. L.; Martin, J. C. J. Org. Chem. 1987, 52, 4147. (b)  Kolomeitsev, A. A.; Vorobyev, M.; Gillandt, H. 
Tetrahedron Lett. 2008, 49, 449. 
16 (a)  Kraft, B. M.; Lachicotte, R. J.; Jones, W. D. Organometallics 2002, 21, 727. (b)  Fout, A. R.; Scott, J.; Miller, 
D. L.; Bailey, B. C.; Pink, M.; Mindiola, D. J. Organometallics 2009, 28, 331. 
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fluorine in the trifluoromethoxy group, as observed in cross-coupling with weaker nucleophiles.17 Identification of a 
transition metal capable of accomplishing difficult aryl carbon±OCF3 bond formation at 25 °C was key for the 
successful development of oxidative cross-coupling between aryl nucleophiles and trifluoromethoxide. 
Aryl carbon±fluorine bonds have been difficult to form through cross-coupling reactions with transition metals due 
to difficulties in reductive elimination.18 Our research group has advantageously utilized the reactivity of silver salts 
to mediate the fluorination of aryl stannanes,9 aryl boronic acids,19 and aryl silanes,20 which can be accomplished at 
room temperature with stannanes and boronic acids.  Additionally, silver catalysis allowed for the development of 
the most functional group tolerant fluorination method with the broadest substrate scope to date for the synthesis of 
complex aryl fluorides.21 These silver-mediated and -catalyzed fluorination reactions are hypothesized to proceed 
via high valent multi-metallic silver complexes generated upon oxidation of the aryl silver complex from 
transmetalation of the aryl nucleophile to silver (Figure 5).  This proposed multi-metallic silver redox activity is 
rationalized to be the enabling factor for aryl carbon±fluorine bond formation at 23 °C and may be a consequence of 
synergistic metal±metal interactions that can lower activation barriers, as identified for bimetallic catalysis.22 Thus, 
the synergistic reactivity of high valent silver for fluorination offered a promising avenue to explore 
trifluoromethoxylation. 
 
F igure 5. Proposed mechanism for the Ag-mediated fluorination of aryl stannanes to afford aryl fluorides 
                                                          
17 Hartwig, J. F. Acc. Chem. Res. 1998, 31, 852. 
18 (a)  Grushin, V. V. Chem. Eur. J. 2002, 8, 1006. (b)  Yandulov, D. V.; Tran, N. T. J. Am. Chem. Soc. 2007, 129, 
1342. (c) Grushin, V. V.; Marshall, W. J. Organometallics 2007, 26, 4997-5002. 
19 Furuya, T.; Ritter, T. Org. Lett. 2009, 11, 2860. 
20 Tang, P.; Ritter, T. Tetrahedron 2011, 67, 4449. 
21 Tang, P.; Furuya, T.; Ritter, T. J. Am. Chem. Soc. 2010, 132, 12150. 
22 (a) Powers, D. C.; Ritter, T. Nature Chemistry 2009, 1, 302. (b) Powers, D. C.; Benitez, D.; Tkatchouk, E.; 
Goddard, W. A.; Ritter, T. J. Am. Chem. Soc. 2010, 132, 14092. (c) Powers, D. C.; Ritter, T. Acc. Chem. Res. 2012, 
45, 840.  
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The envisioned system for the silver(I)-mediated trifluoromethoxylation of aryl nucleophiles is outlined in Figure 6. 
Transmetalation of the aryl nucleophile to silver(I) would give aryl silver complexes adducted with one or more 
additional silver(I) species.  Subsequent oxidation with an oxidant such as F-TEDA salts would then give a high 
valent multi-metallic silver complex that could undergo fluoride ligand exchange with trifluoromethoxide to arrive 
at a silver-trifluoromethoxide complex.  Reductive elimination from this multi-metallic high valent silver-
trifluoromethoxide complex would then afford the trifluoromethoxy arene.  With this design in mind, aryl stannanes 
would be treated with a silver(I) salt, F-TEDA-PF6, and a trifluoromethoxide salt to afford trifluoromethoxy 
arenes.23 
 
F igure 6. Envisioned reaction mechanism for Ag-mediated trifluoromethoxylation of aryl stannanes 
Trifluoromethyl trifluoromethanesulfonate15 (3) was identified as a ³PDVNHG´ source of trifluoromethoxide anion 
(Figure 7).  Trifluoromethoxide can be liberated with addition of a nucleophile, most commonly fluoride, to afford 
trifluoromethoxide ion-paired with the countercation accompanying the fluoride.  Without a stabilizing 
countercation, trifluoromethoxide readily decomposes to fluoride and carbonyl difluoride.15 Different 
trifluoromethoxide salts can be synthesized in situ with different fluoride sources and evaluated for the 
trifluoromethoxylation reaction. 
 
F igure 7. Liberation of trifluoromethoxide with fluoride source TASF to generate trifluoromethoxide salt 1 
                                                          
23 Professor Tobias Ritter and Mr. Chenghong Huang conceived the design of this method while Mr. Chenghong 
Huang discovered the first silver-mediated trifluoromethoxylation reaction of aryl stannanes and performed all 
initial reaction optimization (not discussed in thesis). 
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2.1.2. Optimization of the tr ifluoromethoxylation reaction 
The reaction conditions for the trifluoromethoxylation reaction were optimized with substrate 4-fluorophenyl 
tributylstannane (4) and monitored by 19F NMR spectroscopy with 3-nitrofluorobenzene as an internal standard. The 
products formed from the reaction include trifluoromethoxylated product 5 as well as fluorinated product 6, biaryl 
homo-coupling 7, hydroxylation product 8, and protodestannylated product 9 (Figure 8).  The mass balance of the 
starting material was unidentified fluorinated byproducts. 
 
F igure 8. Main products formed from the Ag-mediated trifluoromethoxylation reaction 
Effect of fluoride source on trifluoromethoxylation 
The source of fluoride for in situ trifluoromethoxide salt generation was optimized (Table 1).  As shown in Table 1, 
the identity of the trifluoromethoxide salt was imperative for trifluoromethoxylation.  Salts with larger organic 
cations afforded higher yields than inorganic cations.  This phenomenon is hypothesized to come from the stability 
of the trifluoromethoxide salt; unstable salts may decompose prior to participation in the course of the reaction.  
TASF was the best fluoride source screened and thus it was used as the fluoride source in subsequent optimizations. 
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Table 1. Effect of fluoride source on percent yield of trifluoromethoxylation 
 
 
±117.0 ppm 
 
±121.7 ppm  ±118.0 ppm 
 
±128.4 ppm 
 
±115.4 ppm 
KF <1 28 <1 8 <1 
CsF 3 25 <1 <1 3 
AgF <1 18 <1 <1 <1 
TMAF 16 35 <1 <1 <1 
T ASF 41 2 1 <1 <1 
TBAT 18 2 <1 <1 10 
Effect of silver salt on trifluoromethoxylation 
Different silver salts were evaluated for the trifluoromethoxylation reaction (Table 2). As shown in Table 2, the 
choice of silver salt was less critical for trifluoromethoxylation.  Although the silver salt producing the highest yield 
of trifluoromethoxylated product 5 was AgSbF6, trifluoromethoxylation with AgSbF6 afforded multiple additional 
uncharacterized broad fluorine signals in the 19F NMR spectrum while AgPF6 afford the second highest 
trifluoromethoxylation yield without additional fluorine signals.  Use of AgOTf led to mostly fluorinated product 6, 
which was the optimized silver salt reported for the silver-mediated fluorination of aryl stannanes.9 Subsequent 
optimization of the trifluoromethoxylation reaction was performed with AgPF6 as the silver salt of choice. 
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Table 2. Effect of silver salt on percent yield of trifluoromethoxylation 
 
 
±117.0 ppm 
 
±121.7 ppm  ±118.0 ppm 
 
±128.4 ppm 
 
±115.4 ppm 
AgOTf <1 22 <1 5 <1 
Ag2O 15 8 7 <1 8 
AgNO3 29 6 7 <1 8 
AgBF4 32 4 2 <1 2 
AgSbF624 44 <1 <1 <1 <1 
AgPF6 41 2 1 <1 <1 
Effect of solvent on trifluoromethoxylation 
Different solvents and solvent combinations were evaluated for optimization of the trifluoromethoxylation reaction 
(Table 3). Table 3 shows critical dependence of the trifluoromethoxylation reaction on solvent.  Acetone was found 
to decompose TAS OCF3, which explains the lack of successful trifluoromethoxylation (see Chapter 2.1.3 for 
decomposition studies of TAS OCF3).  Use of only THF does not afford products in general most likely due to F-
TEDA-PF6 not dissolving in THF.  A 1:3 mixture of THF/acetone was found to be the optimal solvent mixture 
screened; a potential explanation for this observation is that addition of THF in a 1:3 ratio to acetone slows down the 
decomposition of TAS  OCF3 but still allows for trifluoromethoxylation to proceed.  Both acetonitrile and acetone 
promote the formation of fluorination product 6.  A 1:3 mixture of THF/acetone was used in subsequent 
optimization reactions. 
                                                          
24 Trifluoromethoxylation with AgSbF6 afforded multiple additional uncharacterized broad fluorine signals in the 19F 
NMR spectrum. 
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Table 3. Effect of solvent on percent yield of trifluoromethoxylation 
 
 
±117.0 ppm 
 
±121.7 ppm  ±118.0 ppm 
 
±128.4 ppm 
 
±115.4 ppm 
MeCN 6 19 2 <1 3 
DMF <1 <1 <1 <1 <1 
acetone <1 23 2 1 <1 
THF <1 <1 <1 <1 <1 
1:3 T H F /acetone 41 2 1 <1 <1 
Effect of temperature on trifluoromethoxylation 
A range of reaction temperatures were evaluated for the trifluoromethoxylation reaction (Table 4).  Fluorination 
yields decrease as reaction temperature is decreased; however, trifluoromethoxylation yields peak at ±50 °C and 
then fall at ±70 °C.  This observation may be explained by our hypothesized mechanism for silver-mediated 
trifluoromethoxylation, which proposes the oxidation of the arylsilver species with F-TEDA-PF6 followed by 
fluoride ligand exchange with trifluoromethoxide.  At temperatures lower than ±50 °C, it is possible that ligand 
exchange is too slow for productive trifluoromethoxylation to proceed while fluorination pathways are also 
suppressed.  The temperature chosen for further optimization of the trifluoromethoxylation reaction was ±30 °C 
because the ratio of trifluoromethoxylated product 5 versus the sum of all byproducts was 8.2:1 at ±30 °C compared 
to7.5:1 at ±50 °C. 
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Table 4. Effect of temperature on percent yield of trifluoromethoxylation 
 
 
±117.0 ppm 
 
±121.7 ppm  ±118.0 ppm 
 
±128.4 ppm 
 
±115.4 ppm 
25 °C 21 16 2 <1 3 
0 °C 15 5 1 <1 <1 
±30 °C25 41 2 1 <1 <1 
±50 °C25 68 2 3 <1 <1 
±70 °C 18 <1 1 <1 <1 
Effect of additives on trifluoromethoxylation 
The effect of additives on the yield for trifluoromethylation was evaluated (Table 5).  With the addition of NaOTf, 
an increase of undesired fluorinated product 6 was observed along with 1% formation of trifluoromethoxylated 
product 5.  The triflate counterion seems to play an important role in facilitating fluorination but the role has not 
been clearly established.  The use of sodium bicarbonate is important for trifluoromethoxylation.  Sodium 
bicarbonate was chosen as an additive based on the empirical observation of protodestannylation suppression in the 
silver-catalyzed fluorination of aryl stannanes.21,26  
                                                          
25 The ratio of trifluoromethoxylated product to byproducts is superior at ±30 °C than at ±50 °C (8.2:1 versus 7.5:1).  
With other substrates, suppressed byproduct formation was also empirically observed at ±30 °C compared to at ±50 
°C.  Accordingly, ±30 °C was chosen as the general trifluoromethoxylation reaction temperature such that byproduct 
formation could be minimized. 
26 Special acknowledgement to Dr. Pingping Tang who suggested the additive from his own work on the silver-
catalyzed fluorination of aryl stannanes 
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Table 5. Effect of additives on percent yield of trifluoromethoxylation 
 
 
±117.0 ppm 
 
±121.7 ppm  ±118.0 ppm 
 
±128.4 ppm 
 
±115.4 ppm 
none 1 6 2 12 <1 
NaOTf 1 37 <1 13 <1 
Na2CO3 1 9 <1 14 <1 
NaH C O3 41 2 1 <1 <1 
 
2.1.3. Identification of the tr ifluoromethoxide salt 
Trifluoromethoxide salt 1 was typically prepared in situ during the course of the reaction outside of the glovebox.  
For characterization purposes and decomposition studies, 1 was synthesized, isolated, and purified within a 
glovebox (Scheme 50).27  The decomposition of 1 at 45 °C was monitored with 3-nitrofluorobenzene as an internal 
standard by 19F NMR spectroscopy to afford carbonyl difluoride (COF2) and an unknown byproduct within 15 min 
at 45 °C as shown in Figure 9 (vide infra). 
 
Scheme 50. Synthesis of 1 from 3 and TASF for characterization and decomposition studies 
                                                          
27 See Experimental Section (Chapter 4.1) for detailed procedures.  Dr. Eunsung Lee synthesized and isolated 1 for 
characterization and decomposition purposes according to literature precedent: Farnham, W. B.; Smart, B. E.; 
Middleton, W. J.; Calabrese, J. C.; Dixon, D. A. J. Am. Chem. Soc. 1985, 107, 4565. 
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F igure 9. 19F NMR spectrum of the decomposition of TAS  OCF3 (1) to carbonyl difluoride at 45 °C 
2.1.4. Synthesis of complex, functionalized aryl stannanes 
After reaction optimization, the substrate scope was evaluated.  Aryl stannanes of various complexities were 
synthesized and subjected to the optimized trifluoromethoxylation reaction conditions.  Methods for the synthesis of 
aryl stannanes can be divided into two main classes: (1) functionalization of aryl lithium or Grignard-type reagents 
(usually generated from the corresponding aryl halides) with an electrophilic trialkylstannane source such as 
tributyltin chloride, suitable for arenes containing non-electrophilic, base insensitive functional groups; (2) 
functionalization of aryl halides and sulfonates with tributylstannyl groups via cross-coupling with transition-metals, 
suitable for complex, functionalized arenes.  
Simple aryl stannanes containing non-electrophilic, base insensitive functional groups shown in Scheme 51 were 
synthesized via lithiation of the aryl bromide with nBuLi followed by reaction with tributyltin chloride.28 
                                                          
28 14 was synthesized by Mr. Chenghong Huang, 10±13 were synthesized according to procedures described within 
the group 
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Scheme 51. Synthesis of simple aryl stannane via lithiation-stannylation route 
Complex, functionalized aryl stannanes shown in Scheme 52 were synthesized by Pd-catalyzed cross-coupling of 
aryl halides or sulfonates with hexabutylditin.29 Other aryl stannanes were prepared according to literature precedent 
and are described and referenced in Experimental (Chapter 4.1). 
 
Scheme 52. Synthesis of functionalized aryl stannanes via Pd-catalyzed stannylation of aryl bromides or triflates 
                                                          
29 15 was synthesized by Mr. Chenghong Huang while 16, 17, 18, and 20 were synthesized according to procedures 
described within the group 
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2.1.5. T rifluoromethoxylation of aryl stannanes1 
After synthesizing desired aryl stannanes 10±20, the stannanes were trifluoromethoxylated using the optimized 
reaction conditions (Scheme 53).30 TAS  OCF3 (1) was generated in situ in the presence of NaHCO3 and the 
stannane of interest at ±30 °C by addition of trifluoromethyl trifluoromethanesulfonate (3) to a suspension of 
tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF) in anhydrous THF.  A solution of AgPF6 and F-
TEDA-PF6 in dry acetone was added dropwise to the prior described suspension at ±30 °C and then stirred at ±30 °C 
for 2±4 hours.  As shown in Scheme 53, electron-rich, neutral, and poor aryl stannanes were trifluoromethoxylated 
in 75±88% yield.  Stannane 19 was added dropwise as a solution in dry acetone as the last operation in the sequence 
due to potential reaction of TASF with stannane 19.  As discussed in Chapter 2.1.2, solvent and TAS  OCF3 (1) 
significantly impact the yield; deviations from optimized conditions leads to byproducts resulting from 
fluorodestannylation, hydroxydestannylation, protodestannylation, and biaryl formation via homocoupling.  
Trifluoromethoxylation of stannane 19 afforded 59% trifluoromethoxylation yield in addition to 24% and 10% of 
the corresponding fluorodestannylated and protodestannylated product. 
 
Scheme 53. Ag-mediated trifluoromethoxylation of aryl stannanes (percentages are isolated yields) 
                                                          
30 Yields for trifluoromethoxylated products 21±23 and 27±30 were obtained by Mr. Chenghong Huang 
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When 6-(tributylstannyl)quinoline was subjected the standard trifluoromethyoxylation conditions, <1% yield was 
obtained by 19F NMR spectroscopy. One possible explanation for this phenomenon is the stabilization of the 
putative high valent silver species via coordination of the quinolyl nitrogen lone pair31 and potentially breaking the 
Ag±Ag interaction necessary for reductive elimination (Figure 10), leading to decomposition of the 
trifluoromethoxide-silver complex. 
 
F igure 10. Potential coordination of quinolyl nitrogen disfavoring reductive elimination 
Lowering the reaction temperature to ±50 °C while concurrently increasing the amount of TAS  OCF3 (1) to four 
equivalents and F-TEDA-PF6 to two equivalents afforded 6-trifluoromethoxylquinoline in 16% yield (Scheme 54).  
Nitrogenous heteroaryl substrates remain a limitation for this trifluoromethoxylation method. 
 
Scheme 54. Ag-mediated trifluoromethoxylation of 6-(tributylstannyl)quinoline (13) 
2.1.6. T rifluoromethoxylation of boronic acids1,32 
Commercially available arylboronic acids were treated with one equivalent of NaOH in MeOH at 23 °C and then 
reacted with two equivalents of silver hexafluorophosphate at 0 °C to afford the putative aryl silver complex shown 
in Scheme 55.  After evaporation of MeOH and co-evaporation with THF, TAS  OCF3 (1) was generated in situ in 
anhydrous THF at ±30 °C by addition of trifluoromethyl trifluoromethanesulfonate (3) to a thick suspension of 
tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF).  A solution of F-TEDA-PF6 was added at ±30 °C to 
                                                          
31 For discussions of of high valent silver stabilization by nitrogenous ligands, please see: (a) Po, H. N. Coord. 
Chem. Rev. 1976, 20, 171. (b) Levason, W.; Spicer, M. D. Coord. Chem. Rev. 1987, 76, 45. 
32 The trifluoromethoxylation of arylboronic acids was discovered by Dr. Shinji Harada.  Compounds 21, 24, and 28 
were synthesized by Dr. Shinji Harada and compounds 5, 34, and 35 were synthesized by Dr. Eunsung Lee. 
62 
 
the prior solution and reacted for 1 hour at ±30 °C.  Typically, trifluoromethoxylation reactions with arylboronic 
acids afford yields lower than with aryl stannanes. 
 
Scheme 55. Ag-mediated trifluoromethoxylation of arylboronic acids 
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2.2. Synthesis of 3-deoxy-3-fluoromorphine 
 
F igure 11. Morphine structural numbering of the carbon framework and ring nomenclature 
Since its isolation in 1805, morphine (shown in Figure 11) has been used as an analgesic for relief from severe pain 
associated with cancer and surgical operations. 33  Along with analgesia, morphine elicits side effects such as 
respiratory depression, constipation, nausea, tolerance, and addiction due to unselective agonism of µ-opioid 
receptors thus compromising its use as a clinical treatment for chronic pain.34 Morphine metabolism limits its 
bioavailability via enzymatic glycosylation by glycoprotein UDT2B7 at the phenol to morphine-3-glucuronide 
(M3G, 50%), a biologically inactive metabolite excreted through the kidneys, and at the allylic alcohol to morphine-
6-glucuronide (M6G, 10%), a biologically active metabolite that cannot effectively penetrate the blood-brain barrier 
(Figure 12).35  
 
F igure 12. Metabolism of morphine to M3G and M6G in humans 
                                                          
33 Eguchi, M. Med. Res. Rev. 2004, 24, 182. 
34 (a) Kantor, T. G.; Hopper, M.; Laska, E. J. Clin. Pharmacol. 1981, 21, 1. (b) Lotsch, J.; Geisslinger, G. Clin. 
Pharmacokinet. 2001, 40, 485. 
35 (a) Lotsch, J.; Stockmann, A.; Kobal, G.; Brune, K.; Waibel, R.; Schmidt, N.; Geisslinger, G. Clin. Pharmacol. 
Ther. 1996, 60, 316. (b) Kilpatrick, G. J.; Smith, T. W. Med. Res. Rev. 2005, 25, 521. (c) Wittwer, E.; Kern, S. E. 
AAPS Journal 2006, 8, E348. 
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Glucuronidation can occur after entry into the brain36 with an enzyme that also glucuronidates congeners such as 
codeine, indicating promiscuity for the functional group identity at the 3 position.37 Although the phenol at the 3 
position has been implicated in hydrogen bonding at the receptor pocket,38 oxycodone and dihydrocodeine with 
methoxy substituents at the 3 position show analgesic activity38a, 39  with studies showing that these parent 
compounds and not the O-demethylated metabolites are responsible for pharmacological activity. 40  With the 
rationale that fluorine is an isostere to a hydroxyl group 41  and can also participate in polar interactions, 42 
replacement of the hydroxyl at the 3 position of morphine is expected to block metabolism43 at the 3 position and 
prevent formation of the biologically inactive metabolite M3G, which would lead to a therapeutic with better 
bioavailability (Figure 13).  Additionally, fluorination of morphine to afford 3-deoxy-3-fluoromorphine may provide 
a therapeutic with better pharmacological properties than morphine.44 
                                                          
36 Wahlstrom, A.; Winblad, B.; Bixo, M.; Rane, A. Pain 1988, 35, 121. 
37 Radominska-Pandya, A.; Little, J. M.; Czernik, P. J. Curr. Drug Metab. 2001, 2, 283. (b) Coffman, B. L.; King, 
C. D.; Rios, G. R.; Tephly, T. R. Drug Metab. Dispos. 1998, 26, 73. 
38 (a) Thompson, C. M.; Wojno, H.; Greiner, E.; May, E. L.; Rice, K. C.; Selley, D. E. J. Pharmacol. Exp. Ther. 
2004, 308, 547. (b) Chen, Z. R.; Irvine, R. J.; Somogyi, A. A.; Bochner, F. Life Sci. 1991, 48, 2165. 
39 (a) Kalso, E. J. Pain Symptom Manage. 2005, 29, S47. (b) Bostrom, E.; Hammarlund-Udenaes, M.; Simonsson, 
U. S. H. Anesthesiology 2008, 108, 495. 
40 (a) (b) Wilder-Smith, C. H.; Hufschmid, E.; Thormann, W. Br. J. Clin. Pharmacol. 1998, 45, 575. 
41  Bondi, A. J. Phys. Chem. 1964, 68, 441. 
42 (a) Berkessel, A.; Adrio, J. A.; Huettenhain, D.; Neudorfl, J. M. J. Am. Chem. Soc. 2006, 128, 8421. (b) Anton, D. 
Adv. Mater. 1998, 10, 1197. (c) Cametti, M.; Crousse, B.; Metrangolo, P.; Milani, R.; Resnati, G. Chem. Soc. Rev. 
2012, 41, 31. (d) Berger, R.; Resnati, G.; Metrangolo, P.; Weber, E.; Hulliger, J. Chem. Soc. Rev. 2011, 40, 3496. (e) 
Hoffmann-Roeder, A.; Schweizer, E.; Egger, J.; Seiler, P.; Obst-Sander, U.; Wagner, B.; Kansy, M.; Banner, D. W.; 
Diederich, F. ChemMedChem 2006, 1, 1205. (f)  Biffinger, J. C.; Kim, H. W.; DiMagno, S. G. ChemBioChem 2004, 
5, 622. (g) Kim, C. Y.; Chandra, P. P.; Jain, A.; Christianson, D. W. J. Am. Chem. Soc. 2001, 123, 9620. 
43 For an example of fluorine introduction blocking glucuronidation, please see: Kanou, M.; Saeki, K.; Kato, T. A.; 
Takahashi, K.; Mizutani, T. Fundam. Clin. Pharmacol. 2002, 16, 513. 
44 For discussions on how fluorination can beneficially alter pharmacokinetics and pharmacodynamics, please see: 
(a) Smart, B. E. J. F luorine Chem. 2001, 109, 3. (b) Ismail, F. M. D. J. F luorine Chem. 2002, 118, 27. (c) Bohm, H. 
J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Muller, K.; Obst-Sander, U.; Stahl, M. ChemBioChem 2004, 5, 
637. (d) Ojima, I. ChemBioChem 2004, 5, 628. (e) Kirk, K. L. Curr. Top. Med. Chem. 2006, 6, 1447. (f) Muller, K.; 
Faeh, C.; Diederich, F. Science 2007, 317, 1881. (g) Hagmann, W. K. J. Med. Chem. 2008, 51, 4359. (h) Kirk, K. L. 
Org. Process Res. Dev. 2008, 12, 305. (i) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 
2008, 37, 320. 
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F igure 13. Expected metabolism of 3-deoxy-3-fluoromorphine 
Carbon±fluorine bond replacement of the phenol at the 3 position in morphine is not trivial.  Many past total 
syntheses of morphine utilize the phenol or phenol equivalents to direct the construction of the carbon scaffold of 
morphine (Figure 14).45  As such, prior syntheses do not allow for access of 3-deoxy-fluoromorphine by a simple 
switch of starting materials to the fluorinated analogs, meaning a new total synthesis using fluorinated starting 
materials would need to be conceived.  Designing a new synthesis would not expediently access 3-deoxy-3-
fluoromorphine for in vitro and in vivo studies; the most expedient approach would involve direct deoxyfluorination 
of morphine or late-stage fluorination of a substrate derived from morphine. 
                                                          
45 For prior total syntheses and formal syntheses of morphine, please see: (a) Gates, M.; Tschudi, G. J. Am. Chem. 
Soc. 1956, 78, 1380. (b) Evans, D. A.; Mitch, C. H.; Thomas, R. C.; Zimmerman, D. M.; Robey, R. L. J. Am. Chem. 
Soc. 1980, 102, 5955. (c) Rice, K. C. J. Org. Chem. 1980, 45, 3135. (d) Toth, J. E.; Fuchs, P. L. J. Org. Chem. 1987, 
52, 473. (e) Parker, K. A.; Fokas, D. J. Am. Chem. Soc. 1992, 114, 9688. (f) Hong, C. Y.; Kado, N.; Overman, L. E. 
J. Am. Chem. Soc. 1993, 115, 11028. (g) Mulzer, J.; Durner, G.; Trauner, D. Angewandte Chemie-International 
Edition in English 1996, 35, 2830. (h) Mulzer, J.; Bats, J. W.; List, B.; Opatz, T.; Trauner, D. Synlett 1997,  441. (i) 
Trauner, D.; Bats, J. W.; Werner, A.; Mulzer, J. J. Org. Chem. 1998, 63, 5908. (j) White, J. D.; Hrnciar, P.; 
Stappenbeck, F. J. Org. Chem. 1999, 64, 7871. (k) Nagata, H.; Miyazawa, N.; Ogasawara, K. Chem. Commun. 
2001,  1094. (l) Taber, D. F.; Neubert, T. D.; Rheingold, A. L. J. Am. Chem. Soc. 2002, 124, 12416. (m) Trost, B. 
M.; Tang, W. P. J. Am. Chem. Soc. 2002, 124, 14542. (n) Trost, B. M.; Tang, W. P.; Toste, F. D. J. Am. Chem. Soc. 
2005, 127, 14785. (o) Uchida, K.; Yokoshima, S.; Kan, T.; Fukuyama, T. Org. Lett. 2006, 8, 5311. (p) Omori, A. T.; 
Finn, K. J.; Leisch, H.; Carroll, R. J.; Hudlicky, T. Synlett 2007,  2859. (q) Tanimoto, H.; Saito, R.; Chida, N. 
Tetrahedron Lett. 2008, 49, 358. (r) Varin, M.; Barre, E.; Iorga, B.; Guillou, C. Chem. Eur. J. 2008, 14, 6606. (s) 
Leisch, H.; Omori, A. T.; Finn, K. J.; Gilmet, J.; Bissett, T.; Ilceski, D.; Hudlicky, T. Tetrahedron 2009, 65, 9862. 
(t) Stork, G.; Yamashita, A.; Adams, J.; Schulte, G. R.; Chesworth, R.; Miyazaki, Y.; Farmer, J. J. J. Am. Chem. 
Soc. 2009, 131, 11402. (u) Uchida, K.; Yokoshima, S.; Kan, T.; Fukuyama, T. Heterocycles 2009, 77, 1219. (v) 
Koizumi, H.; Yokoshima, S.; Fukuyama, T. Chem. Asian J. 2010, 5, 2192. (w) Erhard, T.; Ehrlich, G.; Metz, P. 
Angew. Chem. Int. Ed. 2011, 50, 3892. 
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F igure 14. Key steps in various total syntheses of morphine 
2.2.1. Synthetic route to 3-deoxy-3-fluoromorphine 
Our research group has developed methodology for the late-stage fluorination of aryl stannanes9,21 and arylboronic19 
acids with silver salts.  Our original route to 3-deoxy-3-fluoromorphine (TL-270) is shown in Figure 15 and 
involved pre-functionalization of morphine as arylboronic acid 36 or aryl stannane 19 followed by fluorination.  
Despite screening a variety of conditions for fluorination, silver-mediated fluorination of aryl stannane 19 and 
congeners only afforded protodestannylated products while the silver-mediated fluorination of arylboronic acid 36 
and congeners gave low yields of fluorinated product, circa 10%.  With the method for deoxyfluorination of phenols 
developed within our group,46 morphine and protecting group±functionalized derivatives were not viable substrates 
for aromatic deoxyfluorination.47 
                                                          
46 Tang, P.; Wang, W.; Ritter, T. J. Am. Chem. Soc. 2011, 133, 11482. 
47 Experiments for the deoxyfluorination of morphine and protected derivatives were done by Dr. Pingping Tang. 
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F igure 15. Original proposed route to 3-deoxy-3-fluoromorphine 
To our surprise, when the products of the trifluoromethoxylation of stannane 19 were obtained, we observed 
fluorination product 37 in 24% yield.  The formation of 37 is intriguing mainly because the analogous silver-
mediated fluorination reaction of substrate 19 afforded no desired fluorinated product.  This phenomenon may be 
due to the occurrence of a different fluorination pathway during the trifluoromethoxylation reaction; potentially, 
exogenous fluoride liberated from ligand exchange with trifluoromethoxide may be assisting in carbon±fluorine 
bond formation.  With 37 in hand, we proceeded to synthesize 3-deoxy-3-fluoromorphine and other fluorinated 
morphine derivatives for in vitro and in vivo studies. 
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Scheme 56. Synthetic route to 3-deoxy-3-fluoromorphine (TL-270) from morphine 
The full synthetic route to TL-270 is summarized in Scheme 56.  Morphine was first functionalized at the 3 position 
with N-phenylbis(trifluoromethane)sulfonamide as trifluoromethanesulfonate 38 and subsequently demethylated at 
the tertiary amine with concurrent protection as the methyl carbamate with methyl chloroformate to afford 39.  Pd-
catalyzed stannylation of 39 with hexabutylditin afforded stannane 19 which upon trifluoromethoxylation conditions 
produced fluorinated product 37 in 24% yield.  Reduction of the carbamate group in 37 with lithium aluminum 
hydride afforded the final desired product TL-270. 
2.2.2. Biological activity 
In vitro studies have shown that the concentrations necessary for agonist±stimulated binding for oxycodone was 
three to eight times higher than that of morphine.48 Additionally, the morphine affinity for the ȝ-opioid receptor in 
vitro is twenty-six times higher than for oxycodone.48b Despite this, the observed potency when administered to 
                                                          
48 (a) Thompson, C. M.; Wojno, H.; Greiner, E.; May, E. L.; Rice, K. C.; Selley, D. E. J. Pharmacol. Exp. Ther. 
2004, 308, 547. (b) Peckham, E. M.; Traynor, J. R. J. Pharmacol. Exp. Ther. 2006, 316, 1195. (c) Lalovic, B.; 
Kharasch, E.; Hoffer, C.; Risler, L.; Liu-Chen, L. Y.; Shen, D. D. Clin. Pharmacol. Ther. 2006, 79, 461. 
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postoperative patients intravenously was equivalent for both oxycodone and morphine.49 This discrepancy between 
oxycodone and morphine in vitro and in vivo has been investigated through rat model studies of blood versus brain 
concentrations of opiate drugs and demonstrated that oxycodone was two to three times higher in concentration in 
the brain than in blood50 while the concentration of morphine in the brain is two to three times less than in blood.51 
Thus, blood-brain barrier transport plays an important role in in vivo potency and cannot simply be established with 
in vitro IC50 (concentration causing a half-maximal inhibition of control specific binding) or EC50 values 
(concentration causing a half-maximal effect response), as demonstrated with oxycodone and morphine.51c  
First, in vitro cellular functional assays were performed by Cerep to confirm that TL-270 functions as an agonist of 
the ȝ-opioid receptor and not as an antagonist.  The agonist response rate reported by Cerep was 70.3% with rat 
recombinant CHO (Chinese hamster ovary) cells.  Response rates greater than 50% are considered significant effects 
for test compounds and generally the cut-off value for further investigation.  In vitro binding assays performed by 
Cerep were then used to determine IC50 values of TL-270.  The IC50 value as reported by Cerep for TL-270 was 8.0 
× 10-7 M or 800 nM.  When compared to the literature IC50 values for morphine of 53 nM,52 TL-270 is about ten-
fold less effective than morphine at providing inhibition.  This observance is similar to the three to eight-fold 
concentration difference observed for agonist±stimulated binding of oxycodone and morphine.  Subsequent in vivo 
studies of brain±plasma partitioning with fasted male Sprague-Dawley rats with injections at 0.952 mg/kg 
intravenously (i.v.) and 4.78 mg/kg per orem (p.o. or orally) demonstrated that partitioning was 2.91 times greater in 
the brain than in the plasma after four hours.  With the aforementioned in vitro data, an antinociceptive study was 
next logical step for the determination of in vivo potency of TL-270. 
The antinociceptive effects of TL-270 were evaluated by Lichtman and coworkers with traditional warm water tail 
withdrawal and hotplate assays of nociception.  In addition, the mice were observed for straub tail, an opioid 
sensitive measure in which the tail stands up at a near 90 degree angle.  The results of the antinociceptive tests are 
                                                          
49 Silvasti, M.; Rosenberg, P.; Seppala, T.; Svartling, N.; Pitkanen, M. Acta Anaesthesiol. Scand. 1998, 42, 576. 
50 Bostrom, E.; Simonsson, U. S. H.; Hammarlund-Udenaes, M. Drug Metab. Dispos. 2006, 34, 1624. 
51 (a) Letrent, S. P.; Pollack, G. M.; Brouwer, K. R.; Brouwer, K. L. R. Drug Metab. Dispos. 1999, 27, 827. (b) 
Tunblad, K.; Jonsson, E. N.; Hammarlund-Udenaes, M. Pharm. Res. 2003, 20, 618. (c) Bostrom, E.; Hammarlund-
Udenaes, M.; Simonsson, U. S. H. Anesthesiology 2008, 108, 495. 
52  Inturrisi, C. E.; Schultz, M.; Shin, S.; Umans, J. G.; Angel, L.; Simon, E. J. Life Sci. 1983, 33, 773. 
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depicted in Figure 16 (page 71).  As indicated in Figure 16A, 100 mg/kg of each TL compound produced some 
lethality within minutes of administration, most likely from respiratory depression, in contrast to no lethality being 
observed for the saline or morphine groups.  The time courses of the antinociceptive effects of surviving mice are 
shown in Figure 16B (hotplate) and Figure 16C (tail withdraw) while Figure 16D depicts the percentage of surviving 
mice showing straub tail.  Figure 16B shows that at 100 mg/kg TL-270 exhibits a response greater than morphine 
with an induction period of 60 minutes while for the tail withdraw test (Figure 16C), TL-270 at 100 mg/kg exhibits a 
response comparable to morphine with loss of efficacy after 120 minutes.  While TL-270 indicates good response, 
loss of efficacy of TL-270 over 120 minutes in the straub tail tests has discouraged further development of TL-270 
as a therapeutic. 
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F igure 16. Mice were given an i.p. injection of TL-270 (100 mg/kg), TL-286 (100 mg/kg), TL-288 (100 mg/kg), TL-289 (100 mg/kg), morphine (20 mg/kg), or 
saline (n = 6 mice/group).  The time course for nociceptive behavior (hotplate and tail withdrawal assays) and straub tail were evaluated over a 4 h period.  Panel 
A. Percentage of lethality in each group.  The respective numbers of deaths for the TL-270 (100 mg/kg), TL-286 (100 mg/kg), TL-288 (100 mg/kg), and TL-289 
(100 mg/kg) conditions were 3 of 6, 4 of 6, 1 of 6, and 2 of 6.  Panel B. Time course of hotplate antinociception in surviving mice. Panel C. Time course of tail 
withdrawal antinociception in surviving mice. Panel D. Time course of straub tail in surviving mice.  Values represent mean (panels A-D) and error bars 
represent SEM (panels B & C) 
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3. Conclusion and Outlook 
In summary, a novel silver-mediated cross-coupling reaction has been developed for the trifluoromethoxylation of 
aryl stannanes and arylboronic acids.  While the use of aryl stannanes and low trifluoromethoxylation yields for 
nitrogenous heterocyclic substrates are limitations, this method establishes a proof of principle that aryl 
trifluoromethyl ethers can be synthesized via a cross-coupling approach, specifically oxidative cross-coupling of 
aryl nucleophiles with trifluoromethoxide.  The use of silver salts as well as more stable TAS  OCF3 
trifluoromethoxide salt has enabled challenging aryl carbon±OCF3 bond formation.  Future endeavors for the 
synthesis of aryl trifluoromethyl ethers should focus on developing operationally simple, functional group tolerant 
methods using benign aryl substrates such as aryl halides and boronic acids with bench-top stable trifluoromethoxide 
salts or trifluoromethoxide precursors. 
Additionally, 3-deoxy-3-fluoromorphine was synthesized via late-stage fluorination methods starting from 
morphine.  The potential of 3-deoxy-3-fluoromorphine as a therapeutic was assessed with in vitro and in vivo 
studies.  While 3-deoxy-3-fluoromorphine localizes in the brain of male Sprague-Dawley rats three times higher 
than in plasma after four hours, in vivo studies showed the loss of antinociceptive effects after 120 minutes.  Future 
work in analgesics development should focus on creating therapeutics that have prolonged efficacy without side 
effects such as respiratory depression, constipation, nausea, tolerance, and addiction. 
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4. Exper imental 
Ma ter ia ls and Me thods 
All reactions were carried out under an inert nitrogen atmosphere unless otherwise indicated.  Dichloromethane was 
dried by passage through alumina. 1  Except as indicated otherwise, reactions were magnetically stirred and 
monitored by thin layer chromatography (TLC) using EMD TLC plates pre-coated with 250 ȝm thickness silica gel 
60 F254 plates and visualized by fluorescence quenching under UV light.  In addition, TLC plates were stained 
using ceric ammonium molybdate or potassium permanganate stain.  Flash chromatography was performed on 
Dynamic Adsorbents Silica Gel 40±63 ȝm particle size using a forced flow of eluent at 0.3±0.5 bar pressure.2 
Concentration under reduced pressure was performed by rotary evaporation at 25±30 ºC (and at 5 ºC when specified) 
at appropriate pressure.  Purified compounds were further dried under vacuum (0.01±0.2 Torr depending on 
volatility of compound).  NMR spectra were recorded on a Varian Mercury 400 (400 MHz for 1H, 100 MHz for 13C, 
and 375 MHz for 19F acquisitions) or Unity/Inova 500 (500 MHz for 1H, 125 MHz for 13C, and 470 MHz for 19F 
acquisitions).  13C NMR spectra are recorded 1H decoupled.  19F NMR spectra are recorded 1H coupled.  Chemical 
shifts are reported in ppm with the solvent resonance as the internal standard (CDCl3, 23 ºC, 1H NMR: 7.26 ppm, 
13C NMR: 77.16 ppm).2 Data is reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br 
= broad; coupling constants in Hz; integration.  High-resolution mass spectra were obtained on Jeol AX-505 or SX-
102 spectrometers at the Harvard University Mass Spectrometry Facilities.  Anhydrous THF was obtained by 
distillation over sodium/benzophenone.  Dry acetone was obtained by distillation over B2O3.  Triethylamine and 
N,N-diisopropylethylamine were distilled over calcium hydride.  nButyllithium, tris(dimethylamino)sulfonium 
difluorotrimethylsilicate, silver hexafluorophosphate, tetrakis(triphenylphosphine)palladium, lithium chloride, 
hexabutylditin, 1,4-GLR[DQH DQK\GURXV  LQ 6XUH6HDO -(dimethylamino)pyridine, 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), 1-hydroxybenzotriazole (HOBt), N-
phenylbis(trifluoromethane)sulfonimide, and methyl chloroformate were purchased from Aldrich and used as 
received.  Sodium bicarbonate and sand were purchased from Mallinckrodt Chemicals and used as received.  1-
Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate), ammonium hexafluorophosphate, 
                                                          
1 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518. 
2 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
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and tributyltin chloride were purchased from Alfa Aesar and used as received.  Trifluoromethanesulfonic acid was 
purchased from Oakwood Products, Inc. and used as received.  Phosphorus pentoxide was purchased from Acros 
Organics and used as received.  NMR spectroscopic data of known compounds correspond to the data given in the 
appropriate references.  Arylstannanes were prepared and used within 1 week and 1-chloromethyl-4-fluoro-1,4-
diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) 3  was prepared and used within one month for the 
trifluoromethoxylation reactions. 
Exper imental procedures and compound character iza t ion  
4.1. Ag-mediated tr ifluoromethoxylation of aryl stannanes and arylboronic acids 
General procedure for the trifluoromethoxylation of aryl stannanes 
To a 25 mL oven-dried two-neck round-bottom flask charged with a magnetic bar, tris(dimethylamino)sulfonium 
difluorotrimethylsilicate (222 mg, 1.00 mmol, 2.00 equiv) in an one dram vial (prepared in a glove box), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and aryl stannane (0.500 mmol, 1.00 equiv) were added under low 
nitrogen flow.  Anhydrous THF (2.00 mL) was added to the flask DW í & under nitrogen flow using a 3 mL 
syringe.  Trifluoromethyl trifluoromethanesulfonate (3) (0.450 g, 0.300 mL, 2.10 mmol, 4.10 equiv) in a Schlenk 
flask cooled to í50 °C under nitrogen flow was subsequently added using a 1 mL syringe (cooled by crushed dry ice 
wrapped in aluminum foil) while the suspension was stirred vigorously at í30 °C.  The reaction mixture was stirred 
DW í & IRU  PLQXWHV DQG then a solution of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate)3 (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver hexafluorophosphate (252 mg, 1.00 
mmol, 2.00 equiv) in dry acetone (6.0 mL) FRROHG WRí& (prepared in a glovebox in a 25 mL round-bottom 
flask) was added by cannula.  The reaction mixture was stirred for 2 to 4 hours in the dark and then warmed to 23 
°C.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and the filtrate concentrated in 
vacuo.  The residue was purified via column chromatography on silica gel to afford the desired 
trifluoromethoxylated compound. 
Note 1: Most reagents were stored in a glovebox for optimal results.  The reaction could also be performed without 
the use of a glovebox when fresh reagents were used. 
                                                          
3 Furuya, T.; Strom, A. E.; Ritter, T. J. Am. Chem. Soc. 2009, 131, 1662. 
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Note 2: The use of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluoro-phosphate) (2)3 gave 
highest results.  The reaction can also be performed with commercially available 1-chloromethyl-4-fluoro-1,4-
diazoniabicyclo-[2.2.2]octane bis(tetrafluoroborate) but yields are generally around 10% lower. 
General procedure for the trifluoromethoxylation of arylboronic acids 
To an anhydrous solution sodium hydroxide in methanol (1.00 N, 0.500 mL, 1.00 equiv) in an oven-dried 4 dram 
vial with a resealable PTFE/silicone disc charged with a magnetic bar was added under nitrogen flow arylboronic 
acid (0.500 mmol, 1.00 equiv) at 23 ºC and stirred for 15 minutes.  The reaction mixture was then cooled to 0 ºC and 
silver hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) (prepared in an oven-dried 0.5 dram vial in a 
glovebox) was added quickly and the suspension was stirred for 30 minutes at 0 ºC.  The solvent was removed under 
reduced pressure at 0 ºC and the residual methanol removed under reduced pressure by co-evaporation with 
anhydrous THF (2 × 0.500 mL).  To the residue was added tris(dimethylamino)sulfonium difluorotrimethylsilicate 
(276 mg, 1.00 mmol, 2.00 equiv) and sodium bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv) (prepared in a one dram 
vial in a glove box) and then anhydrous THF (2.0 mL) was added to the mixture at ±30 ºC.  Trifluoromethyl 
trifluoromethanesulfonate (3) (0.600 g, 0.400 mL, 2.80 mmol, 5.50 equiv) in a Schlenk flask cooled to í50 °C under 
nitrogen flow was subsequently added using a 1 mL syringe, cooled by crushed dry ice wrapped in aluminum foil, to 
the suspension stirring vigorously at í30 °C.  The suspension was stirred at ±30 ºC for 30 minutes.  A solution of 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2)3 (282 mg, 0.600 mmol, 1.20 
equiv) in dry acetone (6.0 mL) cooled to í30 °C was added to the prior suspension.  The resulting suspension was 
then stirred for 1 hour and filtered through a pad of celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  
The residue was purified via column chromatography to afford the desired trifluoromethoxylated compound. 
Note 1: Most reagents were stored in a glovebox for optimal results.  The reaction could also be performed without 
the use of a glovebox when fresh reagents were used. 
Note 2: Although arylboronic acids are generally preferred reagents over aryl stannanes, for the 
trifluoromethoxylation reaction reported here we generally recommend the stannane version of the method due to a 
simpler procedure and higher observed yields in general. 
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T rifluoromethyl trifluoromethanesulfonate4 (3) 
Note: Trifluoromethyl trifluoromethanesulfonate (3) is commercially available from Oakwood Products, Inc.5. It can 
be prepared in 80% yield by a procedure published by Taylor and Martin in one step from trifluoromethanesulfonic 
anhydride and SbF5 as a catalyst.6 We recommend the procedure by Taylor and Martin but provide an additional 
procedure that affords the product in lower yield (56%).  The method presented here however does not require the 
use of SbF5: 
A 250-mL round-bottomed flask charged with a magnetic stir bar, 30-cm Vigreux column, and 100-mL round-
bottomed receiving flask were dried in an oven for 12 hours at 135 °C.  The system was assembled while the glass 
was hot and cooled under vacuum to 25 °C and then backfilled with N2 and kept under a N2 atmosphere.  To the dry 
250-mL round-bottomed flask charged with a magnetic stir bar was added sequentially sand (10.0 g), phosphorous 
pentoxide (25.0 g, 180 mmol, 0.310 equiv), and trifluoromethanesulfonic acid (50.0 mL, 84.8 g, 565 mmol, 1.00 
equiv).  The receiving flask was FRROHG WR í & 7KH UHDFWLRQPL[WXUHwas stirred at room temperature for 3 
hours, then heated until reaching 110 °C (30 °C every 15 minutes) for a total of 8 hours.  The distillate collected in 
the 100-mL round-bottomed Schlenk flask was then sealed and attached to a N2 line.  To the 100-mL round-
bottomed flask at 0 °C was added a precooled solution of 3 M KOH (50 mL) at 0 °C.  To the 100-mL round-
bottomed flask at 0 °C was attached a short-path distillation apparatus with a 100-mL round-bottomed Schlenk flask 
as the collection flask was cooled to í78 °C.  The 100-mL round-bottomed flask was warmed with a water bath to 
25 °C and the distillate collected via short-path distillation in the 100-mL round-bottomed Schlenk flask cooled to 
í78 °C.  The 100-mL round-bottomed Schlenk flask was then sealed after all the distillate was collected, allowed to 
warm to 25 °C, and attached to a vacuum transfer apparatus with a 50-mL long-bodied Schlenk flask.  The vacuum 
transfer apparatus was flamed dried under vacuum and allowed to cool to 25 °C.  The distillate was then transferred 
via vacuum transfer at 0 °C (frozen solid with liquid nitrogen first, then during vacuum transfer allowed to warm to 
                                                          
4 Noftle, R. E.; Cady, G. H. Inorg. Chem. 1965, 4, 1010. 
5 http://www.oakwoodchemical.com/p-59367-062235.aspx (downloaded 07/16/2011) 
6 Taylor, S. L.; Martin, J. C. J. Org. Chem. 1987, 52, 4147. 
77 
 
0 °C) over 15 minutes and the liquid collected in the 50-mL long-bodied Schlenk flask, cooled with liquid nitrogen, 
to give 34.5 g of the target compound as a colorless liquid (56%).  The compound was stored in the 50-mL long-
bodied Schlenk flask DWí& 
NMR Spectroscopy: 13C NMR (100 MHz, CDCl3, 23 °C, G): 118.8 (q, J = 273 Hz), 118.4 (q, J = 320 Hz).  19F NMR 
(375 MHz, CDCl3, 23 °C, G): ±73.5 (q, J = 4.5 Hz), ±52.9 (q, J = 3.0 Hz).  The previously reported spectroscopic 
data are 19F NMR (CFCl3, 23 °C, G): ±74.0 (q, J = 3.5 Hz), ±53.3 (q, J = 3.5 Hz).6  
T ris(dimethylamino)sulfonium trifluoromethoxide7 (T AS  O C F3) (1) 
Typically, 1 was prepared in situ outside a glovebox (vide infra).  For characterization purposes, we also synthesized 
it independently as follows: 
All manipulations were carried out in a dry box under a N2 atmosphere.  To a suspension of 
tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF) (330 mg, 1.20 mmol, 1.00 equiv) in anhydrous THF 
(12 mL) in a 20 mL vial with a resealable PTFE/silicone disc DW í & ZDV DGGHG WULIOXRURPHWK\O
trifluoromethanesulfonate (3) (0.392 g, 0.261 mL, 1.80 mmol, 1.5 equiv) using a syringe (both 3 and the syringe 
were cooled to í30 °C).  The suspension was stirred vigorously at í30 °C and at 23 °C for 15 min and 30 min, 
respectively.  The suspension was filtered off and washed with THF (3 × 3 mL) to afford 243 mg of the title 
compound as a colorless solid (82% yield). 
NMR Spectroscopy: 1H NMR (500 MHz, CD2Cl2, 23 °C, G): 2.93 (s, 18H).  13C NMR (125 MHz, CD2Cl2, 23 °C, G): 
38.7.  19F NMR (470 MHz, CD2Cl2, 23 °C, G): í20.5 (s, br).  These spectroscopic data correspond to the reported 
data in reference.7b 
Decomposition study of T AS  O C F3 (1) 
In a glove box, 0.60 mL of d6-acetone was added to a J. Y. tube, which contained TAS  OCF3 (1) (5.9 mg, 24 mmol) 
and 3-nitrofluorobenzene (1.0 PL) at 0 °C.  The solution was warmed to 23 °C and immediately placed into the 
                                                          
7 (a) Kolomeitsev, A. A.; Vorobyev, M.; Gillandt, H. Tetrahedron Lett. 2008, 49, 449. (b) Farnham, W. B.; Smart, 
B. E.; Middleton, W. J.; Calabrese, J. C.; Dixon, D. A. J. Am. Chem. Soc. 1985, 107, 4565. 
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NMR machine and the 19F NMR resonances followed by 19F NMR spectroscopy at 45 °C.  TAS  OCF3 was 
completely decomposed to difluorophosgene (COF2) and an unknown byproduct within 15 min at 45 °C. 
 
Effect of fluoride source on the yield of Ag-mediated tr ifluoromethoxylation reaction 
To a suspension of fluoride source (0.400 mmol, 2.00 equiv), sodium bicarbonate (33.6 mg, 0.400 mmol, 2.00 
equiv), and (4-fluorophenyl)tributylstannane3 (4) (77.0 mg, 0.200 mmol, 1.00 equiv) in anhydrous THF (0.800 mL) 
at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (0.18 g, 0.12 mL, 0.83 mmol, 4.1 equiv), and the 
suspension was stirred vigorously.  The reaction mixture was stirred at í30 °C for 30 minutes, then a solution cooled 
to í30 °C of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (113 mg, 0.240 
mmol, 1.20 equiv) and silver hexafluorophosphate (101 mg, 0.400 mmol, 2.00 equiv) in dry acetone (2.4 mL) was 
added.  The reaction mixture was stirred for 2 hours in the dark, then warmed to 23 °C.  To the reaction mixture was 
added 3-nitrofluorobenzene (20.0 PL, 0.188 mmol, 0.939 equiv).  The yield was determined by comparing the 
integration of the 19F NMR (375 MHz, acetone-d6, 23 ºC) resonance of 1-fluoro-4-(trifluoromethoxy)benzene (±
117.0 ppm, ±59.9 ppm), 1,4-difluorobenzene (±121.7 ppm), 4,4'-difluorobiphenyl (±118.0 ppm), 4-fluorophenol (±
128.4 ppm), and fluorobenzene (±115.4 ppm) with that of 3-nitrofluorobenzene (±112.0 ppm).  Yields are reported 
as percentages (by 19F NMR). 
 
Effect of Ag salt on the yield of Ag-mediated trifluoromethoxylation reaction 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (110 mg, 0.400 mmol, 2.00 equiv), 
sodium bicarbonate (33.6 mg, 0.400 mmol, 2.00 equiv), and (4-fluorophenyl)tributylstannane3 (4) (77.0 mg, 0.200 
mmol, 1.00 equiv) in anhydrous THF (0.800 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) 
(0.18 g, 0.12 mL, 0.83 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was 
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stirred at í30 °C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-
diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (113 mg, 0.240 mmol, 1.20 equiv) and silver salt (0.400 
mmol, 2.00 equiv) in dry acetone (2.4 mL) was added.  The reaction mixture was stirred for 2 hours in the dark, then 
warmed to 23 °C.  To the reaction mixture was added 3-nitrofluorobenzene (20.0 PL, 0.188 mmol, 0.939 equiv).  
The yield was determined by comparing the integration of the 19F NMR (375 MHz, acetone-d6, 23 ºC) resonance of 
1-fluoro-4-(trifluoromethoxy)benzene (±117.0 ppm, ±59.9 ppm), 1,4-difluorobenzene (±121.7 ppm), 4,4'-
difluorobiphenyl (±118.0 ppm), 4-fluorophenol (±128.4 ppm), and fluorobenzene (±115.4 ppm) with that of 3-
nitrofluorobenzene (±112.0 ppm).  Yields are reported as percentages (by 19F NMR). 
 
Effect of solvent on the yield of Ag-mediated trifluoromethoxylation reaction 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (110 mg, 0.400 mmol, 2.00 equiv), 
sodium bicarbonate (33.6 mg, 0.400 mmol, 2.00 equiv), and (4-fluorophenyl)tributylstannane3 (4) (77.0 mg, 0.200 
mmol, 1.00 equiv) in anhydrous solvent (0.800 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate 
(3) (0.18 g, 0.12 mL, 0.83 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was 
stirred at í30 °C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-
diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (113 mg, 0.240 mmol, 1.20 equiv) and silver 
hexafluorophosphate (101 mg, 0.400 mmol, 2.00 equiv) in anhydrous solvent (2.4 mL) was added.  The reaction 
mixture was stirred for 2 hours in the dark, then warmed to 23 °C.  To the reaction mixture was added 3-
nitrofluorobenzene (20.0 PL, 0.188 mmol, 0.939 equiv).  The yield was determined by comparing the integration of 
the 19F NMR (375 MHz, acetone-d6, 23 ºC) resonance of 1-fluoro-4-(trifluoromethoxy)benzene (±117.0 ppm, ±59.9 
ppm), 1,4-difluorobenzene (±121.7 ppm), 4,4'-difluorobiphenyl (±118.0 ppm), 4-fluorophenol (±128.4 ppm), and 
fluorobenzene (±115.4 ppm) with that of 3-nitrofluorobenzene (±112.0 ppm).  Yields are reported as percentages (by 
19F NMR). 
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Effect of temperature on the yield of Ag-mediated trifluoromethoxylation reaction 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (110 mg, 0.400 mmol, 2.00 equiv), 
sodium bicarbonate (33.6 mg, 0.400 mmol, 2.00 equiv), and (4-fluorophenyl)tributylstannane3 (4) (77.0 mg, 0.200 
mmol, 1.00 equiv) in anhydrous THF (0.800 mL) at the corresponding temperature was added trifluoromethyl 
trifluoromethanesulfonate (3) (0.18 g, 0.12 mL, 0.83 mmol, 4.1 equiv), and the suspension was stirred vigorously.  
The reaction mixture was stirred at the corresponding temperature for 30 minutes, then a solution cooled to the 
corresponding temperature of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) 
(2) (113 mg, 0.240 mmol, 1.20 equiv) and silver hexafluorophosphate (101 mg, 0.400 mmol, 2.00 equiv) in dry 
acetone (2.4 mL) was added.  The reaction mixture was stirred for 2 hours in the dark, then warmed to 23 °C.  To 
the reaction mixture was added 3-nitrofluorobenzene (20.0 PL, 0.188 mmol, 0.939 equiv).  The yield was 
determined by comparing the integration of the 19F NMR (375 MHz, acetone-d6, 23 ºC) resonance of 1-fluoro-4-
(trifluoromethoxy)benzene (±117.0 ppm, ±59.9 ppm), 1,4-difluorobenzene (±121.7 ppm), 4,4'-difluorobiphenyl (±
118.0 ppm), 4-fluorophenol (±128.4 ppm), and fluorobenzene (±115.4 ppm) with that of 3-nitrofluorobenzene (±
112.0 ppm).  Yields are reported as percentages (by 19F NMR). 
 
Effect of additives on the yield of Ag-mediated trifluoromethoxylation reaction 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (110 mg, 0.400 mmol, 2.00 equiv), 
additive (0.400 mmol, 2.00 equiv), and (4-fluorophenyl)tributylstannane3 (4) (77.0 mg, 0.200 mmol, 1.00 equiv) in 
anhydrous THF (0.800 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (0.18 g, 0.12 mL, 
0.83 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred at í30 °C for 30 
minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate) (2) (113 mg, 0.240 mmol, 1.20 equiv) and silver hexafluorophosphate (101 mg, 0.400 
81 
 
mmol, 2.00 equiv) in dry acetone (2.4 mL) was added.  The reaction mixture was stirred for 2 hours in the dark, then 
warmed to 23 °C.  To the reaction mixture was added 3-nitrofluorobenzene (20.0 PL, 0.188 mmol, 0.939 equiv).  
The yield was determined by comparing the integration of the 19F NMR (375 MHz, acetone-d6, 23 ºC) resonance of 
1-fluoro-4-(trifluoromethoxy)benzene (±117.0 ppm, ±59.9 ppm), 1,4-difluorobenzene (±121.7 ppm), 4,4'-
difluorobiphenyl (±118.0 ppm), 4-fluorophenol (±128.4 ppm), and fluorobenzene (±115.4 ppm) with that of 3-
nitrofluorobenzene (±112.0 ppm).  Yields are reported as percentages (19F NMR). 
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Representative 19F NMR spectrum (375 MHz, CDCl3, 23 ºC) for the trifluoromethoxylation of 4 to give 5 
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T ributyl(4-biphenyl)stannane3 (10) 
To 4-bromobiphenyl (3.00 g, 12.9 mmol, 1.00 equiv) in anhydrous THF (30 mL) at ±78 ºC was added nBuLi (2.5 M 
in hexanes, 5.1 mL, 13 mmol, 1.0 equiv).  The reaction mixture was stirred at ±78 ºC for 30 min before the addition 
of Bu3SnCl (4.20 g, 3.50 mL, 12.9 mmol, 1.00 equiv).  After stirring for 1.0 hr at ±78 ºC, the reaction mixture was 
warmed to 23 ºC and the solvent was removed in vacuo.  The residue was dissolved in 20 mL of Et2O and filtered 
through a plug of neutral alumina.  The filtrate was concentrated in vacuo and the residue purified via column 
chromatography on silica gel eluting with hexanes to afford 3.76 g of the title compound as a colorless oil (88% 
yield). 
Rf = 0.58 (hexanes).  NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 ºC, G): 7.69±7.57 (m, 6H), 7.58±7.51 (m, 
2H), 7.44±7.38 (m, 1H), 1.75±1.59 (m, 6H), 1.52±1.40 (m, 6H), 1.27±1.09 (m, 6H), 0.99 (t, J = 7.3 Hz, 9H).  13C 
NMR (100 MHz, CDCl3, 23 ºCG): 141.5, 140.0, 137.0, 128.9, 127.3, 127.2, 127.1, 126.8, 29.3, 27.6, 13.9, 9.8.  
These spectroscopic data correspond to previously reported data.3  
 
4-(T rifluoromethoxy)biphenyl8 (21) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (222 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and tributyl(4-biphenyl)stannane (10) (253 mg, 0.500 mmol, 1.00 
equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (0.45 g, 0.30 
mL, 2.1 mmol, 4.1 equiv)(0.45 g, 0.30 mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The 
reaction mixture was stirred at í30 °C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-
                                                          
8  Sun, C.-L.; Li, H.; Yu, D.-G.; Yu, M.; Zhou, X.; Lu, X.-Y.; Huang, K.; Zheng, S.-F.; Li, B.-J.; Shi, Z.-J. Nature 
Chemistry 2010, 2, 1044. 
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1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver 
hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction 
mixture was stirred for 2.5 hours in the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad 
of celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column 
chromatography on silica gel eluting with hexanes/CH2Cl2 19:1 (v/v) to afford 104 mg of the title compound as a 
white solid (88% yield). 
Rf = 0.53 (hexanes/CH2Cl2 19:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.64±7.59 (m, 
4H), 7.51±7.48 (m, 2 H), 7.41 (t, J = 7.3 Hz, 1H), 7.34 (d, J = 8.2 Hz, 2H).  13C NMR (100 MHz, CDCl3, 23 °C, G): 
148.8 (q, J = 2 Hz), 140.1, 140.0, 129.0, 128.6, 127.8, 127.3, 121.4, 120.7 (q, J = 256 Hz).  19F NMR (375 MHz, 
CDCl3, 23 °C, G): ±58.2.  These spectroscopic data correspond to previously reported data.8  
 
1-Methoxy-4-(tr ifluoromethoxy)benzene (24) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and tributyl(4-methoxyphenyl)stannane9 (11) (199 mg, 0.500 mmol, 
1.00 equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (0.45 g, 
0.30 mL, 2.1 mmol, 4.1equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred at í30 
°C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver hexafluorophosphate (252 mg, 1.00 
mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction mixture was stirred for 2 hours in 
the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and 
the filtrate concentrated in vacuo at 5 °C.  The residue was purified via column chromatography on silica gel eluting 
with pentane/CH2Cl2 9:1 (v/v) to afford 84 mg of the title compound as a clear liquid (87% yield). 
                                                          
9 Tang, P.; Furuya, T.; Ritter, T. J. Am. Chem. Soc. 2010, 132, 12150. 
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Rf = 0.48 (pentane/CH2Cl2 9:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.15 (d, J = 9.2 
Hz, 2H), 6.89 (dd, J = 9.2 Hz, 3.7 Hz, 2H), 3.81 (s, 3H).  13C NMR (125 MHz, CDCl3, 23 °C, G): 158.3, 142.9 (q, J 
= 2 Hz), 122.6, 120.8 (q, J = 256 Hz), 114.8, 55.7.  19F NMR (470 MHz, CDCl3, 23 °C, G): ±58.9.  These 
spectroscopic data correspond to those obtained from an authentic sample purchased from Strem. 
 
(4-Bromophenyl)tr ibutylstannane (12) 
To 1,4-dibromobenzene (1.2 g, 5.0 mmol, 1.0 equiv) in THF (13 mL) at ±78 ºC was added nBuLi (1.6 M in hexane, 
3.1 mL, 5.0 mmol, 1.0 equiv).  The reaction mixture was stirred at ±78 ºC for 30 min before the addition of Bu3SnCl 
(1.6 g, 1.4 mL, 5.0 mmol, 1.0 equiv).  After stirring for 1 hr at ±78 ºC, the reaction mixture was warmed to 23 ºC 
and the solvent was removed in vacuo.  The residue was dissolved in 20 mL of Et2O and filtered through a plug of 
neutral alumina. The filtrate was concentrated in vacuo and the residue purified via column chromatography on 
silica gel eluting with hexanes to afford 2.1 g of the title compound as a colorless oil (95% yield). 
Rf = 0.50 (hexanes).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 ºC, G): 7.48 (d, J = 7.8 Hz, 2H), 7.35 (d, J 
= 7.8 Hz, 2H), 1.59±1.53 (m, 6H), 1.40±1.32 (m, 6H), 1.10±1.07 (m, 6H), 0.92 (t, J = 7.3 Hz, 9H).  13C NMR (125 
MHz, CDCl3, 23 ºCG): 140.7, 138.0, 131.1, 122.9, 29.2, 27.5, 13.8, 9.8.  These spectroscopic data correspond to 
previously reported data.9  
 
1-Bromo-4-(trifluoromethoxy)benzene (25) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and (4-bromophenyl)tributylstannane9 (12) (223 mg, 0.500 mmol, 
HTXLYLQDQK\GURXV7+)P/DWí&ZDVDGGHGtrifluoromethyl trifluoromethanesulfonate (3) (0.45 g, 
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0.30 mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously7KHUHDFWLRQPL[WXUHZDVVWLUUHGDWí
& IRU PLQXWHV WKHQ D VROXWLRQ FRROHG WR í & RI -chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver hexafluorophosphate (252 mg, 1.00 
mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction mixture was stirred for 2.5 hours in 
the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and 
the filtrate concentrated in vacuo at 5 °C.  The residue was purified via column chromatography on silica gel eluting 
with pentane/CH2Cl2 1:1 (v/v) to afford 101 mg of the title compound as a clear liquid (84% yield). 
Rf = 0.86 (pentane/CH2Cl2 1:1 (v/v)).  NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 °C, G): 7.52 (dd, J = 8.8 
Hz, 1.8 Hz, 2H), 7.10 (d, J = 8.8 Hz, 2H).  13C NMR (100 MHz, CDCl3, 23 °C, G): 148.4 (q, J = 2 Hz), 133.1, 122.9, 
120.3, 120.5 (q, J = 258 Hz).  19F NMR (375 MHz, CDCl3, 23 °C, G): ±58.5.  These spectroscopic data correspond to 
those obtained from an authentic sample purchased from Strem. 
 
T ributyl(3,4,5-trimethoxyphenyl)stannane10 (14) 
To 5-bromo-1,2,3-trimethoxybenzene (1.2 g, 4.9 mmol, 1.0 equiv), in anhydrous THF (12 mL) at ±78 °C was added 
nBuLi (2.5 M in hexanes, 2.1 mL, 5.3 mmol, 1.1 equiv).  The reaction mixture was stirred at ±78 ºC for 30 min 
before the addition of Bu3SnCl (1.6 g, 1.3 mL, 4.9 mmol, 1.0 equiv).  After stirring for 1.0 hr at ±78 ºC, the reaction 
mixture was warmed to 23 ºC and the solvent was removed in vacuo. The residue was dissolved in 20 mL of Et2O 
and filtered through a plug of neutral alumina. The filtrate was concentrated in vacuo and was purified by 
chromatography on silica gel eluting with hexanes/EtOAc 5:1 (v/v) to afford 1.6 g of the title compound as a 
colorless oil (73% yield). 
Rf = 0.47 (hexanes/EtOAc 5:1 (v/v)).  NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 °C, G): 6.66 (s, 2H), 
3.88(s, 6H), 3.86 (s, 3H), 1.59±1.55 (m, 6H), 1.38±1.33 (m, 6H), 1.09±1.05 (m, 6H), 0.91 (t, J = 7.2 Hz, 9H).  13C 
                                                          
10 Suginome, H.; Orito, K.; Yorita, K.; Ishikawa, M.; Shimoyama, N.; Sasaki, T. J. Org. Chem. 1995, 60, 3052. 
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NMR (100 MHz, CDCl3, 23 °C, G): 153.0, 138.4, 136.7, 113.0, 60.8, 56.2, 29.2, 27.4, 13.7, 9.9.  These 
spectroscopic data correspond to previously reported data.10  
 
1,2,3-T rimethoxy-5-(trifluoromethoxy)benzene (23) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and tributyl(3,4,5-trimethoxyphenyl)stannane10 (14) (229 mg, 0.500 
mmol, 1.00 equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) 
(0.45 g, 0.30 mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred 
at í30 °C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-
diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver 
hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction 
mixture was stirred for 4 hours in the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad 
of celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column 
chromatography on silica gel eluting with hexanes/CH2Cl2 1:2 (v/v) to afford 94 mg of the title compound as a clear 
oil (75% yield). 
Rf = 0.28 (hexanes/CH2Cl2 1:2 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 6.45 (s, 2H), 3.84 
(s, 6H), 3.82 (s, 3H).  13C NMR (100 MHz, CDCl3, 23 °C, G): 153.7, 145.3 (q, J = 2 Hz), 136.8, 120.6 (q, J = 257 
Hz), 99.0, 61.0, 56.3.  19F NMR (470 MHz, CDCl3, 23 °C, G): ±58.4.  Mass Spectrometry: HRMS-FIA (m/z): Calcd 
for C10H12F3O4 [M + H]+, 253.0682. Found, 253.0685. 
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Methyl 6-(tr ibutylstannyl)-2-naphthoate (15) 
To a suspension of lithium chloride (635 mg, 15.0 mmol, 5.00 equiv), hexabutylditin (3.44 g, 3.00 mL, 6.00 mmol, 
2.50 equiv), and methyl 6-bromo-2-naphthoate (795 mg, 3.00 mmol, 1.00 equiv) in anhydrous dioxane (30.0 mL) at 
25 °C was added palladium tetrakis triphenylphosphine (173 mg, 0.150 mmol, 0.0500 equiv).  The reaction mixture 
was heated to 100 °C and stirred for 12 hours, then cooled to room temperature.  The reaction mixture was filtered 
through a pad of celite eluting with CH2Cl2, and the filtrate concentrated in vacuo.  The residue was purified via 
column chromatography on silica gel eluting with hexanes/EtOAc 3:1 (v/v) to afford 741 mg of the title compound 
as a clear oil (52% yield). 
Rf = 0.75 (hexanes/EtOAc 3:1 (v/v)).  NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 °C, G): 8.61 (s, 1H), 8.08 
(dd, J = 8.8 Hz, 1.6 Hz, 1H), 8.01 (s, 1H), 7.96±7.86 (m, 2H), 7.66 (d, J = 8.1 Hz, 1H), 3.99 (s, 3H), 1.70±1.53 (m, 
6H), 1.43±1.30 (m, 6H), 1.29±1.09 (m, 6H), 0.93 (t, J = 7.3 Hz, 9H).  13C NMR (125 MHz, CDCl3, 23 °C, G): 167.4, 
143.7, 136.4, 135.1, 134.0, 132.4, 131.2, 128.1, 127.9, 127.3, 125.2, 52.2, 29.2, 27.5, 13.8, 9.8.  Mass Spectrometry: 
HRMS-FIA (m/z): Calcd for C24H37O2Sn [M + H]+, 477.1810. Found, 477.1795. 
 
Methyl 6-(tr ifluoromethoxy)-2-naphthoate (27) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and methyl 6-(tributylstannyl)-2-naphthoate (15) (238 mg, 0.500 
mmol, 1.00 equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) 
(0.45 g, 0.30 mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred 
at í30 °C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-
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diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver 
hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction 
mixture was stirred for 2.5 hours in the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad 
of celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column 
chromatography on silica gel eluting with hexanes/CH2Cl2 1:2 (v/v) to afford 102 mg of the title compound as a 
clear oil (76% yield). 
Rf = 0.52 (hexanes/CH2Cl2 1:2 (v/v)).  NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 °C, G): 8.61 (s, 1H), 
8.11 (dd, J = 8.7 Hz, 1.8 Hz, 1H), 7.98 (d, J = 9.2 Hz, 1H), 7.86 (d, J = 8.7 Hz, 1H), 7.68 (s, 1H), 7.39 (dd, J = 9.2 
Hz, 1.8 Hz, 1H), 3.99 (s, 3H).  13C NMR (100 MHz, CDCl3, 23 °C, G): 167.0, 148.7 (q, J = 2 Hz), 135.9, 131.7, 
130.9, 130.8, 128.2, 128.1, 126.6, 120.9, 120.7 (q, J = 257 Hz), 117.8, 52.5.  19F NMR (375 MHz, CDCl3, 23 °C, G): 
±58.0.  Mass Spectrometry: HRMS-FIA (m/z): Calcd for C13H10F3O3 [M + H]+, 271.0577. Found, 271.0573. 
 
5-T ributylstannyl-N-Boc-indole3 (20) 
To a suspension of lithium chloride (297 mg, 7.00 mmol, 2.00 equiv), hexabutylditin (3.05 g, 2.65 mL, 5.25 mmol, 
1.50 equiv), and 5-bromo-N-Boc-indole (1.04 g, 3.50 mmol, 1.00 equiv) in anhydrous dioxane (17.5 mL) at 25 °C 
was added palladium tetrakis triphenylphosphine (75.0 mg, 0.175 mmol, 0.0500 equiv).  The reaction mixture was 
heated at 100 °C and stirred for 2.5 hours at this temperature, then cooled to room temperature.  The reaction 
mixture was filtered through a pad of celite eluting with CH2Cl2, and the filtrate concentrated in vacuo.  The residue 
was purified via column chromatography on silica gel eluting with hexanes/EtOAc 9:1 (v/v) and further purified by 
evaporation of impurities via kugelrohr at 150 °C at 200 millitorr to afford 1.50 g of the title compound as a clear oil 
(85% yield). 
Rf = 0.50 (hexanes/EtOAc 9:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 8.15 (d, J = 6.0 
Hz, 1H), 7.70 (s, 1H), 7.60 (d, J = 3.2 Hz, 1H), 7.44 (d, J = 6.0 Hz, 1H), 6.59 (d, J = 3.2 Hz, 1H), 1.70 (s, 9H), 1.67±
1.55 (m, 6H), 1.43±1.35 (m, 6H), 1.20±1.06 (m, 6H), 0.96 (t, J = 6.0 Hz, 9H).  13C NMR (100 MHz, CDCl3, 23 °C, 
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G): 150.0, 135.4, 132.0, 134.7, 130.8, 129.2, 125.5, 114.9, 107.2, 83.6, 29.3, 28.3, 27.5, 13.8, 9.8.  These 
spectroscopic data correspond to previously reported data.3  
 
5-T rifluoromethoxy-N-Boc-indole (28) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and 5-tributylstannyl-N-Boc-indole3 (20) (253 mg, 0.500 mmol, 1.00 
equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (0.45 g, 0.30 
mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred at í30 °C for 
30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver hexafluorophosphate (252 mg, 1.00 
mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction mixture was stirred for 2.5 hours in 
the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and 
the filtrate concentrated in vacuo.  The residue was purified via column chromatography on silica gel eluting with 
hexanes/CH2Cl2 1:1 (v/v) to afford 108 mg of the title compound as a clear oil (72% yield). 
Rf = 0.70 (hexanes/CH2Cl2 1:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 8.17 (d, J = 7.8 
Hz, 1H), 7.66 (d, J = 3.4 Hz, 1H), 7.42 (s, 1H), 7.18 (d, J = 7.3 Hz, 1H), 6.57 (d, J = 3.4 Hz, 1H), 1.68 (s, 9H).  13C 
NMR (125 MHz, CDCl3, 23 °C, G): 149.4, 145.0 (q, J = 2 Hz), 133.6, 131.3, 127.8, 123.9 (q, J = 256 Hz), 117.8, 
116.1, 113.4, 107.2, 84.3, 28.3.  19F NMR (375 MHz, CDCl3, 23 °C, G): ±58.5.  Mass Spectrometry: HRMS-FIA 
(m/z): Calcd for C9H7F3NO [M ± C5H9O2 (Boc) + H]+, 202.0480. Found, 202.0485. 
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Ethyl 4-(trifluoromethoxy)benzoate11 (22) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and ethyl 4-(tributylstannyl)benzoate9 (16) (220 mg, 0.500 mmol, 
1.00 equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (0.45 g, 
0.30 mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred at í30 
°C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver hexafluorophosphate (252 mg, 1.00 
mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction mixture was stirred for 2 hours in 
the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and 
the filtrate concentrated in vacuo at 5 °C.  The residue was purified via column chromatography on silica gel eluting 
with pentane/CH2Cl2 1:1 (v/v) to afford 92 mg of the title compound as a light yellow oil (79% yield). 
Rf = 0.89 (pentane/CH2Cl2 1:1 (v/v)).  NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 °C, G): 8.09 (d, J = 9.2 
Hz, 2H), 7.26 (d, J = 9.2 Hz, 2H), 4.39 (q, J = 7.2 Hz, 2H), 1.40 (t, J = 6.8 Hz, 2H).  13C NMR (100 MHz, CDCl3, 
23 °C, G): 165.6, 152.7 (q, J = 2 Hz), 131.6, 129.1, 120.5, 120.4 (q, J = 257 Hz), 61.4, 14.4.  19F NMR (375 MHz, 
CDCl3, 23 °C, G): ±58.1.  These spectroscopic data correspond to previously reported data.11  
 
Synthesis of ethyl 4-(trifluoromethoxy)benzoate11 (22) on gram scale 
                                                          
11 Shang, R.; Fu, Y.; Li, J.-B.; Zhang, S.-L.; Guo, Q.-X.; Liu, L. J. Am. Chem. Soc. 2009, 131, 5738. 
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To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (1.65 g, 6.00 mmol, 2.00 equiv), sodium 
bicarbonate (594 mg, 6.00 mmol, 2.00 equiv), and ethyl 4-(tributylstannyl)benzoate9 (16) (1.32 g, 3.00 mmol, 1.00 
equiv) in anhydrous THF (12.0 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (2.6 g, 1.8 
mL, 12 mmol, 4.0 equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred at í30 °C for 
30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate) (2) (1.69 g, 3.60 mmol, 1.20 equiv) and silver hexafluorophosphate (1.52 mg, 6.00 mmol, 
2.00 equiv) in dry acetone (36.0 mL) was added by cannula.  The reaction mixture was stirred for 2 hours in the 
dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and the 
filtrate concentrated in vacuo at 5 °C.  The residue was purified via column chromatography on silica gel eluting 
with pentane/CH2Cl2 1:1 (v/v) to afford 563 mg of the title compound as a light yellow oil (80% yield). 
Rf = 0.89 (pentane/CH2Cl2 1:1 (v/v)).  NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 °C, G): 8.09 (d, J = 9.2 
Hz, 2H), 7.26 (d, J = 9.2 Hz, 2H), 4.39 (q, J = 7.2 Hz, 2H), 1.40 (t, J = 6.8 Hz, 2H).  13C NMR (100 MHz, CDCl3, 
23 °C, G): 165.6, 152.7 (q, J = 2 Hz), 131.6, 129.1, 120.5, 120.4 (q, J = 257 Hz), 61.4, 14.4.  19F NMR (375 MHz, 
CDCl3, 23 °C, G): ±58.1.  These spectroscopic data correspond to previously reported data.11  
 
1-Methoxy-2-(tr ifluoromethoxy)benzene12 (26) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and tributyl(2-methoxyphenyl)stannane13 (41) (199 mg, 0.500 mmol, 
1.00 equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (0.45 g, 
0.30 mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred at í30 
°C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
                                                          
12 Castagnetti, E.; Schlosser, M. Chem. Eur. J. 2002, 8, 799. 
13 Chun, J.-H.; Lu, S.; Lee, Y.-S.; Pike, V. W. J. Org. Chem. 2010, 75, 3332. 
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bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver hexafluorophosphate (252 mg, 1.00 
mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction mixture was stirred for 2.5 hours in 
the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and 
the filtrate concentrated in vacuo at 5 °C.  The residue was purified via column chromatography on silica gel eluting 
with pentane/CH2Cl2 9:1 (v/v) to afford 74 mg of the title compound as a clear oil (77% yield). 
Rf = 0.57 (pentane/CH2Cl2 9:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.24±7.23 (m, 
2H), 6.99 (d, J = 7.8 Hz, 1H), 6.93 (t, J = 7.8 Hz, 1H), 3.87 (s, 3H).  13C NMR (125 MHz, CDCl3, 23 °C, G): 152.2, 
138.3 (q, J = 2 Hz), 128.0, 123.0, 120.8 (q, J = 257 Hz), 120.7, 113.1, 56.1.  19F NMR (470 MHz, CDCl3, 23 °C, G): 
±58.6.  These spectroscopic data correspond to previously reported data.12  
 
N-Boc-4-(tr ifluoromethoxy)-L-phenylalanine methyl ester (29) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and N-Boc-4-(tributylstannyl)-L-phenylalanine methyl ester9 (17) 
(284 mg, 0.500 mmol, 1.00 equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl 
trifluoromethanesulfonate (3) (0.45 g, 0.30 mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously.  
The reaction mixture was stirred at í30 °C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-
fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver 
hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction 
mixture was stirred for 2.5 hours in the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad 
of celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column 
chromatography on silica gel eluting with CH2Cl2 to afford 136 mg of the title compound as a white solid (75% 
yield). 
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Rf = 0.29 (CH2Cl2).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.17±7.12 (m, 4H), 4.99 (d, J = 7.7 
Hz, 1H), 4.60±4.58 (m, 1H), 3.71 (s, 3H), 3.17±3.00 (m, 1H), 1.41 (s, 9H).  13C NMR (125 MHz, CDCl3, 23 °C, G): 
172.2, 155.1, 148.5, 135.0, 130.8, 121.1, 120.6 (q, J = 255 Hz), 80.2, 54.4, 52.5, 38.0, 28.4.  19F NMR (470 MHz, 
CDCl3, 23 °C, G): ±58.3.  Mass Spectrometry: HRMS-FIA (m/z): Calcd for C16H20F3NO5Na [M + Na]+, 386.1186. 
Found, 386.1190. 
 
3-Deoxy-3-trifluoromethoxyestrone (30) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (275 mg, 1.00 mmol, 2.00 equiv), sodium 
bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv), and 3-deoxy-3-(tributylstannyl)estrone9 (18) (272 mg, 0.500 mmol, 
1.00 equiv) in anhydrous THF (2.00 mL) at í30 °C was added trifluoromethyl trifluoromethanesulfonate (3) (0.45 g, 
0.30 mL, 2.1 mmol, 4.1 equiv), and the suspension was stirred vigorously.  The reaction mixture was stirred at í30 
°C for 30 minutes, then a solution cooled to í30 °C of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv) and silver hexafluorophosphate (252 mg, 1.00 
mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by cannula.  The reaction mixture was stirred for 4 hours in 
the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and 
the filtrate concentrated in vacuo.  The residue was purified via column chromatography on silica gel eluting with 
CH2Cl2 to afford 122 mg of the title compound as a white solid (72% yield). 
Rf = 0.42 (CH2Cl2).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.29 (d, J = 8.7 Hz , 1H), 6.99 (d, J 
= 8.7 Hz, 1H), 6.94 (s, 1H), 2.92 (dd, J = 8.5 Hz, 3.5 Hz, 2 H), 2.51 (dd, J = 18.5 Hz, 8.5 Hz, 1H), 2.42±2.39 (m, 
1H), 2.30±2.26 (m, 1H), 2.19±2.11 (m, 1H), 2.09±2.02 (m, 2H), 1.99±1.96 (m, 1H), 1.66±1.44 (m, 6H), 0.92 (s, 3H).  
13C NMR (125 MHz, CDCl3, 23 °C, G): 220.7, 147.4 (q, J = 2 Hz), 138.6, 138.5, 126.8, 121.1, 120.5 (q, J = 255 Hz), 
118.3, 50.5, 48.0, 44.2, 38.1, 35.9, 31.7, 29.5, 26.4, 25.9, 21.7, 13.9.  19F NMR (375 MHz, CDCl3, 23 °C, G): ±58.2.  
Mass Spectrometry: HRMS-FIA (m/z): Calcd for C20H22F3O2 [M + H]+, 339.1566. Found, 339.1565. 
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N-Boc-4-(tr ibutylstannyl)-L-phenylalanyl-L-phenylalanine methyl ester9 (42) 
To N-Boc-4-(tributylstannyl)-L-phenylalanine9 (422 mg, 0.742 mmol, 1.00 equiv) and L-phenylalanine methyl ester 
hydrochloride (160 mg, 0.742 mmol, 1.00 equiv) in CH2Cl2 (30 mL) at 0 ºC was added 1-(3-dimethylaminopropyl)-
3-ethylcarbodiimide hydrochloride (EDCI) (427 mg, 2.23 mmol, 3.00 equiv), 1-hydroxybenzotriazole (HOBt) (201 
mg, 1.49 mmol, 2.00 equiv), N,N-diisopropylethylamine (288 mg, 388 µL, 2.23 mmol, 3.00 equiv) and 4-
(dimethylamino)pyridine (9.1 mg, 0.074 mmol, 0.10 equiv).  After stirring for 1 hr at 0 ºC, the reaction mixture was 
warmed to 23 ºC and further stirred for 12 hr.  The reaction mixture was quenched with water (10 mL), and CH2Cl2 
(5 mL) was added.  The phases were separated and the aqueous phase was extracted with CH2Cl2 (2 × 5 mL).  The 
combined organic phases were washed with brine (5 mL) and dried (Na2SO4).  The filtrate was concentrated in 
vacuo and the residue was purified by chromatography on silica gel, eluting with hexanes/EtOAc 3:1 (v/v), to afford 
389 mg of the title compound as a colorless foam (73% yield). 
Rf = 0.30 (hexanes/EtOAc 3:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 ºC, G): 7.39 (d, J = 7.3 
Hz, 2H), 7.23±7.21 (m, 3H), 7.15 (d, J = 6.9 Hz, 2H), 6.97 (dd, J = 7.3 Hz, 1.8 Hz, 2H), 6.38 (d, J = 6.9 Hz, 1H), 
4.90 (br s, 1H), 4.80 (br s, 1H), 4.35 (br s, 1H), 3.68 (s, 3H), 3.09±2.99 (m, 4H), 1.55±1.50 (m, 6H), 1.38 (s, 9H), 
1.36±1.29 (m, 6H), 1.05±1.01 (m, 6H), 0.87 (t, J = 7.3 Hz, 9H).  13C NMR (125 MHz, CDCl3, 23 ºC, G): 171.5, 
171.0, 155.4, 140.4, 136.9, 136.2, 135.8, 129.3, 129.1, 129.0, 128.6, 127.2, 80.3, 55.6, 53.4, 52.4, 38.1, 29.1, 28.3, 
27.5, 13.8, 9.7.  These spectroscopic data correspond to previously reported data.9  
 
N-Boc-4-(tr ifluoromethoxy)-L-phenylalanyl-L-phenylalanine methyl ester (31) 
96 
 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (273 mg, 0.992 mmol, 2.00 equiv), 
sodium bicarbonate (83.0 mg, 0.992 mmol, 2.00 equiv), and N-Boc-4-(tributylstannyl)-L-phenylalanyl-L-
phenylalanine methyl ester9 (42 PJPPROHTXLY LQDQK\GURXV7+) P/DWí&ZDV
added trifluoromethyl trifluoromethanesulfonate (3) (0.45 g, 0.30 mL, 2.1 mmol, 4.1 equiv) , and the suspension was 
stirred vigorously7KHUHDFWLRQPL[WXUHZDVVWLUUHGDWí&IRUPLQXWHVWKHQDVROXWLRQFRROHGWRí&RI-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 
equiv) and silver hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) in dry acetone (6.0 mL) was added by 
cannula.  The reaction mixture was stirred for 2 hours in the dark, then warmed to 23 °C.  The reaction mixture was 
filtered through a pad of celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified 
via column chromatography on silica gel eluting with hexanes/acetone 3:1 (v/v) to afford 170 mg of the title 
compound as a white solid (67% yield). 
Rf = 0.45 (hexanes/acetone 3:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.25±7.23 (m, 
3H), 7.20 (d, J = 8.3 Hz , 1H), 7.12 (d, J = 7.8 Hz , 1H), 7.01 (dd, J = 7.8 Hz, 2.0 Hz, 1 H), 6.26±6.24 (m, 1H), 
4.93±4.91 (m, 1H), 4.78±4.77 (m, 1H), 4.32±4.31 (m, 1H), 3.69 (s, 3H), 3.12±2.99 (m, 5H), 1.40 (s, 9H).  13C NMR 
(125 MHz, CDCl3, 23 °C, G): 171.5, 170.6, 155.4, 148.4, 135.6, 130.9, 129.3, 128.7, 127.3, 120.6 (q, J = 255 Hz), 
121.2, 115.6, 80.5, 55.7, 53.3, 52.5, 38.0, 37.8, 28.3.  19F NMR (375 MHz, CDCl3, 23 °C, G): ±58.3.  Mass 
Spectrometry: HRMS-FIA (m/z): Calcd for C25H30F3N2O6 [M + H]+, 511.2051. Found, 511.2040. 
 
3-(T rifluoromethanesulfonyl)morphine14 (39) 
To morphine (23.7 g, 83.1 mmol, 1.00 equiv) in CH2Cl2 (500 mL) was added N-phenyltriflimide (30.0 g, 84.0 
mmol, 1.01 equiv) and triethylamine (24.8 g, 34.0 mL, 0.245 mol, 2.95 equiv).  The reaction mixture was stirred at 
reflux for 10 hours.  The reaction was cooled to 23 °C and diluted with CH2Cl2 (250 mL).  The organic phase was 
                                                          
14 Hedberg, M. H.; Johansson, A. M.; Nordvall, G.; Yliniemela, A.; Li, H. B.; Martin, A. R.; Hjorth, S.; Unelius, L.; 
Sundell, S.; Hacksell, U. J. Med. Chem. 1995, 38, 647. 
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washed with NaHCO3 (30 mL) and the aqueous layer was extracted with CH2Cl2 (3 × 150 mL).  The combined 
organic phases were washed with brine (500 mL) and dried with Na2SO4.  The filtrate was concentrated in vacuo 
and the resulting residue the residue was purified by chromatography on silica gel eluting with CH2Cl2/MeOH 9:1 
(v/v) to afford 30.5 g of the title compound as a light beige solid (88% yield). 
Rf = 0.53 (CH2Cl2/MeOH 9:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 6.89 (d, J = 8.4 
Hz, 1H), 6.64 (d, J = 8.4 Hz, 1H), 5.72±5.69 (m, 1H), 5.30±5.26 (m, 1H), 5.02 (d, J = 6.4 Hz, 1H), 4.24±4.16 (m, 
1H), 3.38 (dd, J = 5.9 Hz, 3.3 Hz , 1H), 3.08 (d, J = 18.8 Hz, 1H), 2.92±2.90 (m, 1H), 2.70 (t, J = 2.6 Hz, 1H), 2.61 
(dd, J = 13.2, Hz, 4.6 Hz, 1H), 2.44 (s, 3H), 2.42±2.28 (m, 2H), 2.10 (dt, J = 12.4 Hz, 5.1 Hz, 1H), 1.90 (d, J = 7.3 
Hz, 1H).  13C NMR (100 MHz, CDCl3, 23 °C, G): 149.7, 135.8, 133.9, 130.8, 129.7, 128.3, 121.3, 120.4, 118.8 (q, J 
= 323 Hz), 93.7, 66.6, 58.7, 46.2, 43.5, 43.2, 40.6, 35.3, 21.1.  19F NMR (375 MHz, CDCl3, 23 °C, G): ±73.4.  These 
spectroscopic data correspond to previously reported data.14  
 
Methyl 3-(tr ifluoromethanesulfonyl)normorphine-carboxylate (40) 
To 3-trifluoromethanesulfonyl morphine14 (39) (4.50 g, 10.8 mmol, 1.00 equiv) in CHCl3 (110 mL) was added 
NaHCO3 (13.6 g, 0.162 mol, 15.0 equiv) and methyl chloroformate (17.4 g, 14.2 mL, 0.183 mol, 17.0 equiv).  The 
reaction mixture was stirred at reflux for 18 h.  The reaction was cooled to 23 °C and quenched with H2O (100 mL).  
The aqueous layer was extracted with CH2Cl2 (3 × 100 mL).  The combined organic phases were washed with brine 
(100 mL) and dried with Na2SO4.  The filtrate was concentrated in vacuo and the resulting residue the residue was 
purified by chromatography on silica gel eluting with hexanes/EtOAc 2:3 (v/v) to afford 4.67 g of the title 
compound as a pale yellow solid (94% yield). 
Rf = 0.29 (hexanes/EtOAc 2:3 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 6.93 (d, J = 8.3 
Hz, 1H), 6.65 (d, J = 8.3 Hz, 1H), 5.76 (d, J = 9.2 Hz, 1H), 5.31±5.28 (m, 1H), 5.02 (d, J = 6.5 Hz, 1H), 4.85±4.84 
(m, 1H), 4.20±4.03 (m, 2H), 3.75 (s, 3H)*, 3.00±2.87 (m, 3H), 2.79 (d, J = 19.0 Hz, 1H), 2.57 (s, 1H), 2.00±1.91 (m, 
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2H).  13C NMR (125 MHz, CDCl3, 23 °C, G): 149.8, 135.0, 134.7, 132.8, 131.0, 127.1, 126.9, 121.8, 120.4, 118.8 (q, 
J = 320 Hz), 93.5, 66.3, 53.0. 50.0, 43.9, 39.6*, 37.3, 35.1, 30.1*.  19F NMR (470 MHz, CDCl3, 23 °C, G): ±73.4.  
Mass Spectrometry: HRMS-FIA (m/z): Calcd for C19H18F3NO7SNa [M + Na]+, 484.0648. Found, 484.0664.  *Two 
signals attributed to a mixture of rotamers 
 
Methyl 3-deoxy-3-(tr ibutylstannyl)normorphine-carboxylate (19) 
To a suspension of lithium chloride (551 mg, 13.0 mmol, 3.00 equiv), hexabutylditin (5.03 g, 4.38 mL, 8.67 mmol, 
2.00 equiv), and methyl 3-(trifluoromethanesulfonyl)normorphine-carboxylate (40) (2.00 g, 4.33 mmol, 1.00 equiv) 
in anhydrous dioxane (40.0 mL) at 25 °C was added palladium tetrakis triphenylphosphine (250 mg, 0.217 mmol, 
0.0500 equiv).  The reaction mixture was heated and stirred at 105 °C for 24 hours, then cooled to room 
temperature.  The reaction mixture was filtered through a pad of celite eluting with CH2Cl2, and the filtrate 
concentrated in vacuo.  The residue was purified via column chromatography on silica gel eluting with 
hexanes/EtOAc 1:1 (v/v) to afford 1.51 g of the title compound as a light yellow oil (58% yield). 
Rf = 0.85 (hexanes/EtOAc 2:3 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.08 (d, J = 7.3 
Hz, 1H), 6.62 (d, J = 7.3 Hz, 1H), 5.72 (d, J = 9.2 Hz, 1H), 5.32±5.26 (m, 1H), 4.96 (s (rotamers), 1H), 4.76 (dd, J = 
6.6 Hz, 1.1 Hz, 1H), 4.18±4.11 (m, 1H), 4.00 (dd, J = 13.5 Hz, 4.0 Hz, 1H), 3.73 (s, 3H)*, 3.06±2.69 (m, 4H), 2.53 
(s, 1H), 1.96±1.85 (m, 2H), 1.61±1.42 (m, 6H), 1.37±1.24 (m, 6H), 1.15±0.98 (m, 6H), 0.88 (t, J = 5.3 Hz, 9H).  13C 
NMR (100 MHz, CDCl3, 23 °C, G): 165.3, 155.9, 136.2, 134.6, 134.4, 127.3, 126.3, 119.6, 116.4, 89.3, 66.6, 52.9, 
50.3, 42.8, 40.1*, 37.6, 35.7, 30.2*, 29.3, 27.4, 13.8, 9.8.  Mass Spectrometry: HRMS-FIA (m/z): Calcd for 
C30H45NO4SnNa [M + Na]+, 626.2262. Found, 626.2251.  *Two signals attributed to a mixture of rotamers 
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Methyl 3-deoxy-3-(tr ifluoromethoxy)normorphine-carboxylate (32) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (497 mg, 1.80 mmol, 2.00 equiv), and 
sodium bicarbonate (151 mg, 1.80 mmol, 2.00 equiv) in anhydrous THF (3.6 P/ DW í & ZDV DGGHG
trifluoromethyl trifluoromethanesulfonate (3) (786 mg, 524 ȝ/PPRO4.0 equiv), and the suspension was stirred 
vigorously.  The reaction mixture was stirred at í30 °C for 30 minutes, then a solution cooled to í30 °C of 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (509 mg, 1.08 mmol, 1.20 
equiv) and silver hexafluorophosphate (456 mg, 1.80 mmol, 2.00 equiv) in dry acetone (8.0 mL) was added by 
cannula.  Immediately afterwards, a solution of methyl 3-deoxy-3-tributylstannyl-normorphine-carboxylate (19) 
(543 mg, 0.901 mmol, 1.00 equiv) in dry acetone (2.8 mL) is added dropwise.  The reaction mixture was stirred for 
4 hours in the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with 
CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column chromatography on silica gel 
eluting with hexanes/acetone 3:1 (v/v) to afford 212 mg of the title compound as a white foam (59% yield). 
Rf = 0.24 (hexanes/acetone 3:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 6.94 (d, J = 8.3 
Hz, 1H), 6.62 (d, J = 8.3 Hz, 1H), 5.75 (d, J = 8.8 Hz, 1H), 5.31±5.26 (m, 1H), 4.98±4.82 (m, 2H), 4.19±4.02 (m, 
2H), 3.73 (s, 3H), 3.02±2.76 (m, 3H), 2.55 (s, 1H), 2.00±1.90 (m, 2H).  13C NMR (100 MHz, CDCl3, 23 °C, G): 
155.9, 150.2, 134.4, 133.2, 131.8, 130.5, 127.2, 123.1, 120.8 (q, J = 257 Hz), 120.5, 92.4, 66.2, 53.0, 50.0, 43.6, 
39.5*, 37.4, 35.3, 29.9*.  19F NMR (375 MHz, CDCl3, 23 °C, G): ±59.2.  Mass Spectrometry: HRMS-FIA (m/z): 
Calcd for C19H19F3NO5 [M + H]+, 398.1210. Found, 398.1212.  *Two signals attributed to a mixture of rotamers 
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6-(T rifluoromethoxy)quinoline (33) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (511 mg, 2.00 mmol, 4.00 equiv), and 
sodium bicarbonate (84.0 PJ  PPRO  HTXLY LQ DQK\GURXV 7+)  P/ DW í & ZDV DGGHG
trifluoromethyl trifluoromethanesulfonate (3) ( PJ  ȝ/  PPRO  equiv) , and the suspension was 
VWLUUHG YLJRURXVO\  7KH UHDFWLRQ PL[WXUH ZDV VWLUUHG DW í & IRU  PLQXWHV WKHQ D VROXWLRQ RI VLOYHU
hexafluorophosphate (253 mg, 1.00 mmol, 2.00 equiv) in dry acetone (1.25 mL) was added dropwise concurrently 
as a separate solution of 6-(tributylstannyl)quinoline3 (13) (209 mg, 0.500 mmol, 1.00 equiv) in dry acetone (1.75 
P/ ZDV DGGHG GURSZLVH DW í &  $ VROXWLRQ RI -chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane 
bis(hexafluorophosphate) (2) (471 mg, 1.00 mmol, 2.00 equiv) in dry acetone (3 mL) was then slowly added 
GURSZLVHRYHUPLQXWHVDWí&7KHUHDFWLRQPL[WXUHZDVVWLUUHGIRUKRXUVLQWKHGDUNWKHn warmed to 23 °C.  
The reaction mixture was filtered through a pad of celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  
The residue was purified via column chromatography on silica gel eluting with hexanes/acetone 3:1 (v/v) to afford 
15.0 mg of the title compound as a clear oil (14% yield).  The experiment was repeated to give 16% yield. 
Rf = 0.40 (hexanes/acetone 3:1 (v/v)).  NMR Spectroscopy: 1H NMR (400 MHz, CDCl3, 23 °C, G): 8.96 (d, J = 2.7 
Hz, 1H), 8.19±8.16 (m, 2H), 7.66 (s, 1H), 7.59 (d, J = 9.2 Hz, 1H), 7.48 (dd, J = 8.2 Hz, 4.1 Hz, 1H).  13C NMR 
(125 MHz, CDCl3, 23 °C, G): 150.8, 147.2, 146.4, 136.3, 131.8, 128.6, 123.9, 122.2, 117.9.  The OCF3 carbon was 
not observed in the 13C NMR due to insufficient quantity of the product.  19F NMR (375 MHz, CDCl3, 23 °C, G): ±
58.2.  Mass Spectrometry: HRMS-FIA (m/z): Calcd for C10H7F3NO [M + H]+, 214.0481. Found, 214.0480. 
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1-F luoro-4-(trifluoromethoxy)benzene (5) 
To a solution of sodium hydroxide in anhydrous methanol (1.00 N, 0.500 mL, 1.00 equiv) at 23 ºC was added 4-
fluorophenylboronic acid (34) (86.0 mg, 0.500 mmol, 1.00 equiv) and stirred for 15 minutes.  The reaction mixture 
was then cooled to 0 ºC and silver hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) was added and the 
suspension was stirred for 30 minutes at 0 ºC.  The solvent was removed under reduced pressure at 0 ºC, and the 
residual methanol was removed under reduced pressure by co-evaporation with anhydrous THF (2 × 0.500 mL). To 
the residue was added anhydrous THF (2.0 mL) and then tris(dimethylamino)sulfonium difluorotrimethylsilicate 
(276 mg, 1.00 mmol, 2.00 equiv) and sodium bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv) successively.  The 
reaction was cooled to ±30 ºC and to the suspension was added trifluoromethyl trifluoromethanesulfonate (3) (0.60 
g, 0.40 mL, 2.8 mmol, 5.5 equiv) and the suspension was then stirred at ±30 ºC for 30 minutes.  A solution of 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 
equiv.) in dry acetone (6.0 mL) was added. The suspension was stirred for 1 hour and 3-nitrofluorobenzene (20.0 
PL, 0.188mmol) was added to the reaction mixture.  The yield (67 %) was determined by comparing integration of 
the peak of 1-fluoro-4-(trifluoromethoxy)benzene (±117.0 ppm) with that of 3-nitrofluorobenzene (±112.0 ppm).  
 
4-(T rifluoromethoxy)biphenyl8 (21) 
To a solution of sodium hydroxide in anhydrous methanol (1.00 N, 0.500 mL, 1.00 equiv) at 23 ºC was added 
biphenyl boronic acid (99.0 mg, 0.500 mmol, 1.00 equiv) and stirred for 15 minutes.  The reaction mixture was then 
cooled to 0 ºC and silver hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) was added and the suspension was 
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stirred for 30 minutes at 0 ºC.  The solvent was removed under reduced pressure at 0 ºC, and the residual methanol 
was removed under reduced pressure by co-evaporation with anhydrous THF (2 × 0.500 mL). To the residue was 
added anhydrous THF (2.0 mL) and then tris(dimethylamino)sulfonium difluorotrimethylsilicate (276 mg, 1.00 
mmol, 2.00 equiv) and sodium bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv) successively.  The reaction was cooled 
to ±30 ºC and to the suspension was added trifluoromethyl trifluoromethanesulfonate (3) (0.60 g, 0.40 mL, 2.8 
mmol, 5.5 equiv) and the suspension was then stirred at ±30 ºC for 30 minutes.  A solution of 1-chloromethyl-4-
fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 equiv.) in dry 
acetone (6.0 mL) was added. The suspension was stirred for 1 hour and then filtered through a pad of celite eluting 
with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column chromatography on silica 
gel eluting with pentane/CH2Cl2 20:1 (v/v) to afford 86.2 mg of the title compound as a white solid (72% yield). 
Rf = 0.53 (hexanes/CH2Cl2 19:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.64±7.59 (m, 
4H), 7.51±7.48 (m, 2 H), 7.41 (t, J = 7.3 Hz, 1H), 7.34 (d, J = 8.2 Hz, 2H).  13C NMR (100 MHz, CDCl3, 23 °C, G): 
148.8 (q, J = 2 Hz), 140.1, 140.0, 129.0, 128.6, 127.8, 127.3, 121.4, 120.7 (q, J = 256 Hz).  19F NMR (375 MHz, 
CDCl3, 23 °C, G): ±58.2.  These spectroscopic data correspond to previously reported data.8  
 
1-Methoxy-4-(tr ifluoromethoxy)benzene (24) 
To a solution of sodium hydroxide in anhydrous methanol (1.00 N, 0.500 mL, 1.00 equiv) at 23 ºC was added 4-
methoxyphenylboronic acid (76.0 mg, 0.500 mmol, 1.00 equiv) and stirred for 15 minutes.  The reaction mixture 
was then cooled to 0 ºC and silver hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) was added and the 
suspension was stirred for 30 minutes at 0 ºC.  The solvent was removed under reduced pressure at 0 ºC, and the 
residual methanol was removed under reduced pressure by co-evaporation with anhydrous THF (2 × 0.500 mL). To 
the residue was added anhydrous THF (2.0 mL) and then tris(dimethylamino)sulfonium difluorotrimethylsilicate 
(276 mg, 1.00 mmol, 2.00 equiv) and sodium bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv) successively.  The 
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reaction was cooled to ±30 ºC and to the suspension was added trifluoromethyl trifluoromethanesulfonate (3) (0.60 
g, 0.40 mL, 2.8 mmol, 5.5 equiv) and the suspension was then stirred at ±30 ºC for 30 minutes.  A solution of 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 
equiv.) in dry acetone (6.0 mL) was added. The suspension was stirred for 1 hour and then filtered through a pad of 
celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column 
chromatography on silica gel eluting with pentane/Et2O 5:1 (v/v) to afford 60.5 mg of the title compound as a pale 
yellow oil (63% yield). 
Rf = 0.48 (pentane/CH2Cl2 9:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.15 (d, J = 8.5 
Hz, 2H), 6.89 (d, J = 9.0 Hz, 2H), 3.81 (s, 3H).  13C NMR (125 MHz, CDCl3, 23 °C, G): 158.3, 142.9 (q, J = 2 Hz), 
122.6, 120.8 (q, J = 254 Hz), 114.8, 55.7.  19F NMR (470 MHz, CDCl3, 23 °C, G): ±58.9.  These spectroscopic data 
correspond to those obtained from an authentic sample purchased from Strem. 
 
5-T rifluoromethoxy-N-Boc-indole (28) 
To a solution of sodium hydroxide in anhydrous methanol (1.00 N, 0.500 mL, 1.00 equiv) at 23 ºC was added N-
Boc-indol-5-ylboronic acid (130.5 mg, 0.500 mmol, 1.00 equiv) and stirred for 15 minutes.  The reaction mixture 
was then cooled to 0 ºC and silver hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) was added and the 
suspension was stirred for 30 minutes at 0 ºC.  The solvent was removed under reduced pressure at 0 ºC, and the 
residual methanol was removed under reduced pressure by co-evaporation with anhydrous THF (2 × 0.500 mL). To 
the residue was added anhydrous THF (2.0 mL) and then tris(dimethylamino)sulfonium difluorotrimethylsilicate 
(276 mg, 1.00 mmol, 2.00 equiv) and sodium bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv) successively.  The 
reaction was cooled to ±30 ºC and to the suspension was added trifluoromethyl trifluoromethanesulfonate (3) (0.60 
g, 0.40 mL, 2.8 mmol, 5.5 equiv) and the suspension was then stirred at ±30 ºC for 30 minutes.  A solution of 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 
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equiv.) in dry acetone (6.0 mL) was added. The suspension was stirred for 1 hour and then filtered through a pad of 
celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column 
chromatography on silica gel eluting with pentane/CH2Cl2 10:1 (v/v) to afford 114 mg of the title compound as a 
pale yellow oil (76% yield). 
Rf = 0.70 (hexanes/CH2Cl2 1:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 8.17 (d, J = 7.8 
Hz, 1H), 7.66 (d, J = 3.4 Hz, 1H), 7.42 (s, 1H), 7.18 (d, J = 7.3 Hz, 1H), 6.57 (d, J = 3.4 Hz, 1H), 1.68 (s, 9H).  13C 
NMR (125 MHz, CDCl3, 23 °C, G): 149.4, 145.0 (q, J = 2 Hz), 133.6, 131.3, 127.8, 123.9 (q, J = 256 Hz), 117.8, 
116.1, 113.4, 107.2, 84.3, 28.3.  19F NMR (375 MHz, CDCl3, 23 °C, G): ±58.5.  Mass Spectrometry: HRMS-FIA 
(m/z): Calcd for C9H7F3NO [M ± C5H9O2 (Boc) + H]+, 202.0480. Found, 202.0485. 
 
2-(T rifluoromethoxy)naphthalene15 (34) 
To a solution of sodium hydroxide in anhydrous methanol (1.00 N, 0.500 mL, 1.00 equiv) at 23 ºC was added 2-
naphthylboronic acid (30) (86.0 mg, 0.500 mmol, 1.00 equiv) and stirred for 15 minutes.  The reaction mixture was 
then cooled to 0 ºC and silver hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) was added and the suspension 
was stirred for 30 minutes at 0 ºC.  The solvent was removed under reduced pressure at 0 ºC, and the residual 
methanol was removed under reduced pressure by co-evaporation with anhydrous THF (2 × 0.500 mL). To the 
residue was added anhydrous THF (2.0 mL) and then tris(dimethylamino)sulfonium difluorotrimethylsilicate (276 
mg, 1.00 mmol, 2.00 equiv) and sodium bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv) successively.  The reaction 
was cooled to ±30 ºC and to the suspension was added trifluoromethyl trifluoromethanesulfonate (3) (0.60 g, 0.40 
mL, 2.8 mmol, 5.5 equiv) and the suspension was then stirred at ±30 ºC for 30 minutes.  A solution of 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 
equiv.) in dry acetone (6.0 mL) was added. The suspension was stirred for 1 hour and then filtered through a pad of 
                                                          
15 Schlosser, M.; Castagnetti, E. Eur. J. Org. Chem. 2001, 3991. 
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celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column 
chromatography on silica gel eluting with pentane/CH2Cl2 9:1 (v/v) to afford 68.2 mg of the title compound as a pale 
yellow oil (64% yield). 
Rf = 0.75 (pentane/CH2Cl2 9:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.89±7.83 (m, 
3H), 7.68 (s, 1H), 7.56±7.52 (m, 2H), 7.35 (d, J = 7.3 Hz, 1H).  13C NMR (100 MHz, CDCl3, 23 °C, G): 147.0 (q, J = 
2 Hz), 133.7, 131.9, 130.2, 127.9, 127.2, 126.5, 120.8 (q, J = 258 Hz), 120.3, 118.3.* 19F NMR (375 MHz, CDCl3, 
23 °C, G): ±59.2.  These spectroscopic data correspond to previously reported data.15 *Only 9 aromatic carbon 
signals observed due to overlap of two carbon signals 
 
Methyl 3-methyl-5-(trifluoromethoxy)benzoate (35) 
To a solution of sodium hydroxide in anhydrous methanol (1.00 N, 0.500 mL, 1.00 equiv) at 23 ºC was added 3-
methoxycarbonyl-5-methylphenylboronic acid (32) (97.0 mg, 0.500 mmol, 1.00 equiv) and stirred for 15 minutes.  
The reaction mixture was then cooled to 0 ºC and silver hexafluorophosphate (252 mg, 1.00 mmol, 2.00 equiv) was 
added and the suspension was stirred for 30 minutes at 0 ºC.  The solvent was removed under reduced pressure at 0 
ºC, and the residual methanol was removed under reduced pressure by co-evaporation with anhydrous THF (2 × 
0.500 mL). To the residue was added anhydrous THF (2.0 mL) and then tris(dimethylamino)sulfonium 
difluorotrimethylsilicate (276 mg, 1.00 mmol, 2.00 equiv) and sodium bicarbonate (84.0 mg, 1.00 mmol, 2.00 equiv) 
successively.  The reaction was cooled to ±30 ºC and to the suspension was added trifluoromethyl 
trifluoromethanesulfonate (3) (0.60 g, 0.40 mL, 2.8 mmol, 5.5 equiv) and the suspension was then stirred at ±30 ºC 
for 30 minutes.  A solution of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) 
(2) (282 mg, 0.600 mmol, 1.20 equiv.) in dry acetone (6.0 mL) was added. The suspension was stirred for 1 hour 
and then filtered through a pad of celite eluting with CH2Cl2 and the filtrate concentrated in vacuo.  The residue was 
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purified via column chromatography on silica gel eluting with pentane/CH2Cl2 4:1 (v/v) to afford 75.6 mg of the title 
compound as a colorless oil (65% yield). 
Rf = 0.57 (pentane/CH2Cl2 3:1 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 7.80 (s, 1H), 7.69 
(s, 1H), 7.22 (s, 1H), 3.93 (s, 3H), 2.43 (s, 3H).  13C NMR (125 MHz, CDCl3, 23 °C, G): 166.1, 149.3 (q, J = 2 Hz), 
140.6, 131.9, 128.8, 126.2, 120.6 (q, J = 258 Hz), 119.3, 52.6, 21.4.  19F NMR (470 MHz, CDCl3, 23 °C, G): ±59.4.  
Mass Spectrometry: HRMS-FIA (m/z): Calcd for C10H9F3O3 [M + H]+, 235.0577. Found, 235.0590. 
4.2. Synthesis of 3-deoxy-3-fluoromorphine 
 
Methyl 3-deoxy-3-fluoro-normorphine-carboxylate (37) 
To a suspension of tris(dimethylamino)sulfonium difluorotrimethylsilicate (551 mg, 2.00 mmol, 4.00 equiv), and 
sodium bicarbonate (84.0 mg, 1.80 mmol, 2.00 equiv) in anhydrous THF (2.00 P/ DW í & ZDV DGGHG
trifluoromethyl trifluoromethanesulfonate (3) (763 mg, ȝ/ mmol, 7.0 equiv), and the suspension was stirred 
vigorously.  The reaction mixture was stirred at í50 °C for 30 minutes, then a solution cooled to í50 °C of 1-
chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(hexafluorophosphate) (2) (282 mg, 0.600 mmol, 1.20 
equiv) and silver hexafluorophosphate (253 mg, 1.00 mmol, 2.00 equiv) in dry acetone (4.00 mL) was added by 
cannula.  Immediately afterwards, a solution of methyl 3-deoxy-3-tributylstannyl-normorphine-carboxylate (19) 
(301 mg, 0.500 mmol, 1.00 equiv) in dry acetone (2.00 mL) is added dropwise.  The reaction mixture was stirred for 
4 hours in the dark, then warmed to 23 °C.  The reaction mixture was filtered through a pad of celite eluting with 
CH2Cl2 and the filtrate concentrated in vacuo.  The residue was purified via column chromatography on silica gel 
eluting with hexanes/acetone 3:1 (v/v) and then by prepTLC with EtOAc/hexanes 3:2 (v/v) as the eluent to afford 
39.0 mg of the title compound as a clear foam (24% yield). 
Rf = 0.29 (EtOAc/hex 3:2 (v/v)).  NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 °C, G): 6.83 (dd, J = 2.3 Hz, 
9.5 Hz, 1H), 6.56 (dd, J = 5.5 Hz, 11.5 Hz, 1H), 5.77 (d, J = 8.5 Hz, 1H), 5.33±5.27 (m, 1H), 4.98±4.82 (m, 2H), 
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4.22±4.00 (m, 3H), 3.75 (s, 3H),* 3.03±2.73 (m, 3H), 2.55 (s, 1H), 1.99±1.90 (m, 2H).  13C NMR (100 MHz, CDCl3, 
23 °C, G):155.6, 145.6 (d, J = 244 Hz), 134.4, 134.2, 131.9, 129.1, 127.0 (d, J = 19.8 Hz), 120.3, 116.6 (d, J = 18.3 
Hz), 92.2, 66.1, 52.9, 50.2, 43.6, 39.6,* 37.3, 34.6, 29.6*.  19F NMR (280 MHz, CDCl3, 23 °C, G): ±139.2.  Mass 
Spectrometry: HRMS-FIA (m/z): Calcd for C18H18FNO4 [M + H]+, 332.1292. Found, 332.1286.  *Two signals 
attributed to a mixture of rotamers 
 
3-Deoxy-3-fluoromorphine (T L-270) 
To methyl 3-deoxy-3-fluoro-normorphine-carboxylate (37) (34.5 mg, 0.104 mmol, 1.00 equiv) in THF (0.5 mL) is 
added lithium aluminum hydride (1.0 M solution in THF) (520 ȝ/PPROHTXLY  The reaction mixture 
is stirred for 30 min at 23 °C.  7KH UHDFWLRQ LV TXHQFKHGZLWK 0 VROXWLRQ RI5RFKHOOH¶V VDOW.  The resulting 
solution is diluted with Et2O (2 mL) and stirred vigorously overnight.  The aqueous layer is extracted with Et2O (10 
× 1 mL), washed with brine (5 mL), dried (Na2SO4), and the filtrate is concentrated in vacuo.  The resulting residue 
is purified by chromatography on silica gel eluting with CH2Cl2/MeOH 9:1 (v/v) to afford 23.4 mg of the title 
compound as a white solid (78% yield). 
Rf = 0.05 (CH2Cl2/MeOH 9:1 (v/v)).   NMR Spectroscopy: 1H NMR (500 MHz, CDCl3, 23 ºC, G): 6.81 (dd, J = 8.5 
Hz, 5.35 Hz, 1H), 6.55 (dd, J = 3.5 Hz, 3.8 Hz, 1H), 5.71 (dd, J = 1.5 Hz, 5.0 Hz, 1H), 5.30±5.28 (m, 1H), 4.95 (d, J 
= 6.0 Hz, 1H), 4.21±4.20 (m, 1H), 3.37 (dd, J = 3.0 Hz, 2.8 Hz, 1H), 3.07 (d, J = 18.5 Hz, 1H), 2.68 (s, 1H), 2.62 
(dd, J = 4.5 Hz, 6.0 Hz, 1H), 2.43 (s, 3H), 2.40 (dt, J = 3.5 Hz, 12.3 Hz, 6.1 Hz, 1H), 2.31 (dd, J = 5.5 Hz, 9.3 Hz, 
1H), 2.11 (dt, J = 5.0 Hz, 12.4 Hz, 6.1 Hz, 1H), 1.89±1.87 (m, 1H).  13C NMR (125 MHz, CDCl3, 23 ºC, G): 146.4 
(d, J = 244 Hz), 144.3 (d, J = 10.1 Hz), 133.26, 133.1 (d, J = 2.75 Hz), 130.3, 128.4, 119.8 (d, J = 4.58 Hz), 115.97 
(d, J = 17.4 Hz), 92.4, 66.4, 58.7, 46.2, 43.2, 43.0, 40.7, 35.6, 20.6. 19F NMR (280 MHz, CDCl3, 23 ºC, G):±139.8.  
Mass Spectrometry: HRMS-FIA (m/z): Calcd for [C17H18FNO2 + H]+, 288.1394. Found, 288.1396. 
